activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650522	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	1650522	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	1650523	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	1650524	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	1650525	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	1650526	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	1650527	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL2068	Homo sapiens	Kd		
	1650528	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	4800.0	CHEMBL2068	Homo sapiens	Kd	uM	4.8
Not Active	1650529	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	1650530	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL2068	Homo sapiens	Kd		
	1651621	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	870.0	CHEMBL2068	Homo sapiens	Kd	uM	0.87
Not Active	1651622	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	1651623	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL2068	Homo sapiens	Kd		
	1651624	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	2100.0	CHEMBL2068	Homo sapiens	Kd	uM	2.1
	1651625	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	3100.0	CHEMBL2068	Homo sapiens	Kd	uM	3.1
Not Active	1651626	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	1651627	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	1651628	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	1651629	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL2068	Homo sapiens	Kd		
	1651630	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1900.0	CHEMBL2068	Homo sapiens	Kd	uM	1.9
Not Active	1651631	CHEMBL860779	Average Binding Constant for EPHA2; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL2068	Homo sapiens	Kd		
	1744480	CHEMBL867308	Inhibition of EphA2	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	8000.0	CHEMBL2068	Homo sapiens	Ki	uM	8.0
	1824541	CHEMBL913852	Inhibition of EphA2	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL2068	Homo sapiens	Ki	uM	10.0
	1824715	CHEMBL913852	Inhibition of EphA2	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL2068	Homo sapiens	Ki	uM	10.0
	1824789	CHEMBL913852	Inhibition of EphA2	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL2068	Homo sapiens	Ki	uM	10.0
	1968055	CHEMBL895276	Inhibition of ECK	B	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1cccs1)n2CCCN		CHEMBL233338	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	1989382	CHEMBL898064	Inhibition of ECK at 1 uM	B	CC(C)NCc1ccc(Nc2cc(-c3ccc(-c4ccc(O)cc4O)cc3)[nH]n2)cc1	Outside typical range	CHEMBL398606	=	Inhibition	%	-11.0	CHEMBL2068	Homo sapiens	Inhibition	%	-11.0
	2000772	CHEMBL900482	Inhibition of EphA2 at 10 nM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCF)CC2)n1		CHEMBL240158	=	Inhibition	%	98.1	CHEMBL2068	Homo sapiens	Inhibition	%	98.1
	2000792	CHEMBL900482	Inhibition of EphA2 at 10 nM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	92.6	CHEMBL2068	Homo sapiens	Inhibition	%	92.6
	2051616	CHEMBL941754	Inhibition of EPHA2	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	8000.0	CHEMBL2068	Homo sapiens	Ki	uM	8.0
	2147106	CHEMBL934738	Inhibition of EphA2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Inhibition	%	69.0	CHEMBL2068	Homo sapiens	Inhibition	%	69.0
	2147247	CHEMBL922822	Activity of human EphA2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	31.0	CHEMBL2068	Homo sapiens	Activity	%	31.0
Not Active	2170353	CHEMBL930308	Activity at Eck at 10 uM	B	COc1c(NC(=O)c2ccc(C)c(N3C=C(C(=O)NCC(C)(C)CN(C)C)NN3)c2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL254992		Activity			CHEMBL2068	Homo sapiens	Activity		
	2182421	CHEMBL941320	Inhibition of EphA2 at 1 uM	B	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1		CHEMBL514554	=	Inhibition	%	15.0	CHEMBL2068	Homo sapiens	INH	%	15.0
	2182856	CHEMBL945530	Inhibition of EPHA2 at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12	Outside typical range	CHEMBL179242	=	Inhibition	%	-13.0	CHEMBL2068	Homo sapiens	INH	%	-13.0
	2200437	CHEMBL997067	Inhibition of EPHA2	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	137.0	CHEMBL2068	Homo sapiens	IC50	nM	137.0
	2239372	CHEMBL980061	Inhibition of EphA2 assessed as residual enzyme activity at 1 uM	B	Cc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)s1		CHEMBL462132	=	Activity	%	5.0	CHEMBL2068	Homo sapiens	Activity	%	5.0
	2264679	CHEMBL1011753	Binding affinity to EPHA2 at 10 uM	B	O=C(NOCCO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL244488	=	Inhibition	%	9.0	CHEMBL2068	Homo sapiens	INH	%	9.0
	2264680	CHEMBL1011753	Binding affinity to EPHA2 at 10 uM	B	O=C(NOCCO)c1cc(COCCO)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL464238	=	Inhibition	%	13.0	CHEMBL2068	Homo sapiens	INH	%	13.0
	2264681	CHEMBL1011753	Binding affinity to EPHA2 at 10 uM	B	O=C(NOCCO)c1cc(/C=N/OCCO)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL464239	=	Inhibition	%	9.0	CHEMBL2068	Homo sapiens	INH	%	9.0
	2264682	CHEMBL1011753	Binding affinity to EPHA2 at 10 uM	B	COCCCNC(=O)N/N=C/c1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL518248	=	Inhibition	%	7.0	CHEMBL2068	Homo sapiens	INH	%	7.0
	2264683	CHEMBL1011753	Binding affinity to EPHA2 at 10 uM	B	O=C(O)CCCO/N=C/c1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL464257	=	Inhibition	%	37.0	CHEMBL2068	Homo sapiens	INH	%	37.0
	2264684	CHEMBL1011753	Binding affinity to EPHA2 at 10 uM	B	O=C(O)c1ccc(CO/N=C/c2cc(C(=O)NOCCO)c(Nc3ccc(I)cc3F)c(F)c2F)o1		CHEMBL464258	=	Inhibition	%	22.0	CHEMBL2068	Homo sapiens	INH	%	22.0
	2264737	CHEMBL963870	Binding affinity to ECK	B	CS(=O)(=O)c1ccc(CNCc2cc(C(=O)O)c(Nc3ccc(I)cc3F)c(F)c2F)cc1		CHEMBL465465	>	IC50	nM	30000.0	CHEMBL2068	Homo sapiens	IC50	uM	30.0
	2264738	CHEMBL963870	Binding affinity to ECK	B	NC(=O)C[C@H](N)C(=O)NCc1cc(C(=O)O)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL517647	>	IC50	nM	30000.0	CHEMBL2068	Homo sapiens	IC50	uM	30.0
	2264739	CHEMBL963870	Binding affinity to ECK	B	O=C(N/N=C/c1cc(C(=O)O)c(Nc2ccc(I)cc2F)c(F)c1F)c1ccc(CO)o1		CHEMBL481968	=	IC50	nM	3000.0	CHEMBL2068	Homo sapiens	IC50	uM	3.0
	2264740	CHEMBL963870	Binding affinity to ECK	B	O=C(CS(=O)(=O)c1ccc(Cl)cc1)N/N=C/c1cc(C(=O)O)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL481969	>	IC50	nM	30000.0	CHEMBL2068	Homo sapiens	IC50	uM	30.0
Not Active	2302217	CHEMBL945710	Inhibition of human EPHA2 at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	2470169	CHEMBL1034118	Inhibition of EPHA2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2068	Homo sapiens	INH	%	10.0
	2476665	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	12.4	CHEMBL2068	Homo sapiens	Activity	%	12.4
Not Evaluated	2476868	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Evaluated	2478707	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL2068	Homo sapiens	Activity		
	2479544	CHEMBL988938	Binding affinity to human EPHA2	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Kd	nM	8.0	CHEMBL2068	Homo sapiens	Kd	nM	8.0
Not Evaluated	2479765	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Evaluated	2480562	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL2068	Homo sapiens	Activity		
	2480764	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	1.5	CHEMBL2068	Homo sapiens	Activity	%	1.5
	2527195	CHEMBL984176	Inhibition of ECK	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL451523	=	IC50	nM	5200.0	CHEMBL2068	Homo sapiens	IC50	uM	5.2
Not Evaluated	2577386	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL2068	Homo sapiens	Activity		
	2593591	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	6.2	CHEMBL2068	Homo sapiens	Activity	%	6.2
	2593794	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	0.1	CHEMBL2068	Homo sapiens	Activity	%	0.1
Not Evaluated	2593857	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Evaluated	2594060	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Evaluated	2595003	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL2068	Homo sapiens	Activity		
	2595272	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	3.6	CHEMBL2068	Homo sapiens	Activity	%	3.6
Not Evaluated	2596200	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Evaluated	2596403	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Evaluated	2597672	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Evaluated	2597875	CHEMBL1024917	Binding affinity to human EPHA2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL2068	Homo sapiens	Activity		
	2691858	CHEMBL1054682	Inhibition of human EphA2 assessed as remaining activity at 10 uM	B	Cc1ccccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL551717	=	Activity	%	93.0	CHEMBL2068	Homo sapiens	Activity	%	93.0
Active	2719537	CHEMBL1059987	Inhibition of EphA2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL556140		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	2721021	CHEMBL1061754	Inhibition of EphA2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
Antagonist	2897297	CHEMBL1062882	Inhibition of Eph-A2 in the presence of 50uM ATP	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	IC50	nM	760.0	CHEMBL2068	Homo sapiens	IC50	uM	0.76
	2904821	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904822	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904823	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	160.0	CHEMBL2068	Homo sapiens	Kd	nM	160.0
	2904824	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904825	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	6200.0	CHEMBL2068	Homo sapiens	Kd	nM	6200.0
	2904826	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904827	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904828	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	2900.0	CHEMBL2068	Homo sapiens	Kd	nM	2900.0
	2904829	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904830	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904831	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904832	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.85	CHEMBL2068	Homo sapiens	Kd	nM	0.85
	2904833	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904834	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904835	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	2500.0	CHEMBL2068	Homo sapiens	Kd	nM	2500.0
	2904836	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904837	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904838	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904839	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904840	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904841	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904842	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904843	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904844	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	370.0	CHEMBL2068	Homo sapiens	Kd	nM	370.0
	2904845	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904846	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904847	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904848	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904849	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904850	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904851	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904852	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2000.0	CHEMBL2068	Homo sapiens	Kd	nM	2000.0
	2904853	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1200.0	CHEMBL2068	Homo sapiens	Kd	nM	1200.0
	2904854	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904855	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904856	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	840.0	CHEMBL2068	Homo sapiens	Kd	nM	840.0
	2904857	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	2904858	CHEMBL1051287	Binding constant for EPHA2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1100.0	CHEMBL2068	Homo sapiens	Kd	nM	1100.0
	2921359	CHEMBL1056099	Inhibition of EPHA2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	2.8	CHEMBL2068	Homo sapiens	Activity	%	2.8
	2926252	CHEMBL1056925	Inhibition of EPHA2 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	10.0	CHEMBL2068	Homo sapiens	Activity	%	10.0
	2926273	CHEMBL1046771	Inhibition of EphA2 by [gamma33-P]ATP based assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	IC50	nM	2.3	CHEMBL2068	Homo sapiens	IC50	nM	2.3
	2928438	CHEMBL1055349	Inhibition of EPHA2 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	7.0	CHEMBL2068	Homo sapiens	Activity	%	7.0
	2992205	CHEMBL1044508	Inhibition of human EPHA2 at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	23.0	CHEMBL2068	Homo sapiens	INH	%	23.0
	2999050	CHEMBL1044626	Inhibition of EPHA2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	79.0	CHEMBL2068	Homo sapiens	Activity	%	79.0
	2999840	CHEMBL1044626	Inhibition of EPHA2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	81.0	CHEMBL2068	Homo sapiens	Activity	%	81.0
	2999911	CHEMBL1050753	Inhibition of EPHA2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	97.0	CHEMBL2068	Homo sapiens	Activity	%	97.0
	2999987	CHEMBL1050753	Inhibition of EPHA2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	95.0	CHEMBL2068	Homo sapiens	Activity	%	95.0
	3005035	CHEMBL1049081	Inhibition of Eck	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989	>	IC50	nM	7000.0	CHEMBL2068	Homo sapiens	IC50	uM	7.0
	3006312	CHEMBL1049081	Inhibition of Eck	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887	>	IC50	nM	7000.0	CHEMBL2068	Homo sapiens	IC50	uM	7.0
	3006313	CHEMBL1049081	Inhibition of Eck	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922	>	IC50	nM	7000.0	CHEMBL2068	Homo sapiens	IC50	uM	7.0
	3006314	CHEMBL1049081	Inhibition of Eck	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601	>	IC50	nM	7000.0	CHEMBL2068	Homo sapiens	IC50	uM	7.0
	3052592	CHEMBL1037133	Residual activity of EPHA2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	109.0	CHEMBL2068	Homo sapiens	Residual activity	%	109.0
	3053901	CHEMBL1044301	Residual activity of EPHA2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	73.0	CHEMBL2068	Homo sapiens	Residual activity	%	73.0
	3054153	CHEMBL1049470	Residual activity of EPHA2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	99.0	CHEMBL2068	Homo sapiens	Residual activity	%	99.0
	3055440	CHEMBL1037133	Residual activity of EPHA2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	111.0	CHEMBL2068	Homo sapiens	Residual activity	%	111.0
	3055692	CHEMBL1044301	Residual activity of EPHA2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	190.0	CHEMBL2068	Homo sapiens	Residual activity	%	190.0
	3056997	CHEMBL1049470	Residual activity of EPHA2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	76.0	CHEMBL2068	Homo sapiens	Residual activity	%	76.0
	3058317	CHEMBL1037133	Residual activity of EPHA2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	97.0	CHEMBL2068	Homo sapiens	Residual activity	%	97.0
	3058569	CHEMBL1044301	Residual activity of EPHA2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	187.0	CHEMBL2068	Homo sapiens	Residual activity	%	187.0
	3062461	CHEMBL1037144	Binding affinity to human EPHA2 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	3063596	CHEMBL1039793	Binding affinity to human EPHA2 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	80.0	CHEMBL2068	Homo sapiens	Activity	%	80.0
	3063686	CHEMBL1047838	Binding affinity to human EPHA2 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	99.0	CHEMBL2068	Homo sapiens	Activity	%	99.0
	3065865	CHEMBL1069297	Inhibition of EPHA2 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	13.0	CHEMBL2068	Homo sapiens	INH	%	13.0
	3066931	CHEMBL1069297	Inhibition of EPHA2 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	13.0	CHEMBL2068	Homo sapiens	INH	%	13.0
	3072915	CHEMBL1049470	Residual activity of EPHA2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	94.0	CHEMBL2068	Homo sapiens	Residual activity	%	94.0
	3084431	CHEMBL1073294	Inhibition of EPHA2	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	3104124	CHEMBL1066392	Inhibition of recombinant EphA2 by TR-FRET assay	B	C[C@@H](Oc1ccc2ncc(/C=C/C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602471	=	IC50	nM	4400.0	CHEMBL2068	Homo sapiens	IC50	uM	4.4
	3104150	CHEMBL1066392	Inhibition of recombinant EphA2 by TR-FRET assay	B	C[C@@H](Oc1ccc2ncccc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL600795	>	IC50	nM	50000.0	CHEMBL2068	Homo sapiens	IC50	uM	50.0
	3104197	CHEMBL1066392	Inhibition of recombinant EphA2 by TR-FRET assay	B	C[C@@H](Oc1ccc2ncc(C3CC3C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602472	=	IC50	nM	5200.0	CHEMBL2068	Homo sapiens	IC50	uM	5.2
	3210399	CHEMBL1109426	Inhibition of EPHA2 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081198	=	IC50	nM	35.0	CHEMBL2068	Homo sapiens	IC50	uM	0.035
	3213798	CHEMBL1108385	Inhibition of EPHA2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	100.0	CHEMBL2068	Homo sapiens	INH	%	100.0
	3224806	CHEMBL1102800	Inhibition of EPHA2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	3225056	CHEMBL1102800	Inhibition of EPHA2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	3240802	CHEMBL1109665	Inhibition of EphA2	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	IC50	nM	370.0	CHEMBL2068	Homo sapiens	IC50	uM	0.37
	3260102	CHEMBL1108066	Inhibition of EPHA2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	26.0	CHEMBL2068	Homo sapiens	Activity	%	26.0
	3261371	CHEMBL1108066	Inhibition of EPHA2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	53.0	CHEMBL2068	Homo sapiens	Activity	%	53.0
	3331916	CHEMBL1169206	Inhibition of EPHA2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	3333331	CHEMBL1169206	Inhibition of EPHA2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	3334736	CHEMBL1169206	Inhibition of EPHA2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	3336156	CHEMBL1169206	Inhibition of EPHA2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	3337511	CHEMBL1169206	Inhibition of EPHA2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	3337760	CHEMBL1169206	Inhibition of EPHA2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	3339094	CHEMBL1169206	Inhibition of EPHA2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	3340396	CHEMBL1169206	Inhibition of EPHA2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	3340684	CHEMBL1169206	Inhibition of EPHA2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	3342100	CHEMBL1169206	Inhibition of EPHA2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	3358551	CHEMBL1174396	Inhibition of EPHA2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.4	CHEMBL2068	Homo sapiens	INH	%	0.4
	3358993	CHEMBL1174396	Inhibition of EPHA2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.35	CHEMBL2068	Homo sapiens	INH	%	0.35
	3359777	CHEMBL1177626	Inhibition EphA2 at 10 uM	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957	=	Inhibition	%	48.7	CHEMBL2068	Homo sapiens	INH	%	48.7
	3359778	CHEMBL1177625	Inhibition EphA2	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957	=	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	3443383	CHEMBL1244416	Inhibition of EPHA2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	87.0	CHEMBL2068	Homo sapiens	INH	%	87.0
	3443600	CHEMBL1244416	Inhibition of EPHA2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	77.0	CHEMBL2068	Homo sapiens	INH	%	77.0
	3444755	CHEMBL1244416	Inhibition of EPHA2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	78.0	CHEMBL2068	Homo sapiens	INH	%	78.0
	3445102	CHEMBL1244813	Binding affinity to EPHA2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	790.0	CHEMBL2068	Homo sapiens	Kd	nM	790.0
	3445379	CHEMBL1244416	Inhibition of EPHA2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	65.0	CHEMBL2068	Homo sapiens	INH	%	65.0
	3445596	CHEMBL1244416	Inhibition of EPHA2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	39.0	CHEMBL2068	Homo sapiens	INH	%	39.0
	3445805	CHEMBL1244416	Inhibition of EPHA2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	88.0	CHEMBL2068	Homo sapiens	INH	%	88.0
	3445995	CHEMBL1244416	Inhibition of EPHA2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	61.0	CHEMBL2068	Homo sapiens	INH	%	61.0
	3448410	CHEMBL1244813	Binding affinity to EPHA2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	3448735	CHEMBL1244813	Binding affinity to EPHA2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	3449418	CHEMBL1244813	Binding affinity to EPHA2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2000.0	CHEMBL2068	Homo sapiens	Kd	nM	2000.0
	3449646	CHEMBL1244813	Binding affinity to EPHA2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	3450326	CHEMBL1244813	Binding affinity to EPHA2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	3450978	CHEMBL1244813	Binding affinity to EPHA2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	3463216	CHEMBL1252304	Inhibition of EPHA2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	8.0	CHEMBL2068	Homo sapiens	INH	%	8.0
	3463435	CHEMBL1252304	Inhibition of EPHA2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	24.0	CHEMBL2068	Homo sapiens	INH	%	24.0
	3463979	CHEMBL1252304	Inhibition of EPHA2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	22.0	CHEMBL2068	Homo sapiens	INH	%	22.0
Not Active	3499126	CHEMBL1259870	Inhibition of EPHA2 at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	3526788	CHEMBL1272380	Inhibition of EphA2 by Hot Spot filtration binding assay	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	IC50	nM	11.0	CHEMBL2068	Homo sapiens	IC50	uM	0.011
	3526796	CHEMBL1272380	Inhibition of EphA2 by Hot Spot filtration binding assay	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)ccn1		CHEMBL324153	=	IC50	nM	250.0	CHEMBL2068	Homo sapiens	IC50	uM	0.25
	3526804	CHEMBL1272380	Inhibition of EphA2 by Hot Spot filtration binding assay	B	O=c1ccc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)c[nH]1		CHEMBL1271480	=	IC50	nM	260.0	CHEMBL2068	Homo sapiens	IC50	uM	0.26
	3526812	CHEMBL1272380	Inhibition of EphA2 by Hot Spot filtration binding assay	B	c1cc(-c2cnc3c(-c4cn[nH]c4)cnn3c2)ccc1OCCN1CCOCC1		CHEMBL1271532	=	IC50	nM	300.0	CHEMBL2068	Homo sapiens	IC50	uM	0.3
	3526820	CHEMBL1272380	Inhibition of EphA2 by Hot Spot filtration binding assay	B	Nc1cc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)ccn1		CHEMBL1271533	=	IC50	nM	840.0	CHEMBL2068	Homo sapiens	IC50	uM	0.84
	3526828	CHEMBL1272380	Inhibition of EphA2 by Hot Spot filtration binding assay	B	Oc1ccc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)cc1O		CHEMBL1271641	=	IC50	nM	740.0	CHEMBL2068	Homo sapiens	IC50	uM	0.74
	3526836	CHEMBL1272380	Inhibition of EphA2 by Hot Spot filtration binding assay	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccc(O)c(O)c3)o2)cc1		CHEMBL1271642	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	3526844	CHEMBL1272380	Inhibition of EphA2 by Hot Spot filtration binding assay	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccc(=O)[nH]c3)o2)cc1		CHEMBL1271692	=	IC50	nM	5600.0	CHEMBL2068	Homo sapiens	IC50	uM	5.6
	5120337	CHEMBL1645948	Inhibition of human EphA2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	102.0	CHEMBL2068	Homo sapiens	INH	%	102.0
	5120823	CHEMBL1646807	Inhibition of EPHA2 at 10 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	10.0	CHEMBL2068	Homo sapiens	INH	%	10.0
	5133692	CHEMBL1648720	Inhibition of EPHA2 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	73.0	CHEMBL2068	Homo sapiens	Activity	%	73.0
	5133787	CHEMBL1648720	Inhibition of EPHA2 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	84.0	CHEMBL2068	Homo sapiens	Activity	%	84.0
	5133884	CHEMBL1648720	Inhibition of EPHA2 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	87.0	CHEMBL2068	Homo sapiens	Activity	%	87.0
	5140523	CHEMBL1646071	Inhibition of EPHA2 at 1 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	10.0	CHEMBL2068	Homo sapiens	INH	%	10.0
	5191457	CHEMBL1664085	Inhibition of EPHA2 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	10.0	CHEMBL2068	Homo sapiens	INH	%	10.0
	5191458	CHEMBL1664085	Inhibition of EPHA2 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	43.0	CHEMBL2068	Homo sapiens	INH	%	43.0
	5242961	CHEMBL1685655	Inhibition of EphA2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	25.0	CHEMBL2068	Homo sapiens	INH	%	25.0
	5243800	CHEMBL1685904	Inhibition of EphA2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	7.0	CHEMBL2068	Homo sapiens	INH	%	7.0
	5243913	CHEMBL1685655	Inhibition of EphA2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	47.0	CHEMBL2068	Homo sapiens	INH	%	47.0
	5244021	CHEMBL1685904	Inhibition of EphA2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	13.0	CHEMBL2068	Homo sapiens	INH	%	13.0
	5244894	CHEMBL1685655	Inhibition of EphA2 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	128.0	CHEMBL2068	Homo sapiens	INH	%	128.0
	5245002	CHEMBL1685904	Inhibition of EphA2 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	102.0	CHEMBL2068	Homo sapiens	INH	%	102.0
	5245153	CHEMBL1685655	Inhibition of EphA2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	63.0	CHEMBL2068	Homo sapiens	INH	%	63.0
	5245983	CHEMBL1685904	Inhibition of EphA2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	40.0	CHEMBL2068	Homo sapiens	INH	%	40.0
	5310427	CHEMBL1693591	Inhibition of EPHA2	B	CN(C)Cc1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1		CHEMBL1688860	=	IC50	nM	18.0	CHEMBL2068	Homo sapiens	IC50	nM	18.0
	5310428	CHEMBL1693591	Inhibition of EPHA2	B	CC(C)(N)c1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1		CHEMBL1688861	=	IC50	nM	11.0	CHEMBL2068	Homo sapiens	IC50	nM	11.0
	6171347	CHEMBL1768696	Inhibition of EPH-A2	B	CC(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1		CHEMBL1766529	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	nM	10000.0
	6193896	CHEMBL1777655	Inhibition of EPHA2 at 10 uM by ELISA based method	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177	=	Inhibition	%	24.0	CHEMBL2068	Homo sapiens	INH	%	24.0
	6193907	CHEMBL1777655	Inhibition of EPHA2 at 10 uM by ELISA based method	B	Oc1ccc(NCn2nnc3ccccc32)cc1		CHEMBL1775067	=	Inhibition	%	38.2	CHEMBL2068	Homo sapiens	INH	%	38.2
	6193918	CHEMBL1777655	Inhibition of EPHA2 at 10 uM by ELISA based method	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	70.7	CHEMBL2068	Homo sapiens	INH	%	70.7
	6198116	CHEMBL1776207	Inhibition of EphA2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	6210065	CHEMBL1781032	Inhibition of EPHA2 at 4 uM by mobility shift assay	B	Cc1cc(-c2cccc(N)c2)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL1778718	=	Inhibition	%	4.9	CHEMBL2068	Homo sapiens	INH	%	4.9
	6212371	CHEMBL1786255	Inhibition of EphA2 expressed in Bac-to-Bac Baculovirus expression system using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784725	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	6219889	CHEMBL1785577	Inhibition of human EPHA2 using poly[Glu:Tyr] peptide substrate by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	=	IC50	nM	0.6	CHEMBL2068	Homo sapiens	IC50	nM	0.6
	6264919	CHEMBL1799802	Inhibition of EPHA2 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL2068	Homo sapiens	INH	%	65.0
	6265643	CHEMBL1799802	Inhibition of EPHA2 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL2068	Homo sapiens	INH	%	65.0
	6304892	CHEMBL1816283	Inhibition of EPHA2	B	O=C(Nc1ccc(Oc2ncnc3scc(-c4ccccc4)c23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL1813632	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	nM	10000.0
	6339943	CHEMBL1826626	Activity of EPHA2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	78.0	CHEMBL2068	Homo sapiens	Activity	%	78.0
	6352202	CHEMBL1825739	Inhibition of EPHA2 assessed as residual activity at 10 uM by radioactivity assay in presence of 50 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	101.0	CHEMBL2068	Homo sapiens	Activity	%	101.0
	7567349	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7567808	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7568305	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	3.8	CHEMBL2068	Homo sapiens	Kd	nM	3.8
	7568737	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7569322	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7569812	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7570275	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7570702	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7571298	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7571313	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	100.0	CHEMBL2068	Homo sapiens	Kd	nM	100.0
	7571789	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7572252	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7572668	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	890.0	CHEMBL2068	Homo sapiens	Kd	nM	890.0
	7573294	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.85	CHEMBL2068	Homo sapiens	Kd	nM	0.85
	7573770	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	6100.0	CHEMBL2068	Homo sapiens	Kd	nM	6100.0
	7574239	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7574647	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7574815	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	2900.0	CHEMBL2068	Homo sapiens	Kd	nM	2900.0
	7575276	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7575747	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7576212	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7576620	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	4400.0	CHEMBL2068	Homo sapiens	Kd	nM	4400.0
	7576789	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7577248	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	3.6	CHEMBL2068	Homo sapiens	Kd	nM	3.6
	7577726	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1500.0	CHEMBL2068	Homo sapiens	Kd	nM	1500.0
	7578196	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	620.0	CHEMBL2068	Homo sapiens	Kd	nM	620.0
	7578601	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1100.0	CHEMBL2068	Homo sapiens	Kd	nM	1100.0
	7578797	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7579171	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	6200.0	CHEMBL2068	Homo sapiens	Kd	nM	6200.0
	7579621	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	2500.0	CHEMBL2068	Homo sapiens	Kd	nM	2500.0
	7580095	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7581155	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7581540	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7581985	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7582478	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7582878	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	840.0	CHEMBL2068	Homo sapiens	Kd	nM	840.0
	7583501	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7583898	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7584343	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7584372	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7584834	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	140.0	CHEMBL2068	Homo sapiens	Kd	nM	140.0
	7585238	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7585831	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7586239	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7586714	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7587168	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7588222	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7588693	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7589144	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7589315	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7589739	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	790.0	CHEMBL2068	Homo sapiens	Kd	nM	790.0
	7590206	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7590680	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7591131	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7591288	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7591710	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7592182	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7592655	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	370.0	CHEMBL2068	Homo sapiens	Kd	nM	370.0
	7593108	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	18.0	CHEMBL2068	Homo sapiens	Kd	nM	18.0
	7593255	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	160.0	CHEMBL2068	Homo sapiens	Kd	nM	160.0
	7593690	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	2900.0	CHEMBL2068	Homo sapiens	Kd	nM	2900.0
	7594162	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7594635	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	230.0	CHEMBL2068	Homo sapiens	Kd	nM	230.0
	7595223	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7595667	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7596141	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7596617	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2000.0	CHEMBL2068	Homo sapiens	Kd	nM	2000.0
	7597195	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7597648	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7598121	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7598149	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	nM	10000.0
	7598591	CHEMBL1908648	Binding constant for EPHA2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1200.0	CHEMBL2068	Homo sapiens	Kd	nM	1200.0
	7939636	CHEMBL1919596	Inhibition of human EphA2	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	7959737	CHEMBL1932843	Inhibition of EPHA2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	=	IC50	nM	16000.0	CHEMBL2068	Homo sapiens	IC50	uM	16.0
	7959738	CHEMBL1932843	Inhibition of EPHA2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	160.0	CHEMBL2068	Homo sapiens	IC50	uM	0.16
	7969714	CHEMBL1931214	Inhibition of EPHA2 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	29.0	CHEMBL2068	Homo sapiens	Activity	%	29.0
	7991928	CHEMBL1937682	Inhibition of EPH-A2 at 10 uM	B	Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934300	=	Inhibition	%	53.2	CHEMBL2068	Homo sapiens	INH	%	53.2
	7991929	CHEMBL1937682	Inhibition of EPH-A2 at 10 uM	B	CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934301	=	Inhibition	%	22.8	CHEMBL2068	Homo sapiens	INH	%	22.8
	7991930	CHEMBL1937682	Inhibition of EPH-A2 at 10 uM	B	CCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934302	=	Inhibition	%	32.9	CHEMBL2068	Homo sapiens	INH	%	32.9
	7991931	CHEMBL1937682	Inhibition of EPH-A2 at 10 uM	B	CCCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934303	=	Inhibition	%	22.7	CHEMBL2068	Homo sapiens	INH	%	22.7
	7991932	CHEMBL1937682	Inhibition of EPH-A2 at 10 uM	B	CCCC(CCC)C(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934304	=	Inhibition	%	15.7	CHEMBL2068	Homo sapiens	INH	%	15.7
	7991933	CHEMBL1937682	Inhibition of EPH-A2 at 10 uM	B	C=CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934305	=	Inhibition	%	19.0	CHEMBL2068	Homo sapiens	INH	%	19.0
	7991934	CHEMBL1937682	Inhibition of EPH-A2 at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccco1		CHEMBL1934306	=	Inhibition	%	37.8	CHEMBL2068	Homo sapiens	INH	%	37.8
	7991935	CHEMBL1937682	Inhibition of EPH-A2 at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccncc1		CHEMBL1934307	=	Inhibition	%	41.2	CHEMBL2068	Homo sapiens	INH	%	41.2
Not Determined	7991936	CHEMBL1937682	Inhibition of EPH-A2 at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Determined	7991937	CHEMBL1937682	Inhibition of EPH-A2 at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	7991938	CHEMBL1937682	Inhibition of EPH-A2 at 10 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	94.5	CHEMBL2068	Homo sapiens	INH	%	94.5
Not Determined	7991939	CHEMBL1937682	Inhibition of EPH-A2 at 10 uM	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Determined	7991940	CHEMBL1937682	Inhibition of EPH-A2 at 10 uM	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccc(O)c(O)c1		CHEMBL56393		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Determined	7991941	CHEMBL1937682	Inhibition of EPH-A2 at 10 uM	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	7992183	CHEMBL1935895	Inhibition of EPHA2 at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	39.0	CHEMBL2068	Homo sapiens	INH	%	39.0
	8002137	CHEMBL1942195	Inhibition of EPHA2 at 1 uM	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	Inhibition	%	7.0	CHEMBL2068	Homo sapiens	INH	%	7.0
	8002138	CHEMBL1942195	Inhibition of EPHA2 at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	Inhibition	%	1.0	CHEMBL2068	Homo sapiens	INH	%	1.0
	8002139	CHEMBL1942195	Inhibition of EPHA2 at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	Inhibition	%	3.0	CHEMBL2068	Homo sapiens	INH	%	3.0
Active	8010526	CHEMBL1942360	Inhibition of EphA2 at 10 uM	B	CC(C)c1nnc2ccc(Sc3ccccc3CNC(=O)Nc3cc(C(C)(C)C)nn3-c3ccccc3)cn12		CHEMBL1938736		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	8012227	CHEMBL1941638	Inhibition of EPHA2 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	8012228	CHEMBL1941638	Inhibition of EPHA2 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	8012229	CHEMBL1941638	Inhibition of EPHA2 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	8012230	CHEMBL1941638	Inhibition of EPHA2 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	8039272	CHEMBL1953265	Inhibition of EPHA2	B	COc1ccc(C(=O)NC[C@@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949788	>	IC50	nM	50000.0	CHEMBL2068	Homo sapiens	IC50	uM	50.0
	8039273	CHEMBL1953265	Inhibition of EPHA2	B	COc1ccc(C(=O)NC[C@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949789	>	IC50	nM	50000.0	CHEMBL2068	Homo sapiens	IC50	uM	50.0
	8047103	CHEMBL1958844	Inhibition of EPHA2 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	8061368	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.14	CHEMBL2068	Homo sapiens	Inhibition	%	2.14
	8061545	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	32.44	CHEMBL2068	Homo sapiens	Inhibition	%	32.44
	8061652	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.44	CHEMBL2068	Homo sapiens	Inhibition	%	0.44
	8061876	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.04	CHEMBL2068	Homo sapiens	Inhibition	%	0.04
	8062067	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.74	CHEMBL2068	Homo sapiens	Inhibition	%	1.74
	8062407	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.97	CHEMBL2068	Homo sapiens	Inhibition	%	1.97
	8062569	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-2.77	CHEMBL2068	Homo sapiens	Inhibition	%	-2.77
	8062891	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.77	CHEMBL2068	Homo sapiens	Inhibition	%	1.77
	8063247	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	8.19	CHEMBL2068	Homo sapiens	Inhibition	%	8.19
	8063414	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.97	CHEMBL2068	Homo sapiens	Inhibition	%	0.97
	8063746	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-0.18	CHEMBL2068	Homo sapiens	Inhibition	%	-0.18
	8063928	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.79	CHEMBL2068	Homo sapiens	Inhibition	%	0.79
	8064267	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.07	CHEMBL2068	Homo sapiens	Inhibition	%	1.07
	8064477	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.17	CHEMBL2068	Homo sapiens	Inhibition	%	-0.17
	8064839	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.89	CHEMBL2068	Homo sapiens	Inhibition	%	0.89
	8065005	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.97	CHEMBL2068	Homo sapiens	Inhibition	%	0.97
	8065345	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-0.13	CHEMBL2068	Homo sapiens	Inhibition	%	-0.13
	8065520	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.29	CHEMBL2068	Homo sapiens	Inhibition	%	2.29
	8065744	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.84	CHEMBL2068	Homo sapiens	Inhibition	%	1.84
	8065859	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-2.08	CHEMBL2068	Homo sapiens	Inhibition	%	-2.08
	8066069	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.05	CHEMBL2068	Homo sapiens	Inhibition	%	1.05
	8066293	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.61	CHEMBL2068	Homo sapiens	Inhibition	%	0.61
	8066429	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.73	CHEMBL2068	Homo sapiens	Inhibition	%	2.73
	8066595	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.96	CHEMBL2068	Homo sapiens	Inhibition	%	0.96
	8066819	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.05	CHEMBL2068	Homo sapiens	Inhibition	%	0.05
	8066943	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	28.09	CHEMBL2068	Homo sapiens	Inhibition	%	28.09
	8067342	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.49	CHEMBL2068	Homo sapiens	Inhibition	%	2.49
	8067463	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-3.39	CHEMBL2068	Homo sapiens	Inhibition	%	-3.39
	8067897	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.69	CHEMBL2068	Homo sapiens	Inhibition	%	0.69
	8068032	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	2.66	CHEMBL2068	Homo sapiens	Inhibition	%	2.66
	8068420	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.14	CHEMBL2068	Homo sapiens	Inhibition	%	1.14
	8068545	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	55.2	CHEMBL2068	Homo sapiens	Inhibition	%	55.2
	8068769	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-2.58	CHEMBL2068	Homo sapiens	Inhibition	%	-2.58
	8068943	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	6.48	CHEMBL2068	Homo sapiens	Inhibition	%	6.48
	8069068	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-1.52	CHEMBL2068	Homo sapiens	Inhibition	%	-1.52
	8069292	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-1.41	CHEMBL2068	Homo sapiens	Inhibition	%	-1.41
	8069363	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	24.31	CHEMBL2068	Homo sapiens	Inhibition	%	24.31
	8069587	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	-0.18	CHEMBL2068	Homo sapiens	Inhibition	%	-0.18
	8069748	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.54	CHEMBL2068	Homo sapiens	Inhibition	%	0.54
	8070098	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-2.61	CHEMBL2068	Homo sapiens	Inhibition	%	-2.61
	8070270	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.69	CHEMBL2068	Homo sapiens	Inhibition	%	1.69
	8070619	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-1.11	CHEMBL2068	Homo sapiens	Inhibition	%	-1.11
	8070917	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	-0.78	CHEMBL2068	Homo sapiens	Inhibition	%	-0.78
	8071074	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.34	CHEMBL2068	Homo sapiens	Inhibition	%	1.34
	8071424	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-2.12	CHEMBL2068	Homo sapiens	Inhibition	%	-2.12
	8071597	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.61	CHEMBL2068	Homo sapiens	Inhibition	%	1.61
	8071821	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.53	CHEMBL2068	Homo sapiens	Inhibition	%	1.53
	8071946	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-2.27	CHEMBL2068	Homo sapiens	Inhibition	%	-2.27
	8072260	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-2.35	CHEMBL2068	Homo sapiens	Inhibition	%	-2.35
	8072417	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.02	CHEMBL2068	Homo sapiens	Inhibition	%	1.02
	8072641	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.42	CHEMBL2068	Homo sapiens	Inhibition	%	2.42
	8072766	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-2.51	CHEMBL2068	Homo sapiens	Inhibition	%	-2.51
	8073157	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.29	CHEMBL2068	Homo sapiens	Inhibition	%	1.29
	8073282	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	63.5	CHEMBL2068	Homo sapiens	Inhibition	%	63.5
	8073625	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.34	CHEMBL2068	Homo sapiens	Inhibition	%	1.34
	8073858	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	3.83	CHEMBL2068	Homo sapiens	Inhibition	%	3.83
	8074234	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.37	CHEMBL2068	Homo sapiens	Inhibition	%	3.37
	8074364	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-1.69	CHEMBL2068	Homo sapiens	Inhibition	%	-1.69
	8074745	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-0.02	CHEMBL2068	Homo sapiens	Inhibition	%	-0.02
	8074872	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	93.51	CHEMBL2068	Homo sapiens	Inhibition	%	93.51
	8075096	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-1.62	CHEMBL2068	Homo sapiens	Inhibition	%	-1.62
	8075207	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2	Outside typical range	CHEMBL271843	=	Inhibition	%	-11.35	CHEMBL2068	Homo sapiens	Inhibition	%	-11.35
	8075444	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.52	CHEMBL2068	Homo sapiens	Inhibition	%	-1.52
	8075809	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.74	CHEMBL2068	Homo sapiens	Inhibition	%	0.74
	8075951	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-2.94	CHEMBL2068	Homo sapiens	Inhibition	%	-2.94
	8076175	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-3.1	CHEMBL2068	Homo sapiens	Inhibition	%	-3.1
	8076323	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-0.27	CHEMBL2068	Homo sapiens	Inhibition	%	-0.27
	8076681	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-2.47	CHEMBL2068	Homo sapiens	Inhibition	%	-2.47
	8076783	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.95	CHEMBL2068	Homo sapiens	Inhibition	%	0.95
	8077007	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.3	CHEMBL2068	Homo sapiens	Inhibition	%	1.3
	8077030	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-2.75	CHEMBL2068	Homo sapiens	Inhibition	%	-2.75
	8077254	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-2.73	CHEMBL2068	Homo sapiens	Inhibition	%	-2.73
	8077382	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.86	CHEMBL2068	Homo sapiens	Inhibition	%	0.86
	8077757	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-4.03	CHEMBL2068	Homo sapiens	Inhibition	%	-4.03
	8077900	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.97	CHEMBL2068	Homo sapiens	Inhibition	%	1.97
	8078263	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.33	CHEMBL2068	Homo sapiens	Inhibition	%	-1.33
	8078589	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.25	CHEMBL2068	Homo sapiens	Inhibition	%	1.25
	8078839	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-4.53	CHEMBL2068	Homo sapiens	Inhibition	%	-4.53
	8078955	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-0.29	CHEMBL2068	Homo sapiens	Inhibition	%	-0.29
	8079179	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-0.3	CHEMBL2068	Homo sapiens	Inhibition	%	-0.3
	8079337	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-4.23	CHEMBL2068	Homo sapiens	Inhibition	%	-4.23
	8079479	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.66	CHEMBL2068	Homo sapiens	Inhibition	%	0.66
	8079703	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.8	CHEMBL2068	Homo sapiens	Inhibition	%	0.8
	8079842	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.33	CHEMBL2068	Homo sapiens	Inhibition	%	-1.33
	8080171	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.6	CHEMBL2068	Homo sapiens	Inhibition	%	0.6
	8080423	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-3.29	CHEMBL2068	Homo sapiens	Inhibition	%	-3.29
	8080762	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.06	CHEMBL2068	Homo sapiens	Inhibition	%	1.06
	8080926	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-4.51	CHEMBL2068	Homo sapiens	Inhibition	%	-4.51
	8081285	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.21	CHEMBL2068	Homo sapiens	Inhibition	%	-0.21
	8081429	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	1.29	CHEMBL2068	Homo sapiens	Inhibition	%	1.29
	8081756	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.74	CHEMBL2068	Homo sapiens	Inhibition	%	0.74
	8082008	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-3.24	CHEMBL2068	Homo sapiens	Inhibition	%	-3.24
	8082345	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.85	CHEMBL2068	Homo sapiens	Inhibition	%	0.85
	8082518	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.11	CHEMBL2068	Homo sapiens	Inhibition	%	-1.11
	8082865	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.5	CHEMBL2068	Homo sapiens	Inhibition	%	0.5
	8083021	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	-0.82	CHEMBL2068	Homo sapiens	Inhibition	%	-0.82
	8083245	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	0.32	CHEMBL2068	Homo sapiens	Inhibition	%	0.32
	8083344	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.32	CHEMBL2068	Homo sapiens	Inhibition	%	1.32
	8083598	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-4.45	CHEMBL2068	Homo sapiens	Inhibition	%	-4.45
	8083822	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-4.85	CHEMBL2068	Homo sapiens	Inhibition	%	-4.85
	8083932	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.47	CHEMBL2068	Homo sapiens	Inhibition	%	0.47
	8084117	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.3	CHEMBL2068	Homo sapiens	Inhibition	%	-3.3
	8084341	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	1.99	CHEMBL2068	Homo sapiens	Inhibition	%	1.99
	8084459	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.07	CHEMBL2068	Homo sapiens	Inhibition	%	0.07
	8084844	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.41	CHEMBL2068	Homo sapiens	Inhibition	%	2.41
	8084942	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.19	CHEMBL2068	Homo sapiens	Inhibition	%	0.19
	8085166	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.68	CHEMBL2068	Homo sapiens	Inhibition	%	1.68
	8085422	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	15.6	CHEMBL2068	Homo sapiens	Inhibition	%	15.6
	8085530	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-0.42	CHEMBL2068	Homo sapiens	Inhibition	%	-0.42
	8085943	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	9.56	CHEMBL2068	Homo sapiens	Inhibition	%	9.56
	8086058	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.12	CHEMBL2068	Homo sapiens	Inhibition	%	0.12
	8086282	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.17	CHEMBL2068	Homo sapiens	Inhibition	%	0.17
	8086444	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-3.15	CHEMBL2068	Homo sapiens	Inhibition	%	-3.15
	8086767	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.93	CHEMBL2068	Homo sapiens	Inhibition	%	1.93
	8086978	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.35	CHEMBL2068	Homo sapiens	Inhibition	%	0.35
	8087136	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	0.47	CHEMBL2068	Homo sapiens	Inhibition	%	0.47
	8087360	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-1.79	CHEMBL2068	Homo sapiens	Inhibition	%	-1.79
	8087474	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	10.07	CHEMBL2068	Homo sapiens	Inhibition	%	10.07
	8087836	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-2.73	CHEMBL2068	Homo sapiens	Inhibition	%	-2.73
	8087978	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.29	CHEMBL2068	Homo sapiens	Inhibition	%	1.29
	8088202	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.16	CHEMBL2068	Homo sapiens	Inhibition	%	1.16
	8088350	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-3.41	CHEMBL2068	Homo sapiens	Inhibition	%	-3.41
	8088702	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.55	CHEMBL2068	Homo sapiens	Inhibition	%	1.55
	8088795	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	-0.14	CHEMBL2068	Homo sapiens	Inhibition	%	-0.14
	8089019	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.64	CHEMBL2068	Homo sapiens	Inhibition	%	0.64
	8089147	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-1.48	CHEMBL2068	Homo sapiens	Inhibition	%	-1.48
	8089519	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.83	CHEMBL2068	Homo sapiens	Inhibition	%	0.83
	8089639	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	2.65	CHEMBL2068	Homo sapiens	Inhibition	%	2.65
	8090043	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.02	CHEMBL2068	Homo sapiens	Inhibition	%	-0.02
	8090208	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.37	CHEMBL2068	Homo sapiens	Inhibition	%	1.37
	8090599	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.3	CHEMBL2068	Homo sapiens	Inhibition	%	0.3
	8090738	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.67	CHEMBL2068	Homo sapiens	Inhibition	%	0.67
	8091167	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.77	CHEMBL2068	Homo sapiens	Inhibition	%	1.77
	8091304	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	17.3	CHEMBL2068	Homo sapiens	Inhibition	%	17.3
	8091683	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-2.2	CHEMBL2068	Homo sapiens	Inhibition	%	-2.2
	8091799	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.74	CHEMBL2068	Homo sapiens	Inhibition	%	2.74
	8092023	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	1.76	CHEMBL2068	Homo sapiens	Inhibition	%	1.76
	8092160	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-5.61	CHEMBL2068	Homo sapiens	Inhibition	%	-5.61
	8092535	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	0.54	CHEMBL2068	Homo sapiens	Inhibition	%	0.54
	8092683	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-2.62	CHEMBL2068	Homo sapiens	Inhibition	%	-2.62
	8093036	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.17	CHEMBL2068	Homo sapiens	Inhibition	%	1.17
	8093348	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.26	CHEMBL2068	Homo sapiens	Inhibition	%	1.26
	8093488	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.75	CHEMBL2068	Homo sapiens	Inhibition	%	0.75
	8093851	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	3.1	CHEMBL2068	Homo sapiens	Inhibition	%	3.1
	8093971	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.32	CHEMBL2068	Homo sapiens	Inhibition	%	1.32
	8094195	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.73	CHEMBL2068	Homo sapiens	Inhibition	%	1.73
	8094375	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.36	CHEMBL2068	Homo sapiens	Inhibition	%	1.36
	8094550	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.53	CHEMBL2068	Homo sapiens	Inhibition	%	0.53
	8094774	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.87	CHEMBL2068	Homo sapiens	Inhibition	%	0.87
	8094930	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-0.95	CHEMBL2068	Homo sapiens	Inhibition	%	-0.95
	8095070	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	3.48	CHEMBL2068	Homo sapiens	Inhibition	%	3.48
	8095294	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	35.39	CHEMBL2068	Homo sapiens	Inhibition	%	35.39
	8095497	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.18	CHEMBL2068	Homo sapiens	Inhibition	%	1.18
	8095638	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	1.69	CHEMBL2068	Homo sapiens	Inhibition	%	1.69
	8095862	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	-0.07	CHEMBL2068	Homo sapiens	Inhibition	%	-0.07
	8096010	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	-2.8	CHEMBL2068	Homo sapiens	Inhibition	%	-2.8
	8096351	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.29	CHEMBL2068	Homo sapiens	Inhibition	%	1.29
	8096490	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-5.64	CHEMBL2068	Homo sapiens	Inhibition	%	-5.64
	8096714	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-3.15	CHEMBL2068	Homo sapiens	Inhibition	%	-3.15
	8096870	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	-0.67	CHEMBL2068	Homo sapiens	Inhibition	%	-0.67
	8097017	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-3.04	CHEMBL2068	Homo sapiens	Inhibition	%	-3.04
	8097241	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-2.75	CHEMBL2068	Homo sapiens	Inhibition	%	-2.75
	8097328	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-2.71	CHEMBL2068	Homo sapiens	Inhibition	%	-2.71
	8097548	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.9	CHEMBL2068	Homo sapiens	Inhibition	%	1.9
	8097698	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-1.19	CHEMBL2068	Homo sapiens	Inhibition	%	-1.19
	8097922	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.2	CHEMBL2068	Homo sapiens	Inhibition	%	0.2
	8098055	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-2.05	CHEMBL2068	Homo sapiens	Inhibition	%	-2.05
	8098399	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.52	CHEMBL2068	Homo sapiens	Inhibition	%	1.52
	8098579	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.78	CHEMBL2068	Homo sapiens	Inhibition	%	1.78
	8098988	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	-0.92	CHEMBL2068	Homo sapiens	Inhibition	%	-0.92
	8099132	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.56	CHEMBL2068	Homo sapiens	Inhibition	%	2.56
	8099498	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.98	CHEMBL2068	Homo sapiens	Inhibition	%	1.98
	8099692	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-2.09	CHEMBL2068	Homo sapiens	Inhibition	%	-2.09
	8100063	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	2.45	CHEMBL2068	Homo sapiens	Inhibition	%	2.45
	8100209	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	-2.26	CHEMBL2068	Homo sapiens	Inhibition	%	-2.26
	8100549	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.66	CHEMBL2068	Homo sapiens	Inhibition	%	1.66
	8100913	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-2.96	CHEMBL2068	Homo sapiens	Inhibition	%	-2.96
	8101073	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	0.83	CHEMBL2068	Homo sapiens	Inhibition	%	0.83
	8101439	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-3.3	CHEMBL2068	Homo sapiens	Inhibition	%	-3.3
	8101624	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-1.86	CHEMBL2068	Homo sapiens	Inhibition	%	-1.86
	8101877	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.62	CHEMBL2068	Homo sapiens	Inhibition	%	3.62
	8102256	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	7.85	CHEMBL2068	Homo sapiens	Inhibition	%	7.85
	8102387	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-4.67	CHEMBL2068	Homo sapiens	Inhibition	%	-4.67
	8102731	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.85	CHEMBL2068	Homo sapiens	Inhibition	%	1.85
	8102909	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.9	CHEMBL2068	Homo sapiens	Inhibition	%	0.9
	8103133	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.47	CHEMBL2068	Homo sapiens	Inhibition	%	-0.47
	8103329	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	0.4	CHEMBL2068	Homo sapiens	Inhibition	%	0.4
	8103467	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.15	CHEMBL2068	Homo sapiens	Inhibition	%	0.15
	8103691	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-0.63	CHEMBL2068	Homo sapiens	Inhibition	%	-0.63
	8103841	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.23	CHEMBL2068	Homo sapiens	Inhibition	%	2.23
	8104026	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.16	CHEMBL2068	Homo sapiens	Inhibition	%	-0.16
	8104398	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.1	CHEMBL2068	Homo sapiens	Inhibition	%	1.1
	8104544	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-5.84	CHEMBL2068	Homo sapiens	Inhibition	%	-5.84
	8104768	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-4.92	CHEMBL2068	Homo sapiens	Inhibition	%	-4.92
	8104882	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.81	CHEMBL2068	Homo sapiens	Inhibition	%	0.81
	8105246	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-3.79	CHEMBL2068	Homo sapiens	Inhibition	%	-3.79
	8105412	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	0.98	CHEMBL2068	Homo sapiens	Inhibition	%	0.98
	8105774	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-1.26	CHEMBL2068	Homo sapiens	Inhibition	%	-1.26
	8106054	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	4.33	CHEMBL2068	Homo sapiens	Inhibition	%	4.33
	8106219	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	14.61	CHEMBL2068	Homo sapiens	Inhibition	%	14.61
	8106443	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.91	CHEMBL2068	Homo sapiens	Inhibition	%	-2.91
	8106599	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	53.56	CHEMBL2068	Homo sapiens	Inhibition	%	53.56
	8106728	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	4.36	CHEMBL2068	Homo sapiens	Inhibition	%	4.36
	8106952	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.14	CHEMBL2068	Homo sapiens	Inhibition	%	2.14
	8107073	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.83	CHEMBL2068	Homo sapiens	Inhibition	%	1.83
	8107469	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.18	CHEMBL2068	Homo sapiens	Inhibition	%	2.18
	8107670	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	-0.31	CHEMBL2068	Homo sapiens	Inhibition	%	-0.31
	8108029	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	17.92	CHEMBL2068	Homo sapiens	Inhibition	%	17.92
	8108187	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.6	CHEMBL2068	Homo sapiens	Inhibition	%	2.6
	8108362	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	7.68	CHEMBL2068	Homo sapiens	Inhibition	%	7.68
	8108586	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	41.17	CHEMBL2068	Homo sapiens	Inhibition	%	41.17
	8108733	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	1.42	CHEMBL2068	Homo sapiens	Inhibition	%	1.42
	8109099	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-3.01	CHEMBL2068	Homo sapiens	Inhibition	%	-3.01
	8109213	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.1	CHEMBL2068	Homo sapiens	Inhibition	%	0.1
	8109437	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.32	CHEMBL2068	Homo sapiens	Inhibition	%	1.32
	8109567	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-2.87	CHEMBL2068	Homo sapiens	Inhibition	%	-2.87
	8109738	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-2.62	CHEMBL2068	Homo sapiens	Inhibition	%	-2.62
	8109962	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-3.66	CHEMBL2068	Homo sapiens	Inhibition	%	-3.66
	8110094	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.21	CHEMBL2068	Homo sapiens	Inhibition	%	2.21
	8110373	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.42	CHEMBL2068	Homo sapiens	Inhibition	%	2.42
	8110763	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.04	CHEMBL2068	Homo sapiens	Inhibition	%	-2.04
	8110921	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	5.32	CHEMBL2068	Homo sapiens	Inhibition	%	5.32
	8111268	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	49.4	CHEMBL2068	Homo sapiens	Inhibition	%	49.4
	8111395	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.05	CHEMBL2068	Homo sapiens	Inhibition	%	0.05
	8111619	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.83	CHEMBL2068	Homo sapiens	Inhibition	%	1.83
	8111785	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.32	CHEMBL2068	Homo sapiens	Inhibition	%	0.32
	8111990	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.27	CHEMBL2068	Homo sapiens	Inhibition	%	2.27
	8112351	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-1.68	CHEMBL2068	Homo sapiens	Inhibition	%	-1.68
	8112519	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.61	CHEMBL2068	Homo sapiens	Inhibition	%	2.61
	8112915	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-2.48	CHEMBL2068	Homo sapiens	Inhibition	%	-2.48
	8113067	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	1.71	CHEMBL2068	Homo sapiens	Inhibition	%	1.71
	8113427	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-2.3	CHEMBL2068	Homo sapiens	Inhibition	%	-2.3
	8113775	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	0.66	CHEMBL2068	Homo sapiens	Inhibition	%	0.66
	8113891	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-3.79	CHEMBL2068	Homo sapiens	Inhibition	%	-3.79
	8114291	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.34	CHEMBL2068	Homo sapiens	Inhibition	%	0.34
	8114423	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.39	CHEMBL2068	Homo sapiens	Inhibition	%	2.39
	8114647	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.14	CHEMBL2068	Homo sapiens	Inhibition	%	2.14
	8114699	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.02	CHEMBL2068	Homo sapiens	Inhibition	%	2.02
	8114923	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.67	CHEMBL2068	Homo sapiens	Inhibition	%	1.67
	8115089	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	22.38	CHEMBL2068	Homo sapiens	Inhibition	%	22.38
	8115254	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	1.78	CHEMBL2068	Homo sapiens	Inhibition	%	1.78
	8115598	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	65.73	CHEMBL2068	Homo sapiens	Inhibition	%	65.73
	8115955	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.02	CHEMBL2068	Homo sapiens	Inhibition	%	0.02
	8116114	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-2.4	CHEMBL2068	Homo sapiens	Inhibition	%	-2.4
	8116317	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.53	CHEMBL2068	Homo sapiens	Inhibition	%	1.53
	8116541	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.52	CHEMBL2068	Homo sapiens	Inhibition	%	1.52
	8116675	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-1.94	CHEMBL2068	Homo sapiens	Inhibition	%	-1.94
	8116847	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	40.96	CHEMBL2068	Homo sapiens	Inhibition	%	40.96
	8117071	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	89.7	CHEMBL2068	Homo sapiens	Inhibition	%	89.7
	8117242	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-2.19	CHEMBL2068	Homo sapiens	Inhibition	%	-2.19
	8117400	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	0.18	CHEMBL2068	Homo sapiens	Inhibition	%	0.18
	8117624	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	-0.52	CHEMBL2068	Homo sapiens	Inhibition	%	-0.52
	8117754	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-2.92	CHEMBL2068	Homo sapiens	Inhibition	%	-2.92
	8118116	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-2.47	CHEMBL2068	Homo sapiens	Inhibition	%	-2.47
	8118232	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-2.96	CHEMBL2068	Homo sapiens	Inhibition	%	-2.96
	8118456	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.79	CHEMBL2068	Homo sapiens	Inhibition	%	1.79
	8118628	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.55	CHEMBL2068	Homo sapiens	Inhibition	%	0.55
	8118988	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.92	CHEMBL2068	Homo sapiens	Inhibition	%	1.92
	8119259	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.91	CHEMBL2068	Homo sapiens	Inhibition	%	0.91
	8119418	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	80.51	CHEMBL2068	Homo sapiens	Inhibition	%	80.51
	8119585	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.75	CHEMBL2068	Homo sapiens	Inhibition	%	2.75
	8119809	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.53	CHEMBL2068	Homo sapiens	Inhibition	%	1.53
	8119928	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.15	CHEMBL2068	Homo sapiens	Inhibition	%	2.15
	8120291	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.03	CHEMBL2068	Homo sapiens	Inhibition	%	2.03
	8120451	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-2.69	CHEMBL2068	Homo sapiens	Inhibition	%	-2.69
	8120675	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.74	CHEMBL2068	Homo sapiens	Inhibition	%	-1.74
	8120876	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	0.34	CHEMBL2068	Homo sapiens	Inhibition	%	0.34
	8121004	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-2.0	CHEMBL2068	Homo sapiens	Inhibition	%	-2.0
	8121400	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.49	CHEMBL2068	Homo sapiens	Inhibition	%	-0.49
	8121567	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-2.9	CHEMBL2068	Homo sapiens	Inhibition	%	-2.9
	8121954	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	0.63	CHEMBL2068	Homo sapiens	Inhibition	%	0.63
	8122075	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-2.31	CHEMBL2068	Homo sapiens	Inhibition	%	-2.31
	8122299	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	1.32	CHEMBL2068	Homo sapiens	Inhibition	%	1.32
	8122437	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-2.72	CHEMBL2068	Homo sapiens	Inhibition	%	-2.72
	8122781	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.53	CHEMBL2068	Homo sapiens	Inhibition	%	1.53
	8122948	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	0.84	CHEMBL2068	Homo sapiens	Inhibition	%	0.84
	8123314	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-0.41	CHEMBL2068	Homo sapiens	Inhibition	%	-0.41
	8123592	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-1.18	CHEMBL2068	Homo sapiens	Inhibition	%	-1.18
	8123742	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.61	CHEMBL2068	Homo sapiens	Inhibition	%	3.61
	8124133	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.82	CHEMBL2068	Homo sapiens	Inhibition	%	-0.82
	8124252	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.65	CHEMBL2068	Homo sapiens	Inhibition	%	1.65
	8124476	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	1.1	CHEMBL2068	Homo sapiens	Inhibition	%	1.1
	8124615	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.72	CHEMBL2068	Homo sapiens	Inhibition	%	0.72
	8125004	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-2.68	CHEMBL2068	Homo sapiens	Inhibition	%	-2.68
	8125205	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	0.72	CHEMBL2068	Homo sapiens	Inhibition	%	0.72
	8125335	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-1.68	CHEMBL2068	Homo sapiens	Inhibition	%	-1.68
	8125559	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-3.08	CHEMBL2068	Homo sapiens	Inhibition	%	-3.08
	8125727	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-1.09	CHEMBL2068	Homo sapiens	Inhibition	%	-1.09
	8125891	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-1.98	CHEMBL2068	Homo sapiens	Inhibition	%	-1.98
	8126115	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-3.74	CHEMBL2068	Homo sapiens	Inhibition	%	-3.74
	8126279	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	0.39	CHEMBL2068	Homo sapiens	Inhibition	%	0.39
	8126618	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	56.99	CHEMBL2068	Homo sapiens	Inhibition	%	56.99
	8126754	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	1.01	CHEMBL2068	Homo sapiens	Inhibition	%	1.01
	8127100	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.86	CHEMBL2068	Homo sapiens	Inhibition	%	1.86
	8127267	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	0.25	CHEMBL2068	Homo sapiens	Inhibition	%	0.25
	8127491	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.15	CHEMBL2068	Homo sapiens	Inhibition	%	2.15
	8127633	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.23	CHEMBL2068	Homo sapiens	Inhibition	%	3.23
	8127921	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.16	CHEMBL2068	Homo sapiens	Inhibition	%	1.16
	8128073	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	11.41	CHEMBL2068	Homo sapiens	Inhibition	%	11.41
	8128297	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.13	CHEMBL2068	Homo sapiens	Inhibition	%	2.13
	8128464	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.55	CHEMBL2068	Homo sapiens	Inhibition	%	0.55
	8128807	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	12.15	CHEMBL2068	Homo sapiens	Inhibition	%	12.15
	8128944	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.65	CHEMBL2068	Homo sapiens	Inhibition	%	1.65
	8129339	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.99	CHEMBL2068	Homo sapiens	Inhibition	%	-1.99
	8129528	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	-0.17	CHEMBL2068	Homo sapiens	Inhibition	%	-0.17
	8129891	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-2.73	CHEMBL2068	Homo sapiens	Inhibition	%	-2.73
	8130052	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.5	CHEMBL2068	Homo sapiens	Inhibition	%	0.5
	8130448	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-3.34	CHEMBL2068	Homo sapiens	Inhibition	%	-3.34
	8130608	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	-3.31	CHEMBL2068	Homo sapiens	Inhibition	%	-3.31
	8130948	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.96	CHEMBL2068	Homo sapiens	Inhibition	%	1.96
	8131087	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	1.66	CHEMBL2068	Homo sapiens	Inhibition	%	1.66
	8131311	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	0.33	CHEMBL2068	Homo sapiens	Inhibition	%	0.33
	8131431	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.01	CHEMBL2068	Homo sapiens	Inhibition	%	1.01
	8131822	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	9.85	CHEMBL2068	Homo sapiens	Inhibition	%	9.85
	8131963	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	17.19	CHEMBL2068	Homo sapiens	Inhibition	%	17.19
	8132249	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	-0.33	CHEMBL2068	Homo sapiens	Inhibition	%	-0.33
	8132620	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.81	CHEMBL2068	Homo sapiens	Inhibition	%	4.81
	8132788	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	3.31	CHEMBL2068	Homo sapiens	Inhibition	%	3.31
	8133133	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.88	CHEMBL2068	Homo sapiens	Inhibition	%	1.88
	8133271	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-0.45	CHEMBL2068	Homo sapiens	Inhibition	%	-0.45
	8133495	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.75	CHEMBL2068	Homo sapiens	Inhibition	%	0.75
	8133667	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-3.05	CHEMBL2068	Homo sapiens	Inhibition	%	-3.05
	8133847	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.47	CHEMBL2068	Homo sapiens	Inhibition	%	0.47
	8134071	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	5.09	CHEMBL2068	Homo sapiens	Inhibition	%	5.09
	8134219	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-3.93	CHEMBL2068	Homo sapiens	Inhibition	%	-3.93
	8134379	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-1.3	CHEMBL2068	Homo sapiens	Inhibition	%	-1.3
	8134603	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.92	CHEMBL2068	Homo sapiens	Inhibition	%	0.92
	8134787	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.34	CHEMBL2068	Homo sapiens	Inhibition	%	-2.34
	8134947	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	-5.2	CHEMBL2068	Homo sapiens	Inhibition	%	-5.2
	8135171	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.59	CHEMBL2068	Homo sapiens	Inhibition	%	0.59
	8135286	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.6	CHEMBL2068	Homo sapiens	Inhibition	%	0.6
	8135651	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	0.02	CHEMBL2068	Homo sapiens	Inhibition	%	0.02
	8135772	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.1	CHEMBL2068	Homo sapiens	Inhibition	%	-1.1
	8135996	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.71	CHEMBL2068	Homo sapiens	Inhibition	%	-1.71
	8136164	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-1.3	CHEMBL2068	Homo sapiens	Inhibition	%	-1.3
	8136308	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	84.99	CHEMBL2068	Homo sapiens	Inhibition	%	84.99
	8136532	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.08	CHEMBL2068	Homo sapiens	Inhibition	%	3.08
	8136598	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-2.68	CHEMBL2068	Homo sapiens	Inhibition	%	-2.68
	8136822	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-4.61	CHEMBL2068	Homo sapiens	Inhibition	%	-4.61
	8136957	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-0.63	CHEMBL2068	Homo sapiens	Inhibition	%	-0.63
	8137120	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.6	CHEMBL2068	Homo sapiens	Inhibition	%	2.6
	8137344	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.57	CHEMBL2068	Homo sapiens	Inhibition	%	3.57
	8137464	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.02	CHEMBL2068	Homo sapiens	Inhibition	%	1.02
	8137836	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.02	CHEMBL2068	Homo sapiens	Inhibition	%	1.02
	8138002	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.61	CHEMBL2068	Homo sapiens	Inhibition	%	-2.61
	8138405	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.44	CHEMBL2068	Homo sapiens	Inhibition	%	1.44
	8138553	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-2.53	CHEMBL2068	Homo sapiens	Inhibition	%	-2.53
	8138935	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.44	CHEMBL2068	Homo sapiens	Inhibition	%	-0.44
	8139120	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.5	CHEMBL2068	Homo sapiens	Inhibition	%	-1.5
	8139503	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.96	CHEMBL2068	Homo sapiens	Inhibition	%	2.96
	8139617	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.24	CHEMBL2068	Homo sapiens	Inhibition	%	2.24
	8139841	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.59	CHEMBL2068	Homo sapiens	Inhibition	%	0.59
	8139982	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.19	CHEMBL2068	Homo sapiens	Inhibition	%	1.19
	8140329	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.07	CHEMBL2068	Homo sapiens	Inhibition	%	2.07
	8140488	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-1.94	CHEMBL2068	Homo sapiens	Inhibition	%	-1.94
	8140855	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.37	CHEMBL2068	Homo sapiens	Inhibition	%	2.37
	8141157	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.22	CHEMBL2068	Homo sapiens	Inhibition	%	2.22
	8141287	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.57	CHEMBL2068	Homo sapiens	Inhibition	%	0.57
	8141671	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	5.31	CHEMBL2068	Homo sapiens	Inhibition	%	5.31
	8141790	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	8.07	CHEMBL2068	Homo sapiens	Inhibition	%	8.07
	8142014	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	44.44	CHEMBL2068	Homo sapiens	Inhibition	%	44.44
	8142175	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.24	CHEMBL2068	Homo sapiens	Inhibition	%	-0.24
	8142343	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.44	CHEMBL2068	Homo sapiens	Inhibition	%	-2.44
	8142567	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-3.67	CHEMBL2068	Homo sapiens	Inhibition	%	-3.67
	8142743	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.05	CHEMBL2068	Homo sapiens	Inhibition	%	0.05
	8142892	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.78	CHEMBL2068	Homo sapiens	Inhibition	%	-1.78
	8143116	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.07	CHEMBL2068	Homo sapiens	Inhibition	%	-2.07
	8143271	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.44	CHEMBL2068	Homo sapiens	Inhibition	%	0.44
	8143458	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.35	CHEMBL2068	Homo sapiens	Inhibition	%	1.35
	8143841	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	0.69	CHEMBL2068	Homo sapiens	Inhibition	%	0.69
	8144179	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.09	CHEMBL2068	Homo sapiens	Inhibition	%	-1.09
	8144318	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	0.52	CHEMBL2068	Homo sapiens	Inhibition	%	0.52
	8144672	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.28	CHEMBL2068	Homo sapiens	Inhibition	%	1.28
	8144825	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-2.99	CHEMBL2068	Homo sapiens	Inhibition	%	-2.99
	8145186	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	1.86	CHEMBL2068	Homo sapiens	Inhibition	%	1.86
	8145499	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.11	CHEMBL2068	Homo sapiens	Inhibition	%	2.11
	8145623	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-1.58	CHEMBL2068	Homo sapiens	Inhibition	%	-1.58
	8145847	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.15	CHEMBL2068	Homo sapiens	Inhibition	%	2.15
	8146008	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	3.5	CHEMBL2068	Homo sapiens	Inhibition	%	3.5
	8146352	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	25.79	CHEMBL2068	Homo sapiens	Inhibition	%	25.79
	8146512	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.86	CHEMBL2068	Homo sapiens	Inhibition	%	0.86
	8146903	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-3.26	CHEMBL2068	Homo sapiens	Inhibition	%	-3.26
	8147072	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.0	CHEMBL2068	Homo sapiens	Inhibition	%	0.0
	8147438	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.0	CHEMBL2068	Homo sapiens	Inhibition	%	2.0
	8147591	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.03	CHEMBL2068	Homo sapiens	Inhibition	%	0.03
	8147778	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.12	CHEMBL2068	Homo sapiens	Inhibition	%	1.12
	8148002	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.71	CHEMBL2068	Homo sapiens	Inhibition	%	1.71
	8148160	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	4.04	CHEMBL2068	Homo sapiens	Inhibition	%	4.04
	8148498	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-2.25	CHEMBL2068	Homo sapiens	Inhibition	%	-2.25
	8148637	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-1.82	CHEMBL2068	Homo sapiens	Inhibition	%	-1.82
	8148861	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-2.37	CHEMBL2068	Homo sapiens	Inhibition	%	-2.37
	8148999	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.58	CHEMBL2068	Homo sapiens	Inhibition	%	2.58
	8149158	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-1.92	CHEMBL2068	Homo sapiens	Inhibition	%	-1.92
	8149382	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-5.85	CHEMBL2068	Homo sapiens	Inhibition	%	-5.85
	8149516	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	1.73	CHEMBL2068	Homo sapiens	Inhibition	%	1.73
	8149838	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	11.99	CHEMBL2068	Homo sapiens	Inhibition	%	11.99
	8150187	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	18.83	CHEMBL2068	Homo sapiens	Inhibition	%	18.83
	8150347	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	7.74	CHEMBL2068	Homo sapiens	Inhibition	%	7.74
	8150691	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	89.59	CHEMBL2068	Homo sapiens	Inhibition	%	89.59
	8150856	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.21	CHEMBL2068	Homo sapiens	Inhibition	%	1.21
	8151243	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.76	CHEMBL2068	Homo sapiens	Inhibition	%	-1.76
	8151420	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-1.38	CHEMBL2068	Homo sapiens	Inhibition	%	-1.38
	8151782	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.59	CHEMBL2068	Homo sapiens	Inhibition	%	0.59
	8151936	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.1	CHEMBL2068	Homo sapiens	Inhibition	%	0.1
	8152160	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-0.64	CHEMBL2068	Homo sapiens	Inhibition	%	-0.64
	8152348	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	0.89	CHEMBL2068	Homo sapiens	Inhibition	%	0.89
	8152506	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	1.18	CHEMBL2068	Homo sapiens	Inhibition	%	1.18
	8152844	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.32	CHEMBL2068	Homo sapiens	Inhibition	%	3.32
	8153207	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-2.36	CHEMBL2068	Homo sapiens	Inhibition	%	-2.36
	8153344	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.73	CHEMBL2068	Homo sapiens	Inhibition	%	1.73
	8153725	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-5.32	CHEMBL2068	Homo sapiens	Inhibition	%	-5.32
	8153858	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	0.81	CHEMBL2068	Homo sapiens	Inhibition	%	0.81
	8154082	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	-0.9	CHEMBL2068	Homo sapiens	Inhibition	%	-0.9
	8154179	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	49.58	CHEMBL2068	Homo sapiens	Inhibition	%	49.58
	8154529	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	82.81	CHEMBL2068	Homo sapiens	Inhibition	%	82.81
	8154688	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.11	CHEMBL2068	Homo sapiens	Inhibition	%	2.11
	8154912	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.11	CHEMBL2068	Homo sapiens	Inhibition	%	-0.11
	8155032	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.92	CHEMBL2068	Homo sapiens	Inhibition	%	1.92
	8155208	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-1.44	CHEMBL2068	Homo sapiens	Inhibition	%	-1.44
	8155432	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.62	CHEMBL2068	Homo sapiens	Inhibition	%	0.62
	8155593	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.67	CHEMBL2068	Homo sapiens	Inhibition	%	-1.67
	8155771	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.52	CHEMBL2068	Homo sapiens	Inhibition	%	0.52
	8155995	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.58	CHEMBL2068	Homo sapiens	Inhibition	%	0.58
	8156133	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.2	CHEMBL2068	Homo sapiens	Inhibition	%	1.2
	8156345	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.27	CHEMBL2068	Homo sapiens	Inhibition	%	1.27
	8156569	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.08	CHEMBL2068	Homo sapiens	Inhibition	%	3.08
	8156719	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.23	CHEMBL2068	Homo sapiens	Inhibition	%	2.23
	8156862	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.66	CHEMBL2068	Homo sapiens	Inhibition	%	2.66
	8157086	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.5	CHEMBL2068	Homo sapiens	Inhibition	%	3.5
	8157206	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.9	CHEMBL2068	Homo sapiens	Inhibition	%	2.9
	8157571	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	4.32	CHEMBL2068	Homo sapiens	Inhibition	%	4.32
	8157701	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	26.02	CHEMBL2068	Homo sapiens	Inhibition	%	26.02
	8157925	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.18	CHEMBL2068	Homo sapiens	Inhibition	%	1.18
	8158086	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.74	CHEMBL2068	Homo sapiens	Inhibition	%	2.74
	8158336	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	0.86	CHEMBL2068	Homo sapiens	Inhibition	%	0.86
	8158718	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-2.02	CHEMBL2068	Homo sapiens	Inhibition	%	-2.02
	8158887	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-2.28	CHEMBL2068	Homo sapiens	Inhibition	%	-2.28
	8159246	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.93	CHEMBL2068	Homo sapiens	Inhibition	%	1.93
	8159366	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	-2.1	CHEMBL2068	Homo sapiens	Inhibition	%	-2.1
	8159590	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-5.85	CHEMBL2068	Homo sapiens	Inhibition	%	-5.85
	8159721	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	0.64	CHEMBL2068	Homo sapiens	Inhibition	%	0.64
	8160086	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-2.85	CHEMBL2068	Homo sapiens	Inhibition	%	-2.85
	8160223	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.79	CHEMBL2068	Homo sapiens	Inhibition	%	1.79
	8160597	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.36	CHEMBL2068	Homo sapiens	Inhibition	%	0.36
	8160891	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	7.49	CHEMBL2068	Homo sapiens	Inhibition	%	7.49
	8161041	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.23	CHEMBL2068	Homo sapiens	Inhibition	%	2.23
	8161408	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	2.91	CHEMBL2068	Homo sapiens	Inhibition	%	2.91
	8161533	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.18	CHEMBL2068	Homo sapiens	Inhibition	%	2.18
	8161757	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.61	CHEMBL2068	Homo sapiens	Inhibition	%	2.61
	8161895	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	17.46	CHEMBL2068	Homo sapiens	Inhibition	%	17.46
	8162249	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	0.6	CHEMBL2068	Homo sapiens	Inhibition	%	0.6
	8162409	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-3.26	CHEMBL2068	Homo sapiens	Inhibition	%	-3.26
	8162662	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	-0.29	CHEMBL2068	Homo sapiens	Inhibition	%	-0.29
	8163034	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	2.13	CHEMBL2068	Homo sapiens	Inhibition	%	2.13
	8163203	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-0.08	CHEMBL2068	Homo sapiens	Inhibition	%	-0.08
	8163561	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.46	CHEMBL2068	Homo sapiens	Inhibition	%	1.46
	8163908	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-4.53	CHEMBL2068	Homo sapiens	Inhibition	%	-4.53
	8164042	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	-1.17	CHEMBL2068	Homo sapiens	Inhibition	%	-1.17
	8164406	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-2.86	CHEMBL2068	Homo sapiens	Inhibition	%	-2.86
	8164561	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.43	CHEMBL2068	Homo sapiens	Inhibition	%	1.43
	8164929	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	2.11	CHEMBL2068	Homo sapiens	Inhibition	%	2.11
	8165223	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	0.62	CHEMBL2068	Homo sapiens	Inhibition	%	0.62
	8165364	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.79	CHEMBL2068	Homo sapiens	Inhibition	%	2.79
	8165588	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.32	CHEMBL2068	Homo sapiens	Inhibition	%	3.32
	8165731	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	5.71	CHEMBL2068	Homo sapiens	Inhibition	%	5.71
	8166081	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.5	CHEMBL2068	Homo sapiens	Inhibition	%	1.5
	8166219	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	0.44	CHEMBL2068	Homo sapiens	Inhibition	%	0.44
	8166573	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.93	CHEMBL2068	Homo sapiens	Inhibition	%	1.93
	8166898	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	71.05	CHEMBL2068	Homo sapiens	Inhibition	%	71.05
	8166986	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	-0.49	CHEMBL2068	Homo sapiens	Inhibition	%	-0.49
	8167210	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	-2.53	CHEMBL2068	Homo sapiens	Inhibition	%	-2.53
	8167351	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	7.25	CHEMBL2068	Homo sapiens	Inhibition	%	7.25
	8167515	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	-4.77	CHEMBL2068	Homo sapiens	Inhibition	%	-4.77
	8167739	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	-1.43	CHEMBL2068	Homo sapiens	Inhibition	%	-1.43
	8167872	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	0.18	CHEMBL2068	Homo sapiens	Inhibition	%	0.18
	8168220	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-2.91	CHEMBL2068	Homo sapiens	Inhibition	%	-2.91
	8168361	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	-1.1	CHEMBL2068	Homo sapiens	Inhibition	%	-1.1
	8168585	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.54	CHEMBL2068	Homo sapiens	Inhibition	%	2.54
	8168721	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-2.93	CHEMBL2068	Homo sapiens	Inhibition	%	-2.93
	8168885	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	2.26	CHEMBL2068	Homo sapiens	Inhibition	%	2.26
	8169109	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	15.02	CHEMBL2068	Homo sapiens	Inhibition	%	15.02
	8169251	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.88	CHEMBL2068	Homo sapiens	Inhibition	%	2.88
	8169555	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	0.22	CHEMBL2068	Homo sapiens	Inhibition	%	0.22
	8169913	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.83	CHEMBL2068	Homo sapiens	Inhibition	%	1.83
	8170058	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	7.28	CHEMBL2068	Homo sapiens	Inhibition	%	7.28
	8170407	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.85	CHEMBL2068	Homo sapiens	Inhibition	%	2.85
	8170547	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	0.73	CHEMBL2068	Homo sapiens	Inhibition	%	0.73
	8170771	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-2.64	CHEMBL2068	Homo sapiens	Inhibition	%	-2.64
	8170906	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	7.66	CHEMBL2068	Homo sapiens	Inhibition	%	7.66
	8171103	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	2.37	CHEMBL2068	Homo sapiens	Inhibition	%	2.37
	8171327	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	28.03	CHEMBL2068	Homo sapiens	Inhibition	%	28.03
	8171544	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	-2.47	CHEMBL2068	Homo sapiens	Inhibition	%	-2.47
	8171685	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	1.53	CHEMBL2068	Homo sapiens	Inhibition	%	1.53
	8172062	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-6.37	CHEMBL2068	Homo sapiens	Inhibition	%	-6.37
	8172194	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	0.43	CHEMBL2068	Homo sapiens	Inhibition	%	0.43
	8172418	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.36	CHEMBL2068	Homo sapiens	Inhibition	%	2.36
	8172546	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-2.18	CHEMBL2068	Homo sapiens	Inhibition	%	-2.18
	8172912	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	7.54	CHEMBL2068	Homo sapiens	Inhibition	%	7.54
	8173048	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-4.33	CHEMBL2068	Homo sapiens	Inhibition	%	-4.33
	8173437	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	3.25	CHEMBL2068	Homo sapiens	Inhibition	%	3.25
	8173578	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.54	CHEMBL2068	Homo sapiens	Inhibition	%	1.54
	8173802	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.12	CHEMBL2068	Homo sapiens	Inhibition	%	2.12
	8173889	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	1.93	CHEMBL2068	Homo sapiens	Inhibition	%	1.93
	8174245	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	10.34	CHEMBL2068	Homo sapiens	Inhibition	%	10.34
	8174393	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	41.98	CHEMBL2068	Homo sapiens	Inhibition	%	41.98
	8174617	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.47	CHEMBL2068	Homo sapiens	Inhibition	%	2.47
	8174739	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.42	CHEMBL2068	Homo sapiens	Inhibition	%	3.42
	8175106	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-3.81	CHEMBL2068	Homo sapiens	Inhibition	%	-3.81
	8175242	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	-0.98	CHEMBL2068	Homo sapiens	Inhibition	%	-0.98
	8175498	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	1.55	CHEMBL2068	Homo sapiens	Inhibition	%	1.55
	8175722	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	1.91	CHEMBL2068	Homo sapiens	Inhibition	%	1.91
	8175885	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.28	CHEMBL2068	Homo sapiens	Inhibition	%	1.28
	8176038	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	0.81	CHEMBL2068	Homo sapiens	Inhibition	%	0.81
	8176262	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	0.49	CHEMBL2068	Homo sapiens	Inhibition	%	0.49
	8176411	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-5.64	CHEMBL2068	Homo sapiens	Inhibition	%	-5.64
	8176767	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	3.88	CHEMBL2068	Homo sapiens	Inhibition	%	3.88
	8176897	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-2.85	CHEMBL2068	Homo sapiens	Inhibition	%	-2.85
	8177263	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	39.45	CHEMBL2068	Homo sapiens	Inhibition	%	39.45
	8177401	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-3.03	CHEMBL2068	Homo sapiens	Inhibition	%	-3.03
	8177625	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	2.52	CHEMBL2068	Homo sapiens	Inhibition	%	2.52
	8177789	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	15.76	CHEMBL2068	Homo sapiens	Inhibition	%	15.76
	8178153	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	0.76	CHEMBL2068	Homo sapiens	Inhibition	%	0.76
	8178241	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	1.88	CHEMBL2068	Homo sapiens	Inhibition	%	1.88
	8178465	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	-0.69	CHEMBL2068	Homo sapiens	Inhibition	%	-0.69
	8178592	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	40.22	CHEMBL2068	Homo sapiens	Inhibition	%	40.22
	8178965	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.67	CHEMBL2068	Homo sapiens	Inhibition	%	1.67
	8179088	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.3	CHEMBL2068	Homo sapiens	Inhibition	%	3.3
	8179456	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.72	CHEMBL2068	Homo sapiens	Inhibition	%	1.72
	8179593	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.28	CHEMBL2068	Homo sapiens	Inhibition	%	0.28
	8179817	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-2.13	CHEMBL2068	Homo sapiens	Inhibition	%	-2.13
	8180074	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.84	CHEMBL2068	Homo sapiens	Inhibition	%	1.84
	8180228	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	18.59	CHEMBL2068	Homo sapiens	Inhibition	%	18.59
	8180608	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	0.85	CHEMBL2068	Homo sapiens	Inhibition	%	0.85
	8180756	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	-2.54	CHEMBL2068	Homo sapiens	Inhibition	%	-2.54
	8181113	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	91.34	CHEMBL2068	Homo sapiens	Inhibition	%	91.34
	8181244	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-3.04	CHEMBL2068	Homo sapiens	Inhibition	%	-3.04
	8181468	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-4.14	CHEMBL2068	Homo sapiens	Inhibition	%	-4.14
	8181608	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	84.42	CHEMBL2068	Homo sapiens	Inhibition	%	84.42
	8181971	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	0.85	CHEMBL2068	Homo sapiens	Inhibition	%	0.85
	8182134	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	0.69	CHEMBL2068	Homo sapiens	Inhibition	%	0.69
	8182498	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.87	CHEMBL2068	Homo sapiens	Inhibition	%	2.87
	8182814	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.86	CHEMBL2068	Homo sapiens	Inhibition	%	0.86
	8182936	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.28	CHEMBL2068	Homo sapiens	Inhibition	%	4.28
	8183309	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.67	CHEMBL2068	Homo sapiens	Inhibition	%	3.67
	8183438	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.25	CHEMBL2068	Homo sapiens	Inhibition	%	2.25
	8183662	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	4.63	CHEMBL2068	Homo sapiens	Inhibition	%	4.63
	8183804	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.75	CHEMBL2068	Homo sapiens	Inhibition	%	1.75
	8184164	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-0.4	CHEMBL2068	Homo sapiens	Inhibition	%	-0.4
	8184430	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.09	CHEMBL2068	Homo sapiens	Inhibition	%	2.09
	8184577	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-6.71	CHEMBL2068	Homo sapiens	Inhibition	%	-6.71
	8184801	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-6.16	CHEMBL2068	Homo sapiens	Inhibition	%	-6.16
	8184958	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	2.48	CHEMBL2068	Homo sapiens	Inhibition	%	2.48
	8185107	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	-2.52	CHEMBL2068	Homo sapiens	Inhibition	%	-2.52
	8185331	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-3.31	CHEMBL2068	Homo sapiens	Inhibition	%	-3.31
	8185462	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	95.7	CHEMBL2068	Homo sapiens	Inhibition	%	95.7
	8185817	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-3.36	CHEMBL2068	Homo sapiens	Inhibition	%	-3.36
	8185956	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.75	CHEMBL2068	Homo sapiens	Inhibition	%	1.75
	8186180	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.8	CHEMBL2068	Homo sapiens	Inhibition	%	3.8
	8186321	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.87	CHEMBL2068	Homo sapiens	Inhibition	%	2.87
	8186485	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	0.59	CHEMBL2068	Homo sapiens	Inhibition	%	0.59
	8186709	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.52	CHEMBL2068	Homo sapiens	Inhibition	%	2.52
	8186848	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.53	CHEMBL2068	Homo sapiens	Inhibition	%	0.53
	8187170	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	8.68	CHEMBL2068	Homo sapiens	Inhibition	%	8.68
	8187294	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.62	CHEMBL2068	Homo sapiens	Inhibition	%	5.62
	8187518	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.21	CHEMBL2068	Homo sapiens	Inhibition	%	1.21
	8187666	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.85	CHEMBL2068	Homo sapiens	Inhibition	%	3.85
	8188019	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	3.45	CHEMBL2068	Homo sapiens	Inhibition	%	3.45
	8188162	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.86	CHEMBL2068	Homo sapiens	Inhibition	%	1.86
	8188386	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.3	CHEMBL2068	Homo sapiens	Inhibition	%	1.3
	8188521	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-3.2	CHEMBL2068	Homo sapiens	Inhibition	%	-3.2
	8188795	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.48	CHEMBL2068	Homo sapiens	Inhibition	%	1.48
	8189167	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.56	CHEMBL2068	Homo sapiens	Inhibition	%	1.56
	8189323	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	14.42	CHEMBL2068	Homo sapiens	Inhibition	%	14.42
	8189696	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-4.19	CHEMBL2068	Homo sapiens	Inhibition	%	-4.19
	8189828	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-2.77	CHEMBL2068	Homo sapiens	Inhibition	%	-2.77
	8190184	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.75	CHEMBL2068	Homo sapiens	Inhibition	%	1.75
	8190548	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	15.22	CHEMBL2068	Homo sapiens	Inhibition	%	15.22
	8190685	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	-0.08	CHEMBL2068	Homo sapiens	Inhibition	%	-0.08
	8191073	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	0.56	CHEMBL2068	Homo sapiens	Inhibition	%	0.56
	8191211	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.63	CHEMBL2068	Homo sapiens	Inhibition	%	2.63
	8191531	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	47.23	CHEMBL2068	Homo sapiens	Inhibition	%	47.23
	8191877	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.29	CHEMBL2068	Homo sapiens	Inhibition	%	2.29
	8192026	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.59	CHEMBL2068	Homo sapiens	Inhibition	%	3.59
	8192250	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.3	CHEMBL2068	Homo sapiens	Inhibition	%	2.3
	8192379	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.44	CHEMBL2068	Homo sapiens	Inhibition	%	2.44
	8192747	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.22	CHEMBL2068	Homo sapiens	Inhibition	%	2.22
	8192883	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.45	CHEMBL2068	Homo sapiens	Inhibition	%	1.45
	8193155	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.15	CHEMBL2068	Homo sapiens	Inhibition	%	2.15
	8193524	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	21.07	CHEMBL2068	Homo sapiens	Inhibition	%	21.07
	8193681	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	0.86	CHEMBL2068	Homo sapiens	Inhibition	%	0.86
	8193905	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	1.68	CHEMBL2068	Homo sapiens	Inhibition	%	1.68
	8194054	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-5.01	CHEMBL2068	Homo sapiens	Inhibition	%	-5.01
	8194185	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-2.32	CHEMBL2068	Homo sapiens	Inhibition	%	-2.32
	8194409	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.35	CHEMBL2068	Homo sapiens	Inhibition	%	2.35
	8194540	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.18	CHEMBL2068	Homo sapiens	Inhibition	%	3.18
	8194907	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	56.26	CHEMBL2068	Homo sapiens	Inhibition	%	56.26
	8195040	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.31	CHEMBL2068	Homo sapiens	Inhibition	%	2.31
	8195264	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	-0.04	CHEMBL2068	Homo sapiens	Inhibition	%	-0.04
	8195428	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	-2.48	CHEMBL2068	Homo sapiens	Inhibition	%	-2.48
	8195567	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.36	CHEMBL2068	Homo sapiens	Inhibition	%	1.36
	8195791	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.78	CHEMBL2068	Homo sapiens	Inhibition	%	2.78
	8195889	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-1.16	CHEMBL2068	Homo sapiens	Inhibition	%	-1.16
	8196230	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.21	CHEMBL2068	Homo sapiens	Inhibition	%	1.21
	8196604	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	6.42	CHEMBL2068	Homo sapiens	Inhibition	%	6.42
	8196732	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.41	CHEMBL2068	Homo sapiens	Inhibition	%	2.41
	8197097	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.92	CHEMBL2068	Homo sapiens	Inhibition	%	3.92
	8197234	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-2.58	CHEMBL2068	Homo sapiens	Inhibition	%	-2.58
	8197458	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.79	CHEMBL2068	Homo sapiens	Inhibition	%	-0.79
	8197509	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.4	CHEMBL2068	Homo sapiens	Inhibition	%	0.4
	8197733	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.67	CHEMBL2068	Homo sapiens	Inhibition	%	3.67
	8197873	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-2.86	CHEMBL2068	Homo sapiens	Inhibition	%	-2.86
	8198254	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-3.82	CHEMBL2068	Homo sapiens	Inhibition	%	-3.82
	8198392	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-4.35	CHEMBL2068	Homo sapiens	Inhibition	%	-4.35
	8198746	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	10.61	CHEMBL2068	Homo sapiens	Inhibition	%	10.61
	8198877	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.33	CHEMBL2068	Homo sapiens	Inhibition	%	1.33
	8199101	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.75	CHEMBL2068	Homo sapiens	Inhibition	%	1.75
	8199249	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.13	CHEMBL2068	Homo sapiens	Inhibition	%	2.13
	8199607	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.2	CHEMBL2068	Homo sapiens	Inhibition	%	4.2
	8199770	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	-0.21	CHEMBL2068	Homo sapiens	Inhibition	%	-0.21
	8200132	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.31	CHEMBL2068	Homo sapiens	Inhibition	%	2.31
	8200236	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-0.31	CHEMBL2068	Homo sapiens	Inhibition	%	-0.31
	8200460	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-1.33	CHEMBL2068	Homo sapiens	Inhibition	%	-1.33
	8200575	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.81	CHEMBL2068	Homo sapiens	Inhibition	%	0.81
	8200949	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	14.96	CHEMBL2068	Homo sapiens	Inhibition	%	14.96
	8201079	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-1.31	CHEMBL2068	Homo sapiens	Inhibition	%	-1.31
	8201303	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-1.86	CHEMBL2068	Homo sapiens	Inhibition	%	-1.86
	8201438	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.69	CHEMBL2068	Homo sapiens	Inhibition	%	0.69
	8201795	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.85	CHEMBL2068	Homo sapiens	Inhibition	%	-1.85
	8202074	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.17	CHEMBL2068	Homo sapiens	Inhibition	%	0.17
	8202214	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-1.31	CHEMBL2068	Homo sapiens	Inhibition	%	-1.31
	8202605	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-3.6	CHEMBL2068	Homo sapiens	Inhibition	%	-3.6
	8202730	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.25	CHEMBL2068	Homo sapiens	Inhibition	%	1.25
	8202954	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	0.94	CHEMBL2068	Homo sapiens	Inhibition	%	0.94
	8203084	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	1.09	CHEMBL2068	Homo sapiens	Inhibition	%	1.09
	8203439	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-1.48	CHEMBL2068	Homo sapiens	Inhibition	%	-1.48
	8203585	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.37	CHEMBL2068	Homo sapiens	Inhibition	%	2.37
	8203943	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	0.3	CHEMBL2068	Homo sapiens	Inhibition	%	0.3
	8204109	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	16.55	CHEMBL2068	Homo sapiens	Inhibition	%	16.55
	8204333	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	60.75	CHEMBL2068	Homo sapiens	Inhibition	%	60.75
	8204470	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	34.42	CHEMBL2068	Homo sapiens	Inhibition	%	34.42
	8204799	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.12	CHEMBL2068	Homo sapiens	Inhibition	%	2.12
	8204914	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	6.02	CHEMBL2068	Homo sapiens	Inhibition	%	6.02
	8205138	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	21.04	CHEMBL2068	Homo sapiens	Inhibition	%	21.04
	8205287	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	2.12	CHEMBL2068	Homo sapiens	Inhibition	%	2.12
	8205647	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.57	CHEMBL2068	Homo sapiens	Inhibition	%	2.57
	8205786	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.7	CHEMBL2068	Homo sapiens	Inhibition	%	0.7
	8206142	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.23	CHEMBL2068	Homo sapiens	Inhibition	%	-0.23
	8206418	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.21	CHEMBL2068	Homo sapiens	Inhibition	%	1.21
	8206561	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-4.92	CHEMBL2068	Homo sapiens	Inhibition	%	-4.92
	8206785	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-4.26	CHEMBL2068	Homo sapiens	Inhibition	%	-4.26
	8206965	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	0.86	CHEMBL2068	Homo sapiens	Inhibition	%	0.86
	8207315	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	0.6	CHEMBL2068	Homo sapiens	Inhibition	%	0.6
	8207445	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	0.95	CHEMBL2068	Homo sapiens	Inhibition	%	0.95
	8207801	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.19	CHEMBL2068	Homo sapiens	Inhibition	%	2.19
	8207946	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-0.74	CHEMBL2068	Homo sapiens	Inhibition	%	-0.74
	8208170	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-1.53	CHEMBL2068	Homo sapiens	Inhibition	%	-1.53
	8208302	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.38	CHEMBL2068	Homo sapiens	Inhibition	%	2.38
	8208692	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	-0.93	CHEMBL2068	Homo sapiens	Inhibition	%	-0.93
	8208825	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	80.17	CHEMBL2068	Homo sapiens	Inhibition	%	80.17
	8209154	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-1.44	CHEMBL2068	Homo sapiens	Inhibition	%	-1.44
	8209494	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.85	CHEMBL2068	Homo sapiens	Inhibition	%	0.85
	8209644	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	0.18	CHEMBL2068	Homo sapiens	Inhibition	%	0.18
	8210004	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.93	CHEMBL2068	Homo sapiens	Inhibition	%	1.93
	8210145	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.66	CHEMBL2068	Homo sapiens	Inhibition	%	0.66
	8210369	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.4	CHEMBL2068	Homo sapiens	Inhibition	%	1.4
	8210505	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-3.7	CHEMBL2068	Homo sapiens	Inhibition	%	-3.7
	8210764	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-3.78	CHEMBL2068	Homo sapiens	Inhibition	%	-3.78
	8211132	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.23	CHEMBL2068	Homo sapiens	Inhibition	%	2.23
	8211302	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	0.27	CHEMBL2068	Homo sapiens	Inhibition	%	0.27
	8211649	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	0.92	CHEMBL2068	Homo sapiens	Inhibition	%	0.92
	8211778	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	4.79	CHEMBL2068	Homo sapiens	Inhibition	%	4.79
	8212002	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	24.22	CHEMBL2068	Homo sapiens	Inhibition	%	24.22
	8212134	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.97	CHEMBL2068	Homo sapiens	Inhibition	%	1.97
	8212499	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	-2.34	CHEMBL2068	Homo sapiens	Inhibition	%	-2.34
	8212632	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	1.07	CHEMBL2068	Homo sapiens	Inhibition	%	1.07
	8212856	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.56	CHEMBL2068	Homo sapiens	Inhibition	%	1.56
	8213026	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.37	CHEMBL2068	Homo sapiens	Inhibition	%	0.37
	8213155	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.3	CHEMBL2068	Homo sapiens	Inhibition	%	1.3
	8213379	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.04	CHEMBL2068	Homo sapiens	Inhibition	%	0.04
	8213483	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.56	CHEMBL2068	Homo sapiens	Inhibition	%	-0.56
	8213820	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.89	CHEMBL2068	Homo sapiens	Inhibition	%	0.89
	8213967	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.0	CHEMBL2068	Homo sapiens	Inhibition	%	3.0
	8214191	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.18	CHEMBL2068	Homo sapiens	Inhibition	%	1.18
	8214328	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	5.44	CHEMBL2068	Homo sapiens	Inhibition	%	5.44
	8214686	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	1.66	CHEMBL2068	Homo sapiens	Inhibition	%	1.66
	8214838	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.54	CHEMBL2068	Homo sapiens	Inhibition	%	-1.54
	8215089	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-3.32	CHEMBL2068	Homo sapiens	Inhibition	%	-3.32
	8215313	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	-0.08	CHEMBL2068	Homo sapiens	Inhibition	%	-0.08
	8215466	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.86	CHEMBL2068	Homo sapiens	Inhibition	%	3.86
	8215630	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	0.75	CHEMBL2068	Homo sapiens	Inhibition	%	0.75
	8215854	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	0.06	CHEMBL2068	Homo sapiens	Inhibition	%	0.06
	8215973	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-2.5	CHEMBL2068	Homo sapiens	Inhibition	%	-2.5
	8216316	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-2.06	CHEMBL2068	Homo sapiens	Inhibition	%	-2.06
	8216452	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.53	CHEMBL2068	Homo sapiens	Inhibition	%	1.53
	8216676	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.66	CHEMBL2068	Homo sapiens	Inhibition	%	2.66
	8216814	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	-1.62	CHEMBL2068	Homo sapiens	Inhibition	%	-1.62
	8217172	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	0.66	CHEMBL2068	Homo sapiens	Inhibition	%	0.66
	8217346	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-2.63	CHEMBL2068	Homo sapiens	Inhibition	%	-2.63
	8217701	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	9.06	CHEMBL2068	Homo sapiens	Inhibition	%	9.06
	8217802	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-2.0	CHEMBL2068	Homo sapiens	Inhibition	%	-2.0
	8218026	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.26	CHEMBL2068	Homo sapiens	Inhibition	%	-1.26
	8218141	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.49	CHEMBL2068	Homo sapiens	Inhibition	%	1.49
	8218492	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.33	CHEMBL2068	Homo sapiens	Inhibition	%	1.33
	8218635	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	6.5	CHEMBL2068	Homo sapiens	Inhibition	%	6.5
	8218859	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	87.88	CHEMBL2068	Homo sapiens	Inhibition	%	87.88
	8218990	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	23.28	CHEMBL2068	Homo sapiens	Inhibition	%	23.28
	8219150	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.75	CHEMBL2068	Homo sapiens	Inhibition	%	4.75
	8219374	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	2.42	CHEMBL2068	Homo sapiens	Inhibition	%	2.42
	8219624	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.96	CHEMBL2068	Homo sapiens	Inhibition	%	0.96
	8219785	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.21	CHEMBL2068	Homo sapiens	Inhibition	%	1.21
	8220178	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	0.26	CHEMBL2068	Homo sapiens	Inhibition	%	0.26
	8220307	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-3.57	CHEMBL2068	Homo sapiens	Inhibition	%	-3.57
	8220645	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-1.67	CHEMBL2068	Homo sapiens	Inhibition	%	-1.67
	8221007	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.0	CHEMBL2068	Homo sapiens	Inhibition	%	2.0
	8221143	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-6.99	CHEMBL2068	Homo sapiens	Inhibition	%	-6.99
	8221500	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	0.65	CHEMBL2068	Homo sapiens	Inhibition	%	0.65
	8221665	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-2.48	CHEMBL2068	Homo sapiens	Inhibition	%	-2.48
	8222020	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	34.38	CHEMBL2068	Homo sapiens	Inhibition	%	34.38
	8222342	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.84	CHEMBL2068	Homo sapiens	Inhibition	%	3.84
	8222476	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	0.74	CHEMBL2068	Homo sapiens	Inhibition	%	0.74
	8222818	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	5.44	CHEMBL2068	Homo sapiens	Inhibition	%	5.44
	8223186	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	95.67	CHEMBL2068	Homo sapiens	Inhibition	%	95.67
	8223315	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.75	CHEMBL2068	Homo sapiens	Inhibition	%	2.75
	8223700	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.27	CHEMBL2068	Homo sapiens	Inhibition	%	2.27
	8223950	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	0.22	CHEMBL2068	Homo sapiens	Inhibition	%	0.22
	8224112	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.62	CHEMBL2068	Homo sapiens	Inhibition	%	1.62
	8224336	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-2.27	CHEMBL2068	Homo sapiens	Inhibition	%	-2.27
	8224506	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.45	CHEMBL2068	Homo sapiens	Inhibition	%	1.45
	8224641	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.6	CHEMBL2068	Homo sapiens	Inhibition	%	1.6
	8224865	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.34	CHEMBL2068	Homo sapiens	Inhibition	%	1.34
	8224979	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	-2.83	CHEMBL2068	Homo sapiens	Inhibition	%	-2.83
	8225337	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.13	CHEMBL2068	Homo sapiens	Inhibition	%	1.13
	8225475	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-7.28	CHEMBL2068	Homo sapiens	Inhibition	%	-7.28
	8225699	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-2.56	CHEMBL2068	Homo sapiens	Inhibition	%	-2.56
	8225834	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	-0.38	CHEMBL2068	Homo sapiens	Inhibition	%	-0.38
	8225992	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.31	CHEMBL2068	Homo sapiens	Inhibition	%	-2.31
	8226216	CHEMBL1962269	GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.19	CHEMBL2068	Homo sapiens	Inhibition	%	-3.19
	8226341	CHEMBL1962268	GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	0.65	CHEMBL2068	Homo sapiens	Inhibition	%	0.65
inactive	9607535	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607536	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	39.81	CHEMBL2068	Homo sapiens	pKi		7.4
inactive	9607537	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607538	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607539	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	2511.89	CHEMBL2068	Homo sapiens	pKi		5.6
active	9607540	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	79.43	CHEMBL2068	Homo sapiens	pKi		7.1
inactive	9607541	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
active	9607542	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	=	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
active	9607543	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	398.11	CHEMBL2068	Homo sapiens	pKi		6.4
inactive	9607544	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607545	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
active	9607546	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	=	Ki	nM	1258.93	CHEMBL2068	Homo sapiens	pKi		5.9
inactive	9607547	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607548	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607549	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607550	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607551	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607552	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607553	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607554	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607555	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607556	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	251.19	CHEMBL2068	Homo sapiens	pKi		6.6
inactive	9607557	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607558	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607559	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607560	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607561	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607562	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607563	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607564	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607565	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607566	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607567	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607568	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607569	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607570	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607571	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607572	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	1584.89	CHEMBL2068	Homo sapiens	pKi		5.8
inactive	9607573	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607574	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607575	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	2511.89	CHEMBL2068	Homo sapiens	pKi		5.6
active	9607576	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	100.0	CHEMBL2068	Homo sapiens	pKi		7.0
inactive	9607577	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607578	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607579	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(OC)c(CNC(=O)c2cc(N)c(C#N)c(OC(C)C)n2)c1		CHEMBL1982541	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607580	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607581	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607582	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607583	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607584	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607585	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607586	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607587	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607588	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607589	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	100.0	CHEMBL2068	Homo sapiens	pKi		7.0
inactive	9607590	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607591	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607592	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607593	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607594	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607595	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607596	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607597	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607598	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607599	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607600	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
inactive	9607601	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607602	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607603	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607604	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	=	Ki	nM	19.95	CHEMBL2068	Homo sapiens	pKi		7.7
active	9607605	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	100.0	CHEMBL2068	Homo sapiens	pKi		7.0
inactive	9607606	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607607	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607608	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	39.81	CHEMBL2068	Homo sapiens	pKi		7.4
inactive	9607609	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607610	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607611	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607612	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607613	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607614	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607615	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	794.33	CHEMBL2068	Homo sapiens	pKi		6.1
inactive	9607616	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607617	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607618	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607619	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607620	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607621	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	125.89	CHEMBL2068	Homo sapiens	pKi		6.9
inactive	9607622	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607623	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607624	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607625	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607626	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	=	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607627	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607628	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607629	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607630	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607631	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	100.0	CHEMBL2068	Homo sapiens	pKi		7.0
inactive	9607632	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607633	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	15.85	CHEMBL2068	Homo sapiens	pKi		7.8
inactive	9607634	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607635	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	=	Ki	nM	1258.93	CHEMBL2068	Homo sapiens	pKi		5.9
active	9607636	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	125.89	CHEMBL2068	Homo sapiens	pKi		6.9
inactive	9607637	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607638	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607639	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607640	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607641	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607642	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
inactive	9607643	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607644	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607645	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607646	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
inactive	9607647	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607648	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607649	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607650	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9607651	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	79.43	CHEMBL2068	Homo sapiens	pKi		7.1
inactive	9607652	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607653	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607654	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9607655	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607656	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607657	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607658	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9607659	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611229	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611230	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611231	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	=	Ki	nM	398.11	CHEMBL2068	Homo sapiens	pKi		6.4
inactive	9611232	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611233	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611234	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611235	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611236	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611237	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611238	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	199.53	CHEMBL2068	Homo sapiens	pKi		6.7
inactive	9611239	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611240	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611241	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611242	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611243	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	158.49	CHEMBL2068	Homo sapiens	pKi		6.8
inactive	9611244	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611245	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611246	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	794.33	CHEMBL2068	Homo sapiens	pKi		6.1
inactive	9611247	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611248	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611249	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611250	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
active	9611251	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Ki	nM	794.33	CHEMBL2068	Homo sapiens	pKi		6.1
inactive	9611252	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611253	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	=	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611254	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611255	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611256	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611257	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	316.23	CHEMBL2068	Homo sapiens	pKi		6.5
inactive	9611258	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611259	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611260	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
active	9611261	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	19.95	CHEMBL2068	Homo sapiens	pKi		7.7
active	9611262	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	10.0	CHEMBL2068	Homo sapiens	pKi		8.0
inactive	9611263	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611264	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611265	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611266	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611267	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611268	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	=	Ki	nM	79.43	CHEMBL2068	Homo sapiens	pKi		7.1
inactive	9611269	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611270	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611271	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611272	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611273	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611274	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	<	Ki	nM	19952.62	CHEMBL2068	Homo sapiens	pKi		4.7
inactive	9611275	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611276	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611277	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611278	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611279	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611280	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611281	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611282	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	19.95	CHEMBL2068	Homo sapiens	pKi		7.7
inactive	9611283	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611284	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611285	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611286	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611287	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611288	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611289	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611290	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611291	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	100.0	CHEMBL2068	Homo sapiens	pKi		7.0
inactive	9611292	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611293	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611294	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611295	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611296	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611297	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	251.19	CHEMBL2068	Homo sapiens	pKi		6.6
inactive	9611298	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611299	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611300	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
active	9611301	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	19.95	CHEMBL2068	Homo sapiens	pKi		7.7
inactive	9611302	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611303	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611304	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611305	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611306	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611307	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611308	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611309	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	19.95	CHEMBL2068	Homo sapiens	pKi		7.7
inactive	9611310	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611311	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611312	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611313	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611314	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611315	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611316	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611317	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611318	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611319	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	79.43	CHEMBL2068	Homo sapiens	pKi		7.1
inactive	9611320	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611321	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611322	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611323	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611324	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611325	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611326	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611327	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611328	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611329	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611330	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611331	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611332	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	100.0	CHEMBL2068	Homo sapiens	pKi		7.0
active	9611333	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	125.89	CHEMBL2068	Homo sapiens	pKi		6.9
inactive	9611334	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611335	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611336	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611337	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	794.33	CHEMBL2068	Homo sapiens	pKi		6.1
inactive	9611338	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611339	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611340	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	63.1	CHEMBL2068	Homo sapiens	pKi		7.2
active	9611341	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	199.53	CHEMBL2068	Homo sapiens	pKi		6.7
active	9611342	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	1995.26	CHEMBL2068	Homo sapiens	pKi		5.7
inactive	9611343	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611344	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611345	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611346	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
active	9611347	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	=	Ki	nM	794.33	CHEMBL2068	Homo sapiens	pKi		6.1
inactive	9611348	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611349	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
active	9611350	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	630.96	CHEMBL2068	Homo sapiens	pKi		6.2
inactive	9611351	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611352	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611353	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	15.85	CHEMBL2068	Homo sapiens	pKi		7.8
inactive	9611354	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611355	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611356	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611357	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611358	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611359	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611360	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611361	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611362	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	251.19	CHEMBL2068	Homo sapiens	pKi		6.6
inactive	9611363	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611364	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	Ki	nM	100.0	CHEMBL2068	Homo sapiens	pKi		7.0
inactive	9611365	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611366	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611367	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	=	Ki	nM	398.11	CHEMBL2068	Homo sapiens	pKi		6.4
inactive	9611368	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611369	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611370	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611371	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611372	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611373	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611374	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611375	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611376	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611377	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611378	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	=	Ki	nM	100.0	CHEMBL2068	Homo sapiens	pKi		7.0
inactive	9611379	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611380	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611381	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611382	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611383	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611384	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611385	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	1000.0	CHEMBL2068	Homo sapiens	pKi		6.0
inactive	9611386	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611387	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611388	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611389	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611390	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611391	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611392	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611393	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611394	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611395	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Ki	nM	125.89	CHEMBL2068	Homo sapiens	pKi		6.9
active	9611396	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	=	Ki	nM	1995.26	CHEMBL2068	Homo sapiens	pKi		5.7
inactive	9611397	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611398	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611399	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611400	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611401	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611402	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	1584.89	CHEMBL2068	Homo sapiens	pKi		5.8
inactive	9611403	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611404	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
inactive	9611405	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611406	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611407	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	251.19	CHEMBL2068	Homo sapiens	pKi		6.6
inactive	9611408	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611409	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611410	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611411	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611412	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611413	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611414	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611415	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611416	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611417	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	1995.26	CHEMBL2068	Homo sapiens	pKi		5.7
inactive	9611418	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611419	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611420	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611421	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611422	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611423	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cn1ncc2c1CCCC2=O		CHEMBL1981107	<	Ki	nM	19952.62	CHEMBL2068	Homo sapiens	pKi		4.7
inactive	9611424	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611425	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611426	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611427	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
inactive	9611428	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611429	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	251.19	CHEMBL2068	Homo sapiens	pKi		6.6
inactive	9611430	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611431	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9611432	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611433	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611434	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611435	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	1258.93	CHEMBL2068	Homo sapiens	pKi		5.9
inactive	9611436	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611437	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611438	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611439	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611440	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611441	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	100.0	CHEMBL2068	Homo sapiens	pKi		7.0
active	9611442	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	31.62	CHEMBL2068	Homo sapiens	pKi		7.5
inactive	9611443	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611444	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611445	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611446	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611447	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	1000.0	CHEMBL2068	Homo sapiens	pKi		6.0
active	9611448	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	79.43	CHEMBL2068	Homo sapiens	pKi		7.1
active	9611449	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	=	Ki	nM	12.59	CHEMBL2068	Homo sapiens	pKi		7.9
inactive	9611450	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611451	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611452	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	100.0	CHEMBL2068	Homo sapiens	pKi		7.0
inactive	9611453	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611454	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611455	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611456	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	794.33	CHEMBL2068	Homo sapiens	pKi		6.1
inactive	9611457	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611458	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9611459	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9611460	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	316.23	CHEMBL2068	Homo sapiens	pKi		6.5
active	9611461	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	1258.93	CHEMBL2068	Homo sapiens	pKi		5.9
active	9611462	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	12.59	CHEMBL2068	Homo sapiens	pKi		7.9
inactive	9615030	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615031	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	<	Ki	nM	316.23	CHEMBL2068	Homo sapiens	pKi		6.5
inactive	9615032	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615033	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615034	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615035	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615036	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615037	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615038	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615039	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615040	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615041	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615042	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
active	9615043	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	316.23	CHEMBL2068	Homo sapiens	pKi		6.5
inactive	9615044	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615045	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615046	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615047	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615048	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615049	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	125.89	CHEMBL2068	Homo sapiens	pKi		6.9
inactive	9615050	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615051	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615052	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	316.23	CHEMBL2068	Homo sapiens	pKi		6.5
inactive	9615053	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615054	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615055	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615056	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615057	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615058	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615059	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615060	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615061	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615062	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615063	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	3.981	CHEMBL2068	Homo sapiens	pKi		8.4
inactive	9615064	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615065	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615066	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615067	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615068	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	19.95	CHEMBL2068	Homo sapiens	pKi		7.7
inactive	9615069	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615070	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	2511.89	CHEMBL2068	Homo sapiens	pKi		5.6
inactive	9615071	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615072	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615073	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615074	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615075	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615076	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615077	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615078	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615079	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615080	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	794.33	CHEMBL2068	Homo sapiens	pKi		6.1
inactive	9615081	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615082	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615083	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615084	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	630.96	CHEMBL2068	Homo sapiens	pKi		6.2
inactive	9615085	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615086	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615087	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615088	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	1258.93	CHEMBL2068	Homo sapiens	pKi		5.9
active	9615089	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	100.0	CHEMBL2068	Homo sapiens	pKi		7.0
inactive	9615090	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615091	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	1584.89	CHEMBL2068	Homo sapiens	pKi		5.8
inactive	9615092	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615093	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	63.1	CHEMBL2068	Homo sapiens	pKi		7.2
inactive	9615094	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615095	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615096	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615097	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615098	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615099	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615100	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
active	9615101	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	1258.93	CHEMBL2068	Homo sapiens	pKi		5.9
active	9615102	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	100.0	CHEMBL2068	Homo sapiens	pKi		7.0
inactive	9615103	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615104	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615105	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615106	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615107	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	=	Ki	nM	2511.89	CHEMBL2068	Homo sapiens	pKi		5.6
inactive	9615108	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615109	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615110	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	2511.89	CHEMBL2068	Homo sapiens	pKi		5.6
inactive	9615111	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615112	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615113	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
inactive	9615114	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
inactive	9615115	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615116	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615117	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615118	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615119	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615120	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615121	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615122	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615123	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
inactive	9615124	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615125	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615126	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615127	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615128	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	630.96	CHEMBL2068	Homo sapiens	pKi		6.2
inactive	9615129	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615130	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	=	Ki	nM	251.19	CHEMBL2068	Homo sapiens	pKi		6.6
inactive	9615131	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	1995.26	CHEMBL2068	Homo sapiens	pKi		5.7
inactive	9615132	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615133	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615134	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615135	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	6309.57	CHEMBL2068	Homo sapiens	pKi		5.2
inactive	9615136	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615137	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615138	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615139	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615140	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615141	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615142	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615143	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615144	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
inactive	9615145	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615146	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615147	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615148	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615149	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615150	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615151	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615152	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615153	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615154	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615155	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615156	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615157	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615158	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615159	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615160	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615161	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615162	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615163	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615164	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615165	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615166	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615167	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	=	Ki	nM	1584.89	CHEMBL2068	Homo sapiens	pKi		5.8
active	9615168	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	125.89	CHEMBL2068	Homo sapiens	pKi		6.9
inactive	9615169	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615170	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615171	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615172	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615173	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615174	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615175	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615176	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615177	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615178	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615179	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615180	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	=	Ki	nM	1995.26	CHEMBL2068	Homo sapiens	pKi		5.7
inactive	9615181	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615182	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615183	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615184	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615185	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615186	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	=	Ki	nM	125.89	CHEMBL2068	Homo sapiens	pKi		6.9
inactive	9615187	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615188	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615189	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615190	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615191	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615192	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615193	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	1258.93	CHEMBL2068	Homo sapiens	pKi		5.9
inactive	9615194	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615195	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615196	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615197	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615198	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	=	Ki	nM	199.53	CHEMBL2068	Homo sapiens	pKi		6.7
inactive	9615199	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615200	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	31.62	CHEMBL2068	Homo sapiens	pKi		7.5
inactive	9615201	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615202	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615203	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615204	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615205	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615206	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615207	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	100.0	CHEMBL2068	Homo sapiens	pKi		7.0
active	9615208	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	501.19	CHEMBL2068	Homo sapiens	pKi		6.3
inactive	9615209	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615210	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615211	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615212	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615213	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615214	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615215	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615216	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615217	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615218	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	630.96	CHEMBL2068	Homo sapiens	pKi		6.2
inactive	9615219	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1NC(=O)C(Nc2ccccc2)=C1Cl		CHEMBL2007138	<	Ki	nM	19952.62	CHEMBL2068	Homo sapiens	pKi		4.7
inactive	9615220	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615221	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615222	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615223	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615224	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615225	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615226	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615227	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615228	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615229	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	1258.93	CHEMBL2068	Homo sapiens	pKi		5.9
inactive	9615230	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)Nc1n[nH]c2ccc(N)cc12		CHEMBL1995391	<	Ki	nM	19952.62	CHEMBL2068	Homo sapiens	pKi		4.7
inactive	9615231	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615232	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	398.11	CHEMBL2068	Homo sapiens	pKi		6.4
inactive	9615233	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9615234	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615235	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615236	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615237	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615238	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615239	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615240	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
inactive	9615241	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615242	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615243	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615244	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615245	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	2511.89	CHEMBL2068	Homo sapiens	pKi		5.6
active	9615246	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	158.49	CHEMBL2068	Homo sapiens	pKi		6.8
inactive	9615247	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615248	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615249	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615250	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615251	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615252	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615253	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
inactive	9615254	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
active	9615255	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Ki	nM	31.62	CHEMBL2068	Homo sapiens	pKi		7.5
inactive	9615256	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
active	9615257	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	=	Ki	nM	50.12	CHEMBL2068	Homo sapiens	pKi		7.3
inactive	9615258	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615259	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	6309.57	CHEMBL2068	Homo sapiens	pKi		5.2
inactive	9615260	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9615261	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9615262	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	=	Ki	nM	501.19	CHEMBL2068	Homo sapiens	pKi		6.3
inactive	9618822	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9618823	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	398.11	CHEMBL2068	Homo sapiens	pKi		6.4
inactive	9618824	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9618825	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	Ki	nM	1995.26	CHEMBL2068	Homo sapiens	pKi		5.7
inactive	9618826	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618827	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618828	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618829	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618830	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618831	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618832	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618833	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618834	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9618835	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618836	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618837	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9618838	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	31.62	CHEMBL2068	Homo sapiens	pKi		7.5
inactive	9618839	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618840	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9618841	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	1995.26	CHEMBL2068	Homo sapiens	pKi		5.7
inactive	9618842	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618843	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9618844	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618845	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618846	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9618847	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618848	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9618849	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	100.0	CHEMBL2068	Homo sapiens	pKi		7.0
active	9618850	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	50.12	CHEMBL2068	Homo sapiens	pKi		7.3
inactive	9618851	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
active	9618852	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	19.95	CHEMBL2068	Homo sapiens	pKi		7.7
active	9618853	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	3.162	CHEMBL2068	Homo sapiens	pKi		8.5
active	9618854	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	251.19	CHEMBL2068	Homo sapiens	pKi		6.6
inactive	9618855	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9618856	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9618857	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618858	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618859	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618860	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618861	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9618862	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618863	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618864	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618865	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9618866	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618867	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618868	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618869	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618870	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618871	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9618872	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)cc1C		CHEMBL1991874	=	Ki	nM	1995.26	CHEMBL2068	Homo sapiens	pKi		5.7
active	9618873	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	2511.89	CHEMBL2068	Homo sapiens	pKi		5.6
inactive	9618874	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618875	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618876	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618877	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618878	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618879	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618880	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618881	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
inactive	9618882	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618883	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618884	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618885	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9618886	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	501.19	CHEMBL2068	Homo sapiens	pKi		6.3
inactive	9618887	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618888	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618889	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618890	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618891	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9618892	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9618893	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618894	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618895	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618896	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618897	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9618898	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
active	9618899	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	199.53	CHEMBL2068	Homo sapiens	pKi		6.7
active	9618900	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	=	Ki	nM	398.11	CHEMBL2068	Homo sapiens	pKi		6.4
inactive	9618901	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
inactive	9618902	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9618903	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	125.89	CHEMBL2068	Homo sapiens	pKi		6.9
inactive	9618904	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9618905	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618906	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618907	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618908	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618909	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9618910	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618911	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618912	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618913	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9618914	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618915	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9618916	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	158.49	CHEMBL2068	Homo sapiens	pKi		6.8
inactive	9618917	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618918	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	7943.28	CHEMBL2068	Homo sapiens	pKi		5.1
inactive	9618919	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618920	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618921	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618922	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618923	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9618924	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	63.1	CHEMBL2068	Homo sapiens	pKi		7.2
inactive	9618925	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618926	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	5011.87	CHEMBL2068	Homo sapiens	pKi		5.3
inactive	9618927	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
inactive	9618928	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9618929	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	316.23	CHEMBL2068	Homo sapiens	pKi		6.5
inactive	9618930	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9618931	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	6.31	CHEMBL2068	Homo sapiens	pKi		8.2
inactive	9618932	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
active	9618933	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	50.12	CHEMBL2068	Homo sapiens	pKi		7.3
inactive	9618934	CHEMBL1963791	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: EPHA2	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	3162.28	CHEMBL2068	Homo sapiens	pKi		5.5
	10838568	CHEMBL2014141	Inhibition of EPHA2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	0.0	CHEMBL2068	Homo sapiens	INH	%	0.0
	10839542	CHEMBL2015008	Inhibition of EPH-A2 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	27.0	CHEMBL2068	Homo sapiens	Activity	%	27.0
	10839661	CHEMBL2015951	Inhibition of EPH-A2 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	70.0	CHEMBL2068	Homo sapiens	Activity	%	70.0
	10886020	CHEMBL2033410	Inhibition of EPHA2 in human HEK293 cells after 1 hr by competition binding assay	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	14.0	CHEMBL2068	Homo sapiens	Kd	nM	14.0
	10978476	CHEMBL2066231	Inhibition of human recombinant EphA2 using ulight-TK peptide as substrate assessed as residual activity at 1 uM after 30 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL2068	Homo sapiens	Activity	%	80.0
	10983103	CHEMBL2072606	Inhibition of EPHA2	B	C[C@H](NC(=O)c1cc(-c2cnn(C3CCOCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2071457	=	IC50	nM	6180.0	CHEMBL2068	Homo sapiens	IC50	uM	6.18
	11020081	CHEMBL2091829	Inhibition of EphA2	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(Cl)cc2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086760	=	IC50	nM	1700.0	CHEMBL2068	Homo sapiens	IC50	nM	1700.0
	12046288	CHEMBL2156525	Inhibition of EphA2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	0.8	CHEMBL2068	Homo sapiens	INH	%	0.8
	12170818	CHEMBL2212686	Inhibition of EPH-A2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	92.0	CHEMBL2068	Homo sapiens	Activity	%	92.0
	12172119	CHEMBL2213944	Inhibition of EPH-A2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	104.0	CHEMBL2068	Homo sapiens	Activity	%	104.0
	12173639	CHEMBL2214015	Inhibition of EPHA2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	12183893	CHEMBL2211494	Inhibition of EPHA2	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	pIC50		5.0
	12193488	CHEMBL2215272	Inhibition of EPHA2 at 100 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	83.1	CHEMBL2068	Homo sapiens	INH	%	83.1
	12193489	CHEMBL2215272	Inhibition of EPHA2 at 100 uM	B	O=C1CC(c2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2207940	=	Inhibition	%	0.0	CHEMBL2068	Homo sapiens	INH	%	0.0
	12195490	CHEMBL2210923	Inhibition of recombinant EPHA2 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	>	Ki	nM	2800.0	CHEMBL2068	Homo sapiens	Ki	nM	2800.0
	12195619	CHEMBL2212868	Inhibition of human recombinant EPHA2 using Ulight-TK peptide as substrate assessed as residual activity at 1 uM after 30 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	101.2	CHEMBL2068	Homo sapiens	Activity	%	101.2
	12241991	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	107.0	CHEMBL2068	Homo sapiens	Residual Activity	%	107.0
	12241992	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12241993	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	108.0	CHEMBL2068	Homo sapiens	Residual Activity	%	108.0
	12241994	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	101.0	CHEMBL2068	Homo sapiens	Residual Activity	%	101.0
	12241995	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	94.0	CHEMBL2068	Homo sapiens	Residual Activity	%	94.0
	12241996	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	96.0	CHEMBL2068	Homo sapiens	Residual Activity	%	96.0
	12241997	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12241998	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	89.0	CHEMBL2068	Homo sapiens	Residual Activity	%	89.0
	12241999	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	110.0	CHEMBL2068	Homo sapiens	Residual Activity	%	110.0
	12242000	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	89.0	CHEMBL2068	Homo sapiens	Residual Activity	%	89.0
	12242001	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12242002	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	102.0	CHEMBL2068	Homo sapiens	Residual Activity	%	102.0
	12242003	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	105.0	CHEMBL2068	Homo sapiens	Residual Activity	%	105.0
	12242004	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	33.0	CHEMBL2068	Homo sapiens	Residual Activity	%	33.0
	12242005	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	103.0	CHEMBL2068	Homo sapiens	Residual Activity	%	103.0
	12242006	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	103.0	CHEMBL2068	Homo sapiens	Residual Activity	%	103.0
	12242007	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	109.0	CHEMBL2068	Homo sapiens	Residual Activity	%	109.0
	12242008	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	115.0	CHEMBL2068	Homo sapiens	Residual Activity	%	115.0
	12242009	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	109.0	CHEMBL2068	Homo sapiens	Residual Activity	%	109.0
	12242010	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	103.0	CHEMBL2068	Homo sapiens	Residual Activity	%	103.0
	12242011	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	105.0	CHEMBL2068	Homo sapiens	Residual Activity	%	105.0
	12242012	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12242013	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	106.0	CHEMBL2068	Homo sapiens	Residual Activity	%	106.0
	12242014	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	84.0	CHEMBL2068	Homo sapiens	Residual Activity	%	84.0
	12242015	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	120.0	CHEMBL2068	Homo sapiens	Residual Activity	%	120.0
	12242016	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	85.0	CHEMBL2068	Homo sapiens	Residual Activity	%	85.0
	12242017	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	97.0	CHEMBL2068	Homo sapiens	Residual Activity	%	97.0
	12242018	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	90.0	CHEMBL2068	Homo sapiens	Residual Activity	%	90.0
	12242019	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	101.0	CHEMBL2068	Homo sapiens	Residual Activity	%	101.0
	12242020	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	108.0	CHEMBL2068	Homo sapiens	Residual Activity	%	108.0
	12242021	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	102.0	CHEMBL2068	Homo sapiens	Residual Activity	%	102.0
	12242022	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-3.0	CHEMBL2068	Homo sapiens	Residual Activity	%	-3.0
	12242023	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	103.0	CHEMBL2068	Homo sapiens	Residual Activity	%	103.0
	12242024	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	114.0	CHEMBL2068	Homo sapiens	Residual Activity	%	114.0
	12242025	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	110.0	CHEMBL2068	Homo sapiens	Residual Activity	%	110.0
	12242026	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	108.0	CHEMBL2068	Homo sapiens	Residual Activity	%	108.0
	12242027	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12242028	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	110.0	CHEMBL2068	Homo sapiens	Residual Activity	%	110.0
	12242029	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	106.0	CHEMBL2068	Homo sapiens	Residual Activity	%	106.0
	12242030	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	112.0	CHEMBL2068	Homo sapiens	Residual Activity	%	112.0
	12242031	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	108.0	CHEMBL2068	Homo sapiens	Residual Activity	%	108.0
	12242032	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	102.0	CHEMBL2068	Homo sapiens	Residual Activity	%	102.0
	12242033	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	91.0	CHEMBL2068	Homo sapiens	Residual Activity	%	91.0
	12242034	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	104.0	CHEMBL2068	Homo sapiens	Residual Activity	%	104.0
	12242035	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	91.0	CHEMBL2068	Homo sapiens	Residual Activity	%	91.0
	12242036	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	104.0	CHEMBL2068	Homo sapiens	Residual Activity	%	104.0
	12242037	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	110.0	CHEMBL2068	Homo sapiens	Residual Activity	%	110.0
	12242038	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12242039	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	107.0	CHEMBL2068	Homo sapiens	Residual Activity	%	107.0
	12242040	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	113.0	CHEMBL2068	Homo sapiens	Residual Activity	%	113.0
	12242041	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	104.0	CHEMBL2068	Homo sapiens	Residual Activity	%	104.0
	12242042	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12242043	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	77.0	CHEMBL2068	Homo sapiens	Residual Activity	%	77.0
	12242044	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	92.0	CHEMBL2068	Homo sapiens	Residual Activity	%	92.0
	12242045	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	113.0	CHEMBL2068	Homo sapiens	Residual Activity	%	113.0
	12242046	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	105.0	CHEMBL2068	Homo sapiens	Residual Activity	%	105.0
	12242047	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	113.0	CHEMBL2068	Homo sapiens	Residual Activity	%	113.0
	12242048	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	116.0	CHEMBL2068	Homo sapiens	Residual Activity	%	116.0
	12242049	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	118.0	CHEMBL2068	Homo sapiens	Residual Activity	%	118.0
	12242050	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	106.0	CHEMBL2068	Homo sapiens	Residual Activity	%	106.0
	12242051	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	99.0	CHEMBL2068	Homo sapiens	Residual Activity	%	99.0
	12242052	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	97.0	CHEMBL2068	Homo sapiens	Residual Activity	%	97.0
	12242053	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	102.0	CHEMBL2068	Homo sapiens	Residual Activity	%	102.0
	12242054	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	99.0	CHEMBL2068	Homo sapiens	Residual Activity	%	99.0
	12242055	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	119.0	CHEMBL2068	Homo sapiens	Residual Activity	%	119.0
	12242056	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	123.0	CHEMBL2068	Homo sapiens	Residual Activity	%	123.0
	12242057	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	105.0	CHEMBL2068	Homo sapiens	Residual Activity	%	105.0
	12242058	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	99.0	CHEMBL2068	Homo sapiens	Residual Activity	%	99.0
	12242059	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12242060	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12242061	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	109.0	CHEMBL2068	Homo sapiens	Residual Activity	%	109.0
	12242062	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	79.0	CHEMBL2068	Homo sapiens	Residual Activity	%	79.0
	12242063	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	102.0	CHEMBL2068	Homo sapiens	Residual Activity	%	102.0
	12242064	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	125.0	CHEMBL2068	Homo sapiens	Residual Activity	%	125.0
	12242065	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12242066	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	99.0	CHEMBL2068	Homo sapiens	Residual Activity	%	99.0
	12242067	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	107.0	CHEMBL2068	Homo sapiens	Residual Activity	%	107.0
	12242068	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	94.0	CHEMBL2068	Homo sapiens	Residual Activity	%	94.0
	12242069	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	105.0	CHEMBL2068	Homo sapiens	Residual Activity	%	105.0
	12242070	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	32.0	CHEMBL2068	Homo sapiens	Residual Activity	%	32.0
	12242071	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	106.0	CHEMBL2068	Homo sapiens	Residual Activity	%	106.0
	12242072	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	91.0	CHEMBL2068	Homo sapiens	Residual Activity	%	91.0
	12242073	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	98.0	CHEMBL2068	Homo sapiens	Residual Activity	%	98.0
	12242074	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	96.0	CHEMBL2068	Homo sapiens	Residual Activity	%	96.0
	12242075	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	89.0	CHEMBL2068	Homo sapiens	Residual Activity	%	89.0
	12242076	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	97.0	CHEMBL2068	Homo sapiens	Residual Activity	%	97.0
	12242077	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	87.0	CHEMBL2068	Homo sapiens	Residual Activity	%	87.0
	12242078	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12242079	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12242080	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	61.0	CHEMBL2068	Homo sapiens	Residual Activity	%	61.0
	12242081	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	96.0	CHEMBL2068	Homo sapiens	Residual Activity	%	96.0
	12242082	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	91.0	CHEMBL2068	Homo sapiens	Residual Activity	%	91.0
	12242083	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	75.0	CHEMBL2068	Homo sapiens	Residual Activity	%	75.0
	12242084	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	93.0	CHEMBL2068	Homo sapiens	Residual Activity	%	93.0
	12242085	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12242086	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	98.0	CHEMBL2068	Homo sapiens	Residual Activity	%	98.0
	12242087	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	107.0	CHEMBL2068	Homo sapiens	Residual Activity	%	107.0
	12242088	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	106.0	CHEMBL2068	Homo sapiens	Residual Activity	%	106.0
	12242089	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12242090	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	92.0	CHEMBL2068	Homo sapiens	Residual Activity	%	92.0
	12242091	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	87.0	CHEMBL2068	Homo sapiens	Residual Activity	%	87.0
	12242092	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	44.0	CHEMBL2068	Homo sapiens	Residual Activity	%	44.0
	12242093	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	97.0	CHEMBL2068	Homo sapiens	Residual Activity	%	97.0
	12242094	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	94.0	CHEMBL2068	Homo sapiens	Residual Activity	%	94.0
	12242095	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	97.0	CHEMBL2068	Homo sapiens	Residual Activity	%	97.0
	12242096	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	102.0	CHEMBL2068	Homo sapiens	Residual Activity	%	102.0
	12242097	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	94.0	CHEMBL2068	Homo sapiens	Residual Activity	%	94.0
	12242098	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	89.0	CHEMBL2068	Homo sapiens	Residual Activity	%	89.0
	12242099	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	88.0	CHEMBL2068	Homo sapiens	Residual Activity	%	88.0
	12242100	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	91.0	CHEMBL2068	Homo sapiens	Residual Activity	%	91.0
	12242101	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	89.0	CHEMBL2068	Homo sapiens	Residual Activity	%	89.0
	12242102	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	93.0	CHEMBL2068	Homo sapiens	Residual Activity	%	93.0
	12242103	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12242104	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12242105	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12242106	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	93.0	CHEMBL2068	Homo sapiens	Residual Activity	%	93.0
	12242107	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	32.0	CHEMBL2068	Homo sapiens	Residual Activity	%	32.0
	12242108	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	96.0	CHEMBL2068	Homo sapiens	Residual Activity	%	96.0
	12242109	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	92.0	CHEMBL2068	Homo sapiens	Residual Activity	%	92.0
	12242110	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	99.0	CHEMBL2068	Homo sapiens	Residual Activity	%	99.0
	12242111	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	82.0	CHEMBL2068	Homo sapiens	Residual Activity	%	82.0
	12242112	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	66.0	CHEMBL2068	Homo sapiens	Residual Activity	%	66.0
	12242113	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	82.0	CHEMBL2068	Homo sapiens	Residual Activity	%	82.0
	12242114	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	90.0	CHEMBL2068	Homo sapiens	Residual Activity	%	90.0
	12242115	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	54.0	CHEMBL2068	Homo sapiens	Residual Activity	%	54.0
	12242116	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	86.0	CHEMBL2068	Homo sapiens	Residual Activity	%	86.0
	12242117	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	69.0	CHEMBL2068	Homo sapiens	Residual Activity	%	69.0
	12242118	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	88.0	CHEMBL2068	Homo sapiens	Residual Activity	%	88.0
	12242119	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	87.0	CHEMBL2068	Homo sapiens	Residual Activity	%	87.0
	12242120	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	13.0	CHEMBL2068	Homo sapiens	Residual Activity	%	13.0
	12242121	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12244725	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	94.0	CHEMBL2068	Homo sapiens	Residual Activity	%	94.0
	12244726	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	88.0	CHEMBL2068	Homo sapiens	Residual Activity	%	88.0
	12244727	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	93.0	CHEMBL2068	Homo sapiens	Residual Activity	%	93.0
	12244728	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	30.0	CHEMBL2068	Homo sapiens	Residual Activity	%	30.0
	12244729	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	88.0	CHEMBL2068	Homo sapiens	Residual Activity	%	88.0
	12244730	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	101.0	CHEMBL2068	Homo sapiens	Residual Activity	%	101.0
	12244731	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	77.0	CHEMBL2068	Homo sapiens	Residual Activity	%	77.0
	12244732	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	27.0	CHEMBL2068	Homo sapiens	Residual Activity	%	27.0
	12244733	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	92.0	CHEMBL2068	Homo sapiens	Residual Activity	%	92.0
	12244734	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	98.0	CHEMBL2068	Homo sapiens	Residual Activity	%	98.0
	12244735	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	97.0	CHEMBL2068	Homo sapiens	Residual Activity	%	97.0
	12244736	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	88.0	CHEMBL2068	Homo sapiens	Residual Activity	%	88.0
	12244737	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	59.0	CHEMBL2068	Homo sapiens	Residual Activity	%	59.0
	12244738	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	106.0	CHEMBL2068	Homo sapiens	Residual Activity	%	106.0
	12244739	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	96.0	CHEMBL2068	Homo sapiens	Residual Activity	%	96.0
	12244740	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	92.0	CHEMBL2068	Homo sapiens	Residual Activity	%	92.0
	12244741	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	97.0	CHEMBL2068	Homo sapiens	Residual Activity	%	97.0
	12244742	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	89.0	CHEMBL2068	Homo sapiens	Residual Activity	%	89.0
	12244743	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	105.0	CHEMBL2068	Homo sapiens	Residual Activity	%	105.0
	12244744	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	91.0	CHEMBL2068	Homo sapiens	Residual Activity	%	91.0
	12244745	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	107.0	CHEMBL2068	Homo sapiens	Residual Activity	%	107.0
	12244746	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	103.0	CHEMBL2068	Homo sapiens	Residual Activity	%	103.0
	12244747	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	101.0	CHEMBL2068	Homo sapiens	Residual Activity	%	101.0
	12244748	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	101.0	CHEMBL2068	Homo sapiens	Residual Activity	%	101.0
	12244749	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	98.0	CHEMBL2068	Homo sapiens	Residual Activity	%	98.0
	12244750	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	93.0	CHEMBL2068	Homo sapiens	Residual Activity	%	93.0
	12244751	CHEMBL2219038	Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	96.0	CHEMBL2068	Homo sapiens	Residual Activity	%	96.0
	12244752	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	104.0	CHEMBL2068	Homo sapiens	Residual Activity	%	104.0
	12244753	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	50.0	CHEMBL2068	Homo sapiens	Residual Activity	%	50.0
	12244754	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	98.0	CHEMBL2068	Homo sapiens	Residual Activity	%	98.0
	12244755	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	101.0	CHEMBL2068	Homo sapiens	Residual Activity	%	101.0
	12244756	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	75.0	CHEMBL2068	Homo sapiens	Residual Activity	%	75.0
	12244757	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	103.0	CHEMBL2068	Homo sapiens	Residual Activity	%	103.0
	12244758	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	72.0	CHEMBL2068	Homo sapiens	Residual Activity	%	72.0
	12244759	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	37.0	CHEMBL2068	Homo sapiens	Residual Activity	%	37.0
	12244760	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	105.0	CHEMBL2068	Homo sapiens	Residual Activity	%	105.0
	12244761	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	62.0	CHEMBL2068	Homo sapiens	Residual Activity	%	62.0
	12244762	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	101.0	CHEMBL2068	Homo sapiens	Residual Activity	%	101.0
	12244763	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12244764	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	90.0	CHEMBL2068	Homo sapiens	Residual Activity	%	90.0
	12244765	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	1.0	CHEMBL2068	Homo sapiens	Residual Activity	%	1.0
	12244766	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	76.0	CHEMBL2068	Homo sapiens	Residual Activity	%	76.0
	12244767	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12244768	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	90.0	CHEMBL2068	Homo sapiens	Residual Activity	%	90.0
	12244769	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12244770	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	107.0	CHEMBL2068	Homo sapiens	Residual Activity	%	107.0
	12244771	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	103.0	CHEMBL2068	Homo sapiens	Residual Activity	%	103.0
	12244772	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	110.0	CHEMBL2068	Homo sapiens	Residual Activity	%	110.0
	12244773	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	80.0	CHEMBL2068	Homo sapiens	Residual Activity	%	80.0
	12244774	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	115.0	CHEMBL2068	Homo sapiens	Residual Activity	%	115.0
	12244775	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	81.0	CHEMBL2068	Homo sapiens	Residual Activity	%	81.0
	12244776	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	102.0	CHEMBL2068	Homo sapiens	Residual Activity	%	102.0
	12244777	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	18.0	CHEMBL2068	Homo sapiens	Residual Activity	%	18.0
	12244778	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	67.0	CHEMBL2068	Homo sapiens	Residual Activity	%	67.0
	12244779	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	30.0	CHEMBL2068	Homo sapiens	Residual Activity	%	30.0
	12244780	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	109.0	CHEMBL2068	Homo sapiens	Residual Activity	%	109.0
	12244781	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	98.0	CHEMBL2068	Homo sapiens	Residual Activity	%	98.0
	12244782	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12244783	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-3.0	CHEMBL2068	Homo sapiens	Residual Activity	%	-3.0
	12244784	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12244785	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12244786	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	97.0	CHEMBL2068	Homo sapiens	Residual Activity	%	97.0
	12244787	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12244788	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	57.0	CHEMBL2068	Homo sapiens	Residual Activity	%	57.0
	12244789	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	120.0	CHEMBL2068	Homo sapiens	Residual Activity	%	120.0
	12244790	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	108.0	CHEMBL2068	Homo sapiens	Residual Activity	%	108.0
	12244791	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	97.0	CHEMBL2068	Homo sapiens	Residual Activity	%	97.0
	12244792	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	109.0	CHEMBL2068	Homo sapiens	Residual Activity	%	109.0
	12244793	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	117.0	CHEMBL2068	Homo sapiens	Residual Activity	%	117.0
	12244794	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	92.0	CHEMBL2068	Homo sapiens	Residual Activity	%	92.0
	12244795	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	76.0	CHEMBL2068	Homo sapiens	Residual Activity	%	76.0
	12244796	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	55.0	CHEMBL2068	Homo sapiens	Residual Activity	%	55.0
	12244797	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	92.0	CHEMBL2068	Homo sapiens	Residual Activity	%	92.0
	12244798	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	115.0	CHEMBL2068	Homo sapiens	Residual Activity	%	115.0
	12244799	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	93.0	CHEMBL2068	Homo sapiens	Residual Activity	%	93.0
	12244800	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	116.0	CHEMBL2068	Homo sapiens	Residual Activity	%	116.0
	12244801	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	108.0	CHEMBL2068	Homo sapiens	Residual Activity	%	108.0
	12244802	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	33.0	CHEMBL2068	Homo sapiens	Residual Activity	%	33.0
	12244803	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	55.0	CHEMBL2068	Homo sapiens	Residual Activity	%	55.0
	12244804	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	31.0	CHEMBL2068	Homo sapiens	Residual Activity	%	31.0
	12244805	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	56.0	CHEMBL2068	Homo sapiens	Residual Activity	%	56.0
	12244806	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	101.0	CHEMBL2068	Homo sapiens	Residual Activity	%	101.0
	12244807	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	97.0	CHEMBL2068	Homo sapiens	Residual Activity	%	97.0
	12244808	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	105.0	CHEMBL2068	Homo sapiens	Residual Activity	%	105.0
	12244809	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12244810	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	109.0	CHEMBL2068	Homo sapiens	Residual Activity	%	109.0
	12244811	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	99.0	CHEMBL2068	Homo sapiens	Residual Activity	%	99.0
	12244812	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	76.0	CHEMBL2068	Homo sapiens	Residual Activity	%	76.0
	12244813	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12244814	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12244815	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12244816	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	118.0	CHEMBL2068	Homo sapiens	Residual Activity	%	118.0
	12244817	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	107.0	CHEMBL2068	Homo sapiens	Residual Activity	%	107.0
	12244818	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	113.0	CHEMBL2068	Homo sapiens	Residual Activity	%	113.0
	12244819	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	97.0	CHEMBL2068	Homo sapiens	Residual Activity	%	97.0
	12244820	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	111.0	CHEMBL2068	Homo sapiens	Residual Activity	%	111.0
	12244821	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	116.0	CHEMBL2068	Homo sapiens	Residual Activity	%	116.0
	12244822	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	97.0	CHEMBL2068	Homo sapiens	Residual Activity	%	97.0
	12244823	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	19.0	CHEMBL2068	Homo sapiens	Residual Activity	%	19.0
	12244824	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	68.0	CHEMBL2068	Homo sapiens	Residual Activity	%	68.0
	12244825	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	108.0	CHEMBL2068	Homo sapiens	Residual Activity	%	108.0
	12244826	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	90.0	CHEMBL2068	Homo sapiens	Residual Activity	%	90.0
	12244827	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	103.0	CHEMBL2068	Homo sapiens	Residual Activity	%	103.0
	12244828	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	115.0	CHEMBL2068	Homo sapiens	Residual Activity	%	115.0
	12244829	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	73.0	CHEMBL2068	Homo sapiens	Residual Activity	%	73.0
	12244830	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	93.0	CHEMBL2068	Homo sapiens	Residual Activity	%	93.0
	12244831	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	2.0	CHEMBL2068	Homo sapiens	Residual Activity	%	2.0
	12244832	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	93.0	CHEMBL2068	Homo sapiens	Residual Activity	%	93.0
	12244833	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	39.0	CHEMBL2068	Homo sapiens	Residual Activity	%	39.0
	12244834	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	114.0	CHEMBL2068	Homo sapiens	Residual Activity	%	114.0
	12244835	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	98.0	CHEMBL2068	Homo sapiens	Residual Activity	%	98.0
	12244836	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	103.0	CHEMBL2068	Homo sapiens	Residual Activity	%	103.0
	12244837	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	116.0	CHEMBL2068	Homo sapiens	Residual Activity	%	116.0
	12244838	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	105.0	CHEMBL2068	Homo sapiens	Residual Activity	%	105.0
	12244839	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	62.0	CHEMBL2068	Homo sapiens	Residual Activity	%	62.0
	12244840	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	82.0	CHEMBL2068	Homo sapiens	Residual Activity	%	82.0
	12244841	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	16.0	CHEMBL2068	Homo sapiens	Residual Activity	%	16.0
	12244842	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	101.0	CHEMBL2068	Homo sapiens	Residual Activity	%	101.0
	12244843	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12244844	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	43.0	CHEMBL2068	Homo sapiens	Residual Activity	%	43.0
	12244845	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	85.0	CHEMBL2068	Homo sapiens	Residual Activity	%	85.0
	12244846	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	107.0	CHEMBL2068	Homo sapiens	Residual Activity	%	107.0
	12244847	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	112.0	CHEMBL2068	Homo sapiens	Residual Activity	%	112.0
	12244848	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	114.0	CHEMBL2068	Homo sapiens	Residual Activity	%	114.0
	12244849	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	108.0	CHEMBL2068	Homo sapiens	Residual Activity	%	108.0
	12244850	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	102.0	CHEMBL2068	Homo sapiens	Residual Activity	%	102.0
	12244851	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	109.0	CHEMBL2068	Homo sapiens	Residual Activity	%	109.0
	12244852	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	86.0	CHEMBL2068	Homo sapiens	Residual Activity	%	86.0
	12244853	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	8.0	CHEMBL2068	Homo sapiens	Residual Activity	%	8.0
	12244854	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	117.0	CHEMBL2068	Homo sapiens	Residual Activity	%	117.0
	12244855	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	98.0	CHEMBL2068	Homo sapiens	Residual Activity	%	98.0
	12244856	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12244857	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	112.0	CHEMBL2068	Homo sapiens	Residual Activity	%	112.0
	12244858	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	108.0	CHEMBL2068	Homo sapiens	Residual Activity	%	108.0
	12244859	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	101.0	CHEMBL2068	Homo sapiens	Residual Activity	%	101.0
	12244860	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	93.0	CHEMBL2068	Homo sapiens	Residual Activity	%	93.0
	12244861	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	114.0	CHEMBL2068	Homo sapiens	Residual Activity	%	114.0
	12244862	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	97.0	CHEMBL2068	Homo sapiens	Residual Activity	%	97.0
	12244863	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	59.0	CHEMBL2068	Homo sapiens	Residual Activity	%	59.0
	12244864	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12244865	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	111.0	CHEMBL2068	Homo sapiens	Residual Activity	%	111.0
	12244866	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	116.0	CHEMBL2068	Homo sapiens	Residual Activity	%	116.0
	12244867	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	92.0	CHEMBL2068	Homo sapiens	Residual Activity	%	92.0
	12244868	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	4.0	CHEMBL2068	Homo sapiens	Residual Activity	%	4.0
	12244869	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	86.0	CHEMBL2068	Homo sapiens	Residual Activity	%	86.0
	12244870	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	72.0	CHEMBL2068	Homo sapiens	Residual Activity	%	72.0
	12244871	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	87.0	CHEMBL2068	Homo sapiens	Residual Activity	%	87.0
	12244872	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	60.0	CHEMBL2068	Homo sapiens	Residual Activity	%	60.0
	12244873	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	24.0	CHEMBL2068	Homo sapiens	Residual Activity	%	24.0
	12244874	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	65.0	CHEMBL2068	Homo sapiens	Residual Activity	%	65.0
	12244875	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	91.0	CHEMBL2068	Homo sapiens	Residual Activity	%	91.0
	12244876	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	14.0	CHEMBL2068	Homo sapiens	Residual Activity	%	14.0
	12244877	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	80.0	CHEMBL2068	Homo sapiens	Residual Activity	%	80.0
	12244878	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	27.0	CHEMBL2068	Homo sapiens	Residual Activity	%	27.0
	12244879	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	113.0	CHEMBL2068	Homo sapiens	Residual Activity	%	113.0
	12244880	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	82.0	CHEMBL2068	Homo sapiens	Residual Activity	%	82.0
	12244881	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-2.0	CHEMBL2068	Homo sapiens	Residual Activity	%	-2.0
	12244882	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	117.0	CHEMBL2068	Homo sapiens	Residual Activity	%	117.0
	12244883	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	103.0	CHEMBL2068	Homo sapiens	Residual Activity	%	103.0
	12244884	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	60.0	CHEMBL2068	Homo sapiens	Residual Activity	%	60.0
	12244885	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	111.0	CHEMBL2068	Homo sapiens	Residual Activity	%	111.0
	12244886	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	2.0	CHEMBL2068	Homo sapiens	Residual Activity	%	2.0
	12244887	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	29.0	CHEMBL2068	Homo sapiens	Residual Activity	%	29.0
	12244888	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	111.0	CHEMBL2068	Homo sapiens	Residual Activity	%	111.0
	12244889	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	42.0	CHEMBL2068	Homo sapiens	Residual Activity	%	42.0
	12244890	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	20.0	CHEMBL2068	Homo sapiens	Residual Activity	%	20.0
	12244891	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	97.0	CHEMBL2068	Homo sapiens	Residual Activity	%	97.0
	12244892	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	111.0	CHEMBL2068	Homo sapiens	Residual Activity	%	111.0
	12244893	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	87.0	CHEMBL2068	Homo sapiens	Residual Activity	%	87.0
	12244894	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	102.0	CHEMBL2068	Homo sapiens	Residual Activity	%	102.0
	12244895	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	8.0	CHEMBL2068	Homo sapiens	Residual Activity	%	8.0
	12244896	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	116.0	CHEMBL2068	Homo sapiens	Residual Activity	%	116.0
	12244897	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	103.0	CHEMBL2068	Homo sapiens	Residual Activity	%	103.0
	12244898	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	59.0	CHEMBL2068	Homo sapiens	Residual Activity	%	59.0
	12244899	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	92.0	CHEMBL2068	Homo sapiens	Residual Activity	%	92.0
	12244900	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	50.0	CHEMBL2068	Homo sapiens	Residual Activity	%	50.0
	12244901	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	105.0	CHEMBL2068	Homo sapiens	Residual Activity	%	105.0
	12244902	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	74.0	CHEMBL2068	Homo sapiens	Residual Activity	%	74.0
	12244903	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	113.0	CHEMBL2068	Homo sapiens	Residual Activity	%	113.0
	12244904	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	110.0	CHEMBL2068	Homo sapiens	Residual Activity	%	110.0
	12244905	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	100.0	CHEMBL2068	Homo sapiens	Residual Activity	%	100.0
	12244906	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	95.0	CHEMBL2068	Homo sapiens	Residual Activity	%	95.0
	12244907	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	91.0	CHEMBL2068	Homo sapiens	Residual Activity	%	91.0
	12244908	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	57.0	CHEMBL2068	Homo sapiens	Residual Activity	%	57.0
	12244909	CHEMBL2219039	Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	87.0	CHEMBL2068	Homo sapiens	Residual Activity	%	87.0
	12631702	CHEMBL2317776	Inhibition of ECK (unknown origin) in presence of ATP	B	Cc1cc(-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)on1		CHEMBL2312654	=	IC50	nM	2430.0	CHEMBL2068	Homo sapiens	IC50	uM	2.43
	12631703	CHEMBL2317776	Inhibition of ECK (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2N[C@@H]2COC[C@H]2O)CC1		CHEMBL2312652	=	IC50	nM	30000.0	CHEMBL2068	Homo sapiens	IC50	uM	30.0
	12631704	CHEMBL2317776	Inhibition of ECK (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)CC1		CHEMBL2312649	=	IC50	nM	30000.0	CHEMBL2068	Homo sapiens	IC50	uM	30.0
Not Determined	12631705	CHEMBL2317776	Inhibition of ECK (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC2CCCC2)CC1		CHEMBL2312646		IC50			CHEMBL2068	Homo sapiens	IC50		
Not Determined	12631706	CHEMBL2317776	Inhibition of ECK (unknown origin) in presence of ATP	B	COc1ccccc1CNc1ncc(C(=O)NC2CCN(C)CC2)c(NC2CCCC2)n1		CHEMBL2312645		IC50			CHEMBL2068	Homo sapiens	IC50		
	12649117	CHEMBL2329863	Antagonist activity at EphA2 in human PC3 cells assessed as inhibition of ephrin-A1-Fc-stimulated EphA2 phosphorylation pretreated for 20 mins by sandwich ELISA	B	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1478	=	IC50	nM	50000.0	CHEMBL2068	Homo sapiens	IC50	uM	50.0
	12649118	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1478	=	IC50	nM	57543.99	CHEMBL2068	Homo sapiens	pIC50		4.24
Dose-dependent effect	12649119	CHEMBL2329862	Antagonist activity at EphA2 receptor in human PC3 cells assessed as inhibition of ephrin-A1-Fc-stimulated cell retraction pretreated for 15 mins by fluorescence microscopy	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322989		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Dose-dependent effect	12649120	CHEMBL2329863	Antagonist activity at EphA2 in human PC3 cells assessed as inhibition of ephrin-A1-Fc-stimulated EphA2 phosphorylation pretreated for 20 mins by sandwich ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322989		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Active	12649121	CHEMBL2329859	Reversible inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL258818		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Active	12649123	CHEMBL2329860	Antagonist activity at EphA2 receptor in human PC3 cells assessed as blockade of cell rounding at 12.5 to 50 uM pretreated for 15 mins by fluorescence microscopy	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322989		Activity			CHEMBL2068	Homo sapiens	Activity		
	12649124	CHEMBL2329862	Antagonist activity at EphA2 receptor in human PC3 cells assessed as inhibition of ephrin-A1-Fc-stimulated cell retraction pretreated for 15 mins by fluorescence microscopy	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322989	=	IC50	nM	5100.0	CHEMBL2068	Homo sapiens	IC50	uM	5.1
	12649125	CHEMBL2329863	Antagonist activity at EphA2 in human PC3 cells assessed as inhibition of ephrin-A1-Fc-stimulated EphA2 phosphorylation pretreated for 20 mins by sandwich ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322989	=	IC50	nM	12000.0	CHEMBL2068	Homo sapiens	IC50	uM	12.0
	12649126	CHEMBL2329863	Antagonist activity at EphA2 in human PC3 cells assessed as inhibition of ephrin-A1-Fc-stimulated EphA2 phosphorylation pretreated for 20 mins by sandwich ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2323556	=	IC50	nM	98000.0	CHEMBL2068	Homo sapiens	IC50	uM	98.0
	12649127	CHEMBL2329863	Antagonist activity at EphA2 in human PC3 cells assessed as inhibition of ephrin-A1-Fc-stimulated EphA2 phosphorylation pretreated for 20 mins by sandwich ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2323554	=	IC50	nM	19000.0	CHEMBL2068	Homo sapiens	IC50	uM	19.0
	12649128	CHEMBL2329863	Antagonist activity at EphA2 in human PC3 cells assessed as inhibition of ephrin-A1-Fc-stimulated EphA2 phosphorylation pretreated for 20 mins by sandwich ELISA	B	CSCC[C@H](NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(=O)O		CHEMBL2323552	=	IC50	nM	26000.0	CHEMBL2068	Homo sapiens	IC50	uM	26.0
	12649129	CHEMBL2329863	Antagonist activity at EphA2 in human PC3 cells assessed as inhibition of ephrin-A1-Fc-stimulated EphA2 phosphorylation pretreated for 20 mins by sandwich ELISA	B	C[C@H](CCC(=O)N[C@@H](CO)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	Outside typical range	CHEMBL2322996	=	IC50	nM	101000.0	CHEMBL2068	Homo sapiens	IC50	uM	101.0
	12649130	CHEMBL2329863	Antagonist activity at EphA2 in human PC3 cells assessed as inhibition of ephrin-A1-Fc-stimulated EphA2 phosphorylation pretreated for 20 mins by sandwich ELISA	B	CC(C)[C@H](NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(=O)O		CHEMBL2322994	=	IC50	nM	71000.0	CHEMBL2068	Homo sapiens	IC50	uM	71.0
	12649131	CHEMBL2329863	Antagonist activity at EphA2 in human PC3 cells assessed as inhibition of ephrin-A1-Fc-stimulated EphA2 phosphorylation pretreated for 20 mins by sandwich ELISA	B	C[C@H](NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(=O)O		CHEMBL2322992	=	IC50	nM	79000.0	CHEMBL2068	Homo sapiens	IC50	uM	79.0
	12649132	CHEMBL2329863	Antagonist activity at EphA2 in human PC3 cells assessed as inhibition of ephrin-A1-Fc-stimulated EphA2 phosphorylation pretreated for 20 mins by sandwich ELISA	B	C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	Outside typical range	CHEMBL258818	=	IC50	nM	138000.0	CHEMBL2068	Homo sapiens	IC50	uM	138.0
	12649144	CHEMBL2329911	Displacement of ephrin-A1-Fc from EphA2 receptor Fc ectodomain (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322989	=	IC50	nM	2200.0	CHEMBL2068	Homo sapiens	IC50	uM	2.2
	12649146	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322990	=	IC50	nM	20417.38	CHEMBL2068	Homo sapiens	pIC50		4.69
	12649147	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322989	=	IC50	nM	2041.74	CHEMBL2068	Homo sapiens	pIC50		5.69
	12649148	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@H](Cc1ccc(O)cc1)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322988	=	IC50	nM	100000.0	CHEMBL2068	Homo sapiens	pIC50		4.0
	12649149	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2323556	=	IC50	nM	50118.72	CHEMBL2068	Homo sapiens	pIC50		4.3
	12649150	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@H](Cc1ccccc1)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2323555	=	IC50	nM	7585.78	CHEMBL2068	Homo sapiens	pIC50		5.12
	12649151	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2323554	=	IC50	nM	6606.93	CHEMBL2068	Homo sapiens	pIC50		5.18
	12649152	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	CSCC[C@@H](NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(=O)O		CHEMBL2323553	=	IC50	nM	27542.29	CHEMBL2068	Homo sapiens	pIC50		4.56
	12649153	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	CSCC[C@H](NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(=O)O		CHEMBL2323552	=	IC50	nM	27542.29	CHEMBL2068	Homo sapiens	pIC50		4.56
	12649154	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@H](CC(=O)O)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	Outside typical range	CHEMBL2323551	<	IC50	nM	316227.77	CHEMBL2068	Homo sapiens	pIC50		3.5
	12649155	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@@H](CC(=O)O)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	Outside typical range	CHEMBL2323550	<	IC50	nM	316227.77	CHEMBL2068	Homo sapiens	pIC50		3.5
	12649156	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@H](CC(N)=O)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	Outside typical range	CHEMBL2323549	<	IC50	nM	316227.77	CHEMBL2068	Homo sapiens	pIC50		3.5
	12649157	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@@H](CC(N)=O)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	Outside typical range	CHEMBL2323548	<	IC50	nM	316227.77	CHEMBL2068	Homo sapiens	pIC50		3.5
	12649158	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@H](CO)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322997	=	IC50	nM	60255.96	CHEMBL2068	Homo sapiens	pIC50		4.22
	12649159	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@@H](CO)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322996	=	IC50	nM	33113.11	CHEMBL2068	Homo sapiens	pIC50		4.48
	12649160	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	CC(C)[C@@H](NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(=O)O		CHEMBL2322995	=	IC50	nM	17378.01	CHEMBL2068	Homo sapiens	pIC50		4.76
	12649161	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	CC(C)[C@H](NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(=O)O		CHEMBL2322994	=	IC50	nM	23988.33	CHEMBL2068	Homo sapiens	pIC50		4.62
	12649162	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@@H](NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(=O)O		CHEMBL2322993	=	IC50	nM	30902.95	CHEMBL2068	Homo sapiens	pIC50		4.51
	12649163	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(=O)O		CHEMBL2322992	=	IC50	nM	19952.62	CHEMBL2068	Homo sapiens	pIC50		4.7
	12649164	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	CC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	Outside typical range	CHEMBL2322991	<	IC50	nM	316227.77	CHEMBL2068	Homo sapiens	pIC50		3.5
	12649165	CHEMBL2329875	Inhibition of ephrin-A1-Fc binding to EphA2-Fc receptor (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL258818	=	IC50	nM	48977.88	CHEMBL2068	Homo sapiens	pIC50		4.31
	12670822	CHEMBL2341794	Inhibition of EPHA2 (unknown origin) at 100 uM after 60 mins by ELISA relative to control	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	83.1	CHEMBL2068	Homo sapiens	INH	%	83.1
	12670823	CHEMBL2341794	Inhibition of EPHA2 (unknown origin) at 100 uM after 60 mins by ELISA relative to control	B	O=C1CC(Cc2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]	Outside typical range	CHEMBL2334795	=	Inhibition	%	-24.3	CHEMBL2068	Homo sapiens	INH	%	-24.3
	12673059	CHEMBL2345615	Inhibition of recombinant EPH-A2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	17.0	CHEMBL2068	Homo sapiens	Activity	%	17.0
	12673060	CHEMBL2345615	Inhibition of recombinant EPH-A2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	22.0	CHEMBL2068	Homo sapiens	Activity	%	22.0
	12674222	CHEMBL2344196	Inhibition of human Eph-A2 using [gamma-33P]ATP assessed as residual activity at 3 uM after 30 mins by radiometric assay	B	CCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333603	=	Activity	%	6.0	CHEMBL2068	Homo sapiens	Activity	%	6.0
	12679746	CHEMBL2345857	Inhibition of EPHA2 (unknown origin) at 1 uM	B	Cc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCN(C(=O)[C@H](C)O)CC2)c(=O)n4C)cn1		CHEMBL2331664	=	Inhibition	%	1.5	CHEMBL2068	Homo sapiens	INH	%	1.5
	12688500	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O		CHEMBL2336574	=	IC50	nM	71000.0	CHEMBL2068	Homo sapiens	IC50	uM	71.0
	12688503	CHEMBL2339604	Ratio of compound IC50 to SWL peptide monomer IC50 for IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin)/ephrin-A5 AP interaction	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCNC(=O)CCCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O		CHEMBL2337010	=	Ratio IC50		13.0	CHEMBL2068	Homo sapiens	Ratio IC50		13.0
	12688504	CHEMBL2339604	Ratio of compound IC50 to SWL peptide monomer IC50 for IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin)/ephrin-A5 AP interaction	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCNC(=O)CCCCCCCCCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O		CHEMBL2337009	=	Ratio IC50		8.0	CHEMBL2068	Homo sapiens	Ratio IC50		8.0
	12688505	CHEMBL2339604	Ratio of compound IC50 to SWL peptide monomer IC50 for IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin)/ephrin-A5 AP interaction	B	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C		CHEMBL2337008	=	Ratio IC50		3.0	CHEMBL2068	Homo sapiens	Ratio IC50		3.0
Active	12688506	CHEMBL2339605	Increase in EphA2 tyrosine phosphorylation in human PC3 cells at 50 uM incubated for 20 mins by immunoblot analysis	B	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C		CHEMBL2336575		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	12688507	CHEMBL2339606	Increase in EphA2 tyrosine phosphorylation in human PC3 cells at 0.5 to 50 uM incubated for 20 mins by immunoblot analysis	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCNC(=O)CCCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O		CHEMBL2337010		Activity			CHEMBL2068	Homo sapiens	Activity		
	12688508	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCNC(=O)CCCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O		CHEMBL2337012	=	IC50	nM	470.0	CHEMBL2068	Homo sapiens	IC50	uM	0.47
	12688509	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCNC(=O)CCCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O		CHEMBL2337011	=	IC50	nM	1800.0	CHEMBL2068	Homo sapiens	IC50	uM	1.8
	12688510	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCNC(=O)CCCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O		CHEMBL2337010	=	IC50	nM	310.0	CHEMBL2068	Homo sapiens	IC50	uM	0.31
	12688511	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCNC(=O)CCCCCCCCCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O		CHEMBL2337009	=	IC50	nM	510.0	CHEMBL2068	Homo sapiens	IC50	uM	0.51
	12688512	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C		CHEMBL2337008	=	IC50	nM	1200.0	CHEMBL2068	Homo sapiens	IC50	uM	1.2
	12688513	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL2336586	=	IC50	nM	29000.0	CHEMBL2068	Homo sapiens	IC50	uM	29.0
	12688514	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C		CHEMBL2336585	=	IC50	nM	15000.0	CHEMBL2068	Homo sapiens	IC50	uM	15.0
	12688515	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C		CHEMBL2336584	=	IC50	nM	14000.0	CHEMBL2068	Homo sapiens	IC50	uM	14.0
	12688516	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C		CHEMBL2336583	=	IC50	nM	13000.0	CHEMBL2068	Homo sapiens	IC50	uM	13.0
	12688517	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C		CHEMBL2336582	=	IC50	nM	94000.0	CHEMBL2068	Homo sapiens	IC50	uM	94.0
	12688518	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C		CHEMBL2336581	>=	IC50	nM	100000.0	CHEMBL2068	Homo sapiens	IC50	uM	100.0
	12688519	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C		CHEMBL2336580	>=	IC50	nM	100000.0	CHEMBL2068	Homo sapiens	IC50	uM	100.0
	12688520	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C		CHEMBL2336579	>	IC50	nM	100000.0	CHEMBL2068	Homo sapiens	IC50	uM	100.0
	12688521	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O		CHEMBL2336578	=	IC50	nM	24000.0	CHEMBL2068	Homo sapiens	IC50	uM	24.0
	12688522	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C		CHEMBL2336577	>=	IC50	nM	100000.0	CHEMBL2068	Homo sapiens	IC50	uM	100.0
	12688523	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C		CHEMBL2336576	=	IC50	nM	6300.0	CHEMBL2068	Homo sapiens	IC50	uM	6.3
	12688524	CHEMBL2339607	Agonist activity at IgG1 Fc region fused-immobilized EphA2 ectodomain (unknown origin) assessed as inhibition of EphA2/ephrin-A5 AP interaction incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C		CHEMBL2336575	=	IC50	nM	4100.0	CHEMBL2068	Homo sapiens	IC50	uM	4.1
	12693238	CHEMBL2343922	Inhibition of EPHA2 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	nM	10000.0
	12728847	CHEMBL2352921	Inhibition of EPHA2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	97.0	CHEMBL2068	Homo sapiens	Activity	%	97.0
	12729988	CHEMBL2353632	Inhibition of EPHA2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	12730236	CHEMBL2352921	Inhibition of EPHA2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL2068	Homo sapiens	Activity	%	96.0
	12730866	CHEMBL2352214	Inhibition of EPHA2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	90.0	CHEMBL2068	Homo sapiens	Activity	%	90.0
	13327686	CHEMBL2389839	Inhibition of EPHA2 (unknown origin) at 1 uM	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	19.0	CHEMBL2068	Homo sapiens	INH	%	19.0
Not Determined	13327687	CHEMBL2389839	Inhibition of EPHA2 (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	13328773	CHEMBL2388496	Inhibition of EPHA2 (unknown origin)	B	Cc1cccc2nc(Cn3cnc4ccccc43)cc(=O)n12		CHEMBL2386917		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	13335998	CHEMBL2394049	Inhibition of EPHA2 (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Cc1ccc(-n2cnc3cc(Nc4nnc(C)c5ccccc45)ccc32)cc1		CHEMBL2390986		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	13335999	CHEMBL2394049	Inhibition of EPHA2 (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Fc1ccc(-c2n[nH]cc2-c2ccncc2)cc1Cl		CHEMBL2390985		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	13336065	CHEMBL2394073	Inhibition of EPHA2 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1cccc(C(=O)Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL2390984		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	13336066	CHEMBL2394073	Inhibition of EPHA2 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1ccc(-c2cc(NC(=O)c3ccc(F)cc3)[nH]n2)cc1		CHEMBL2390983		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	13336067	CHEMBL2394073	Inhibition of EPHA2 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	COc1ccc(C(=O)Nc2cc(-c3ccccc3)[nH]n2)cc1		CHEMBL167454		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	13375880	CHEMBL2405144	Inhibition of EPHA2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	4.0	CHEMBL2068	Homo sapiens	INH	%	4.0
	13438068	CHEMBL2422438	Inhibition of EphA2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL2068	Homo sapiens	INH	%	35.0
	13438069	CHEMBL2422438	Inhibition of EphA2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL2068	Homo sapiens	INH	%	35.0
	13438070	CHEMBL2422438	Inhibition of EphA2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL2068	Homo sapiens	INH	%	35.0
	13438071	CHEMBL2422438	Inhibition of EphA2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL2068	Homo sapiens	INH	%	35.0
	13438072	CHEMBL2422438	Inhibition of EphA2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL2068	Homo sapiens	INH	%	35.0
	13438073	CHEMBL2422438	Inhibition of EphA2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL2068	Homo sapiens	INH	%	35.0
	13438074	CHEMBL2422438	Inhibition of EphA2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL2068	Homo sapiens	INH	%	35.0
	13438075	CHEMBL2422438	Inhibition of EphA2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL2068	Homo sapiens	INH	%	35.0
	13438076	CHEMBL2422438	Inhibition of EphA2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL2068	Homo sapiens	INH	%	35.0
	13438077	CHEMBL2422438	Inhibition of EphA2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL2068	Homo sapiens	INH	%	35.0
	13438078	CHEMBL2422438	Inhibition of EphA2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL2068	Homo sapiens	INH	%	35.0
	13438079	CHEMBL2422438	Inhibition of EphA2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL2068	Homo sapiens	INH	%	35.0
	13442373	CHEMBL2427805	Competitive binding affinity to EPHA2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	13445508	CHEMBL2427805	Competitive binding affinity to EPHA2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	13448563	CHEMBL2427805	Competitive binding affinity to EPHA2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	13448699	CHEMBL2427805	Competitive binding affinity to EPHA2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	13451494	CHEMBL2427805	Competitive binding affinity to EPHA2 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	13454679	CHEMBL2427805	Competitive binding affinity to EPHA2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	13464334	CHEMBL2433468	Inhibition of human EPHA2 assessed as residual activity at 1 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	86.0	CHEMBL2068	Homo sapiens	Activity	%	86.0
	13465279	CHEMBL2434026	Inhibition of human EPHA2 assessed as residual activity at 10 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	88.0	CHEMBL2068	Homo sapiens	Activity	%	88.0
	13465357	CHEMBL2433468	Inhibition of human EPHA2 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	91.24	CHEMBL2068	Homo sapiens	Activity	%	91.24
	13465388	CHEMBL2434026	Inhibition of human EPHA2 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	91.86	CHEMBL2068	Homo sapiens	Activity	%	91.86
	13465419	CHEMBL2433468	Inhibition of human EPHA2 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	101.43	CHEMBL2068	Homo sapiens	Activity	%	101.43
	13465450	CHEMBL2434026	Inhibition of human EPHA2 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	69.45	CHEMBL2068	Homo sapiens	Activity	%	69.45
Active	13488419	CHEMBL2439427	Inhibition of human EPHA2 at 1 uM	B	Clc1ccc2ncc(Br)n2n1		CHEMBL2436439		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Active	13488420	CHEMBL2439427	Inhibition of human EPHA2 at 1 uM	B	CN1CCC(Nc2ccc3ncc(-c4cnn(-c5ccc(C#N)cc5)c4)n3n2)CC1		CHEMBL2436446		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Active	13488421	CHEMBL2439427	Inhibition of human EPHA2 at 1 uM	B	c1ccc(-n2cc(-c3cnc4ccc(NC5CCNCC5)nn34)cn2)cc1		CHEMBL2436454		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	13499580	CHEMBL2447146	Inhibition of EPHA2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Sc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2442124	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	13836293	CHEMBL3090901	Inhibition of EphA2 (unknown origin) after 90 mins by TR-FRET/IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3086065	>	IC50	nM	50000.0	CHEMBL2068	Homo sapiens	IC50	uM	50.0
	13851887	CHEMBL3095041	Inhibition of recombinant EPHA2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CCN(CC)CCCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL3092314	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	13851888	CHEMBL3095041	Inhibition of recombinant EPHA2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	O=C(NCCN1CCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL3092308	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	13872161	CHEMBL3101786	Inhibition of human EphA2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	122.0	CHEMBL2068	Homo sapiens	Activity	%	122.0
	14582484	CHEMBL3240444	Inhibition of human EphA2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	99.5	CHEMBL2068	Homo sapiens	Activity	%	99.5
	14589543	CHEMBL3239040	Inhibition of recombinant EPHA2 (unknown origin) using Poly(Glu:Tyr)4:1 after 60 mins by ELISA	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3233767	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	14589544	CHEMBL3239040	Inhibition of recombinant EPHA2 (unknown origin) using Poly(Glu:Tyr)4:1 after 60 mins by ELISA	B	O=C(/C=C/CN1CC2CCC1C(=O)C2)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3233785	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	14664155	CHEMBL3270867	Inhibition of EPHA2 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	78.0	CHEMBL2068	Homo sapiens	INH	%	78.0
	14664156	CHEMBL3270867	Inhibition of EPHA2 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	88.0	CHEMBL2068	Homo sapiens	INH	%	88.0
	14664157	CHEMBL3270867	Inhibition of EPHA2 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	80.0	CHEMBL2068	Homo sapiens	INH	%	80.0
	14746968	CHEMBL3295624	Inhibition of recombinant EPH-A2 (unknown origin) using poly (4 Glu, Tyr) as substrate after 60 mins by ELISA	B	Nc1ncnc2scc(-c3ccc4c(C(=O)Nc5ccccc5)cccc4c3)c12		CHEMBL3288526	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	nM	10000.0
	14751189	CHEMBL3301278	Inhibition of EphA2 (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21		CHEMBL3298400	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	14751752	CHEMBL3301278	Inhibition of EphA2 (unknown origin)	B	CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1		CHEMBL3297762	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	14984380	CHEMBL3384995	Inhibition of EPHA2 (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	17.0	CHEMBL2068	Homo sapiens	INH	%	17.0
	14984446	CHEMBL3382481	Inhibition of EPHA2 (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	8.0	CHEMBL2068	Homo sapiens	INH	%	8.0
	14992116	CHEMBL3374163	Inhibition of EPHA2 (unknown origin) at 1 uM by ELISA method	B	O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c(F)c2)CC1		CHEMBL3360678	=	Inhibition	%	18.8	CHEMBL2068	Homo sapiens	INH	%	18.8
	14992117	CHEMBL3374163	Inhibition of EPHA2 (unknown origin) at 1 uM by ELISA method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	76.2	CHEMBL2068	Homo sapiens	INH	%	76.2
	15018579	CHEMBL3361893	Inhibition of EPHA2 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	5.2	CHEMBL2068	Homo sapiens	INH	%	5.2
	15036778	CHEMBL3381071	Inhibition of EphA2 (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	15036779	CHEMBL3381071	Inhibition of EphA2 (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	15036780	CHEMBL3381071	Inhibition of EphA2 (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	15036781	CHEMBL3381071	Inhibition of EphA2 (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	15036782	CHEMBL3381071	Inhibition of EphA2 (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	15061093	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3cccc(Cl)c3)ncnc2cc1OCC1CN(C(=O)OC(C)(C)C)CCO1		CHEMBL3322972	=	IC50	nM	1190.0	CHEMBL2068	Homo sapiens	IC50	uM	1.19
	15061094	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3cccc(Cl)c3)ncnc2cc1OCC1CNCCO1		CHEMBL3322978	=	IC50	nM	580.0	CHEMBL2068	Homo sapiens	IC50	uM	0.58
	15061095	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3cccc(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3322973	=	IC50	nM	1470.0	CHEMBL2068	Homo sapiens	IC50	uM	1.47
	15061096	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCC1CN(C(=O)OC(C)(C)C)CCO1		CHEMBL3322974	=	IC50	nM	2500.0	CHEMBL2068	Homo sapiens	IC50	uM	2.5
	15061097	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCC1CNCCO1		CHEMBL3322979	=	IC50	nM	730.0	CHEMBL2068	Homo sapiens	IC50	uM	0.73
	15061098	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3322975	=	IC50	nM	750.0	CHEMBL2068	Homo sapiens	IC50	uM	0.75
	15061099	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3ccc(Br)cc3)ncnc2cc1OCC1CN(C(=O)OC(C)(C)C)CCO1		CHEMBL3322976	=	IC50	nM	2310.0	CHEMBL2068	Homo sapiens	IC50	uM	2.31
	15061100	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3ccc(Br)cc3)ncnc2cc1OCC1CNCCO1		CHEMBL3322980	=	IC50	nM	720.0	CHEMBL2068	Homo sapiens	IC50	uM	0.72
	15061101	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3ccc(Br)cc3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3322977	=	IC50	nM	680.0	CHEMBL2068	Homo sapiens	IC50	uM	0.68
	15061102	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3ccc(F)cc3)ncnc2cc1OCC1CNCCO1		CHEMBL3322981	=	IC50	nM	620.0	CHEMBL2068	Homo sapiens	IC50	uM	0.62
	15061103	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3ccc(C)c(Cl)c3)ncnc2cc1OCC1CNCCO1		CHEMBL3322983	=	IC50	nM	300.0	CHEMBL2068	Homo sapiens	IC50	uM	0.3
	15061104	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3cc(Cl)cc(Cl)c3)ncnc2cc1OCC1CNCCO1		CHEMBL3322984	=	IC50	nM	960.0	CHEMBL2068	Homo sapiens	IC50	uM	0.96
	15061105	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3ccc(F)c(C(F)(F)F)c3)ncnc2cc1OCC1CNCCO1		CHEMBL3322985	=	IC50	nM	3210.0	CHEMBL2068	Homo sapiens	IC50	uM	3.21
	15061106	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3ccc(F)cc3C)ncnc2cc1OCC1CNCCO1		CHEMBL3322986	=	IC50	nM	200.0	CHEMBL2068	Homo sapiens	IC50	uM	0.2
	15061107	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CNCCO1		CHEMBL3322987	=	IC50	nM	160.0	CHEMBL2068	Homo sapiens	IC50	uM	0.16
	15061108	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3ccc(Cl)c(C(F)(F)F)c3)ncnc2cc1OCC1CNCCO1		CHEMBL3322988	=	IC50	nM	170.0	CHEMBL2068	Homo sapiens	IC50	uM	0.17
	15061109	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CNCCO1		CHEMBL3322989	=	IC50	nM	450.0	CHEMBL2068	Homo sapiens	IC50	uM	0.45
	15061110	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3ccc(Br)cc3Cl)ncnc2cc1OCC1CNCCO1		CHEMBL3322990	=	IC50	nM	230.0	CHEMBL2068	Homo sapiens	IC50	uM	0.23
	15061111	CHEMBL3376294	Inhibition of EphA2 (unknown origin) pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	COc1cc2c(Nc3ccc(Br)c(C)c3)ncnc2cc1OCC1CNCCO1		CHEMBL3322991	=	IC50	nM	320.0	CHEMBL2068	Homo sapiens	IC50	uM	0.32
	15061112	CHEMBL3376295	Inhibition of EphA2 (unknown origin) at 10 uM pre-incubated with enzyme for 10 mins before adding peptide substrate and ATP using TK-substrate-biotin and SEB by time-resolved fluorescence resonance energy transfer assay	B	CCCc1ccc(Nc2ncnc3cc(OCC4CNCCO4)c(OC)cc23)cc1		CHEMBL3322982	=	Inhibition	%	49.0	CHEMBL2068	Homo sapiens	INH	%	49.0
Dose-dependent effect	15061125	CHEMBL3378771	Inhibition of EphA2 (unknown origin) expressed in CHO-CK cells assessed as reduction in wound closure after 72 hrs by phase contrast microscopy based would healing assay	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CNCCO1		CHEMBL3322987		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	15072600	CHEMBL3382660	Inhibition of EPHA2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	111.0	CHEMBL2068	Homo sapiens	Activity	%	111.0
	15085837	CHEMBL3384098	Inhibition of purified EPH-A2 (unknown origin) at 1 uM after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl		CHEMBL3330859	=	Inhibition	%	23.0	CHEMBL2068	Homo sapiens	INH	%	23.0
	15085902	CHEMBL3384098	Inhibition of purified EPH-A2 (unknown origin) at 1 uM after 60 mins by ELISA kinase assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCNCC3)ncc1Cl		CHEMBL3330850	=	Inhibition	%	63.2	CHEMBL2068	Homo sapiens	INH	%	63.2
	15091099	CHEMBL3390666	Inhibition of human recombinant EphA2 kinase using Ulight-TK peptide substrate assessed as remaining enzyme activity at 1 uM after 30 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	90.0	CHEMBL2068	Homo sapiens	Activity	%	90.0
	15143833	CHEMBL3396219	Inhibition of purified EPH-A2 (unknown origin) at 1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469	=	Inhibition	%	38.4	CHEMBL2068	Homo sapiens	INH	%	38.4
Not Determined	15143848	CHEMBL3396234	Inhibition of purified EPH-A2 (unknown origin) at 0.1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Determined	15143863	CHEMBL3396249	Inhibition of purified EPH-A2 (unknown origin) at 0.01 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	15223353	CHEMBL3420309	Inhibition of EPHA2 (unknown origin)	B	O=c1ccc(-n2ccc3ccc(F)cc32)nn1CCOc1ccnc2cc(OCCCN3CCOCC3)ccc12		CHEMBL3417489	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	15249278	CHEMBL3428308	Inhibition of human EPHA2 using poly[Glu:Tyr] (4:1) peptide substrate at 1 uM by 33P Hotspot assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1		CHEMBL3426891	=	Inhibition	%	31.9	CHEMBL2068	Homo sapiens	INH	%	31.9
	15251855	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	96.0	CHEMBL2068	Homo sapiens	Activity	%	96.0
	15251942	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	89.0	CHEMBL2068	Homo sapiens	Activity	%	89.0
	15252044	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	95.0	CHEMBL2068	Homo sapiens	Activity	%	95.0
	15252689	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	93.0	CHEMBL2068	Homo sapiens	Activity	%	93.0
	15252791	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	74.0	CHEMBL2068	Homo sapiens	Activity	%	74.0
	15252893	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	83.0	CHEMBL2068	Homo sapiens	Activity	%	83.0
	15253567	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	89.0	CHEMBL2068	Homo sapiens	Activity	%	89.0
	15253669	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	97.0	CHEMBL2068	Homo sapiens	Activity	%	97.0
	15253771	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	97.0	CHEMBL2068	Homo sapiens	Activity	%	97.0
	15253818	CHEMBL3429876	Inhibition of human EphA2	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225	=	IC50	nM	16.0	CHEMBL2068	Homo sapiens	IC50	uM	0.016
	15254437	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	67.0	CHEMBL2068	Homo sapiens	Activity	%	67.0
	15254539	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	95.0	CHEMBL2068	Homo sapiens	Activity	%	95.0
	15254641	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	74.0	CHEMBL2068	Homo sapiens	Activity	%	74.0
	15255332	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	30.0	CHEMBL2068	Homo sapiens	Activity	%	30.0
	15255434	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	32.0	CHEMBL2068	Homo sapiens	Activity	%	32.0
	15255537	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	18.0	CHEMBL2068	Homo sapiens	Activity	%	18.0
	15256268	CHEMBL3428226	Inhibition of EPH-A2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	25.0	CHEMBL2068	Homo sapiens	Activity	%	25.0
	15605118	CHEMBL3578499	Competitive binding affinity to EphA2 in human A375 cells after 15 mins in presence of ATP analogue	B	CNc1ncc2cc(-c3cc(NC(=O)NCCC(C)(C)C)c(F)cc3C)c(C)nc2n1		CHEMBL3577124	=	IC50	nM	20.0	CHEMBL2068	Homo sapiens	IC50	nM	20.0
	15649093	CHEMBL3594873	Inhibition of EPHA2 (unknown origin)	B	N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1		CHEMBL3593777	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	15685883	CHEMBL3607959	Inhibition of human EphA2	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	15754932	CHEMBL3631715	Inhibition of EphA2 (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	23.0	CHEMBL2068	Homo sapiens	INH	%	23.0
	15755875	CHEMBL3630652	Inhibition of EPHA2 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	80.0	CHEMBL2068	Homo sapiens	Activity	%	80.0
	15756027	CHEMBL3630358	Inhibition of EPHA2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	67.97	CHEMBL2068	Homo sapiens	INH	%	67.97
	15757032	CHEMBL3630358	Inhibition of EPHA2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	97.33	CHEMBL2068	Homo sapiens	INH	%	97.33
	15758695	CHEMBL3630358	Inhibition of EPHA2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	19.56	CHEMBL2068	Homo sapiens	INH	%	19.56
	16379607	CHEMBL3738402	Inhibition of EPHA2 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	-2.2	CHEMBL2068	Homo sapiens	INH	%	-2.2
	16379608	CHEMBL3738402	Inhibition of EPHA2 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	-0.3	CHEMBL2068	Homo sapiens	INH	%	-0.3
Dose-dependent effect	16392491	CHEMBL3738302	Displacement of biotinylated ephrin-A1-Fc from EphA2 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Active	16392495	CHEMBL3738299	Inhibition of recombinant EphA2 kinase domain (unknown origin) at 1 uM after 30 mins by ELISA	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	16392496	CHEMBL3738298	Inhibition of recombinant EphA2 kinase domain (unknown origin) up to 30 uM after 30 mins by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	16392497	CHEMBL3738297	Antagonist activity at EphA2 receptor in human PC3 cells assessed as inhibition of ephrin-A1-induced protein phosphorylation after 20 mins by sandwich ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3735509	=	IC50	nM	13900.0	CHEMBL2068	Homo sapiens	IC50	uM	13.9
	16392498	CHEMBL3738297	Antagonist activity at EphA2 receptor in human PC3 cells assessed as inhibition of ephrin-A1-induced protein phosphorylation after 20 mins by sandwich ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863	=	IC50	nM	9300.0	CHEMBL2068	Homo sapiens	IC50	uM	9.3
Dose-dependent effect	16392499	CHEMBL3738297	Antagonist activity at EphA2 receptor in human PC3 cells assessed as inhibition of ephrin-A1-induced protein phosphorylation after 20 mins by sandwich ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3735509		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Dose-dependent effect	16392500	CHEMBL3738297	Antagonist activity at EphA2 receptor in human PC3 cells assessed as inhibition of ephrin-A1-induced protein phosphorylation after 20 mins by sandwich ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	16392501	CHEMBL3738296	Binding affinity to EphA2-Fc receptor (unknown origin) treated for 90 secs by SPR analysis	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863	=	Kd	nM	3300.0	CHEMBL2068	Homo sapiens	Kd	uM	3.3
Dose-dependent effect	16392502	CHEMBL3738296	Binding affinity to EphA2-Fc receptor (unknown origin) treated for 90 secs by SPR analysis	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863		Activity			CHEMBL2068	Homo sapiens	Activity		
	16392503	CHEMBL3738295	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by Schild analysis	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3735509	=	Ki	nM	2400.0	CHEMBL2068	Homo sapiens	Ki	uM	2.4
	16392504	CHEMBL3738295	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by Schild analysis	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863	=	Ki	nM	1400.0	CHEMBL2068	Homo sapiens	Ki	uM	1.4
	16392505	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@@]2(C)[C@H]3CC[C@@H]2[C@H](C)CCC(=O)N2Cc3[nH]c4ccccc4c3C[C@H]2C(=O)O)C1		CHEMBL3736171	=	IC50	nM	6309.57	CHEMBL2068	Homo sapiens	pIC50		5.2
	16392506	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@@]2(C)[C@H]3CC[C@@H]2[C@H](C)CCC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)C1		CHEMBL3736006	=	IC50	nM	89125.09	CHEMBL2068	Homo sapiens	pIC50		4.05
	16392507	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@H](CC(=O)O)Cc1c[nH]c2ccccc12)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3735992	=	IC50	nM	4265.8	CHEMBL2068	Homo sapiens	pIC50		5.37
	16392508	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	COc1ccc2[nH]cc(C[C@H](NC(=O)CC[C@@H](C)[C@H]3CC[C@H]4[C@@H]5CC=C6C[C@@H](O)CC[C@]6(C)[C@H]5CC[C@@]43C)C(=O)O)c2c1		CHEMBL3736217	=	IC50	nM	47863.01	CHEMBL2068	Homo sapiens	pIC50		4.32
	16392512	CHEMBL3738302	Displacement of biotinylated ephrin-A1-Fc from EphA2 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863	=	IC50	nM	2900.0	CHEMBL2068	Homo sapiens	IC50	uM	2.9
	16392528	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3735509	=	IC50	nM	6025.6	CHEMBL2068	Homo sapiens	pIC50		5.22
	16392529	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccc(Br)cc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3736176	=	IC50	nM	22387.21	CHEMBL2068	Homo sapiens	pIC50		4.65
	16392530	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccc(F)cc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3736070	=	IC50	nM	8912.51	CHEMBL2068	Homo sapiens	pIC50		5.05
	16392531	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1cccc2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3736250	=	IC50	nM	4073.8	CHEMBL2068	Homo sapiens	pIC50		5.39
	16392532	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1cn(C)c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734937	=	IC50	nM	5011.87	CHEMBL2068	Homo sapiens	pIC50		5.3
	16392533	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3736288	<	IC50	nM	100000.0	CHEMBL2068	Homo sapiens	pIC50		4.0
	16392534	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863	=	IC50	nM	3548.13	CHEMBL2068	Homo sapiens	pIC50		5.45
	16392535	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](COc1ccccc1)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3735472	=	IC50	nM	50118.72	CHEMBL2068	Homo sapiens	pIC50		4.3
	16392536	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3735198	<	IC50	nM	100000.0	CHEMBL2068	Homo sapiens	pIC50		4.0
	16392537	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](CO)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734875	<	IC50	nM	100000.0	CHEMBL2068	Homo sapiens	pIC50		4.0
	16392538	CHEMBL3738294	Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL169264	=	IC50	nM	39810.72	CHEMBL2068	Homo sapiens	pIC50		4.4
Not Active	16392551	CHEMBL3738323	Displacement of biotinylated-ephrin-A1 from EphA2 receptor (unknown origin) up to 100 uM preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3736327		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	16392552	CHEMBL3738323	Displacement of biotinylated-ephrin-A1 from EphA2 receptor (unknown origin) up to 100 uM preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	CSCC[C@H](NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(=O)O		CHEMBL3734799		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	16392553	CHEMBL3738323	Displacement of biotinylated-ephrin-A1 from EphA2 receptor (unknown origin) up to 100 uM preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3735051		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	16392554	CHEMBL3738324	Induction of EphA2 phosphorylation in human PC3 cells after 20 mins by sandwich ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	16392555	CHEMBL3738324	Induction of EphA2 phosphorylation in human PC3 cells after 20 mins by sandwich ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3735509		Activity			CHEMBL2068	Homo sapiens	Activity		
	16396104	CHEMBL3742497	Inhibition of human recombinant EPHA2 using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5ccccc5)cccc4c3)n2)c1		CHEMBL3740721	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	nM	10000.0
	16396105	CHEMBL3742497	Inhibition of human recombinant EPHA2 using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5cccc(F)c5)cccc4c3)n2)c1		CHEMBL3740487	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	nM	10000.0
	16396106	CHEMBL3742497	Inhibition of human recombinant EPHA2 using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5cccnc5)cccc4c3)n2)c1		CHEMBL3739732	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	nM	10000.0
	16413442	CHEMBL3743702	Inhibition of EPHA2 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	16425359	CHEMBL3751233	Inhibition of EphA2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	8.0	CHEMBL2068	Homo sapiens	INH	%	8.0
	16431812	CHEMBL3749435	Inhibition of human EPHA2 using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	16450827	CHEMBL3762683	Inhibition of EPHA2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	12.2	CHEMBL2068	Homo sapiens	INH	%	12.2
	16451714	CHEMBL3762683	Inhibition of EPHA2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758602	=	Inhibition	%	11.8	CHEMBL2068	Homo sapiens	INH	%	11.8
	16461616	CHEMBL3762064	Inhibition of recombinant human EPH-A2 using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	Cn1cc(-c2cnc(Nc3cccc(Cn4nc(-c5cnn(C)c5)ccc4=O)c3)nc2)cn1		CHEMBL3759079	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16461617	CHEMBL3762064	Inhibition of recombinant human EPH-A2 using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16474686	CHEMBL3767172	Inhibition of EPHA2 (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	29.0	CHEMBL2068	Homo sapiens	INH	%	29.0
	16485720	CHEMBL3771447	Inhibition of human recombinant EPHA2 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
Active	16494483	CHEMBL3772794	Induction of EPHA2 phosphorylation in human T47D cells at 2.5 uM after 24 hrs by phospho-RTK array analysis	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H](OC(=O)[C@H]5CCCN5)CC[C@@]43C)[C@@H]1Cc1snnc12		CHEMBL3769913		Activity			CHEMBL2068	Homo sapiens	Activity		
	16495977	CHEMBL3778375	Inhibition of N-terminal His6-tagged recombinant human EPHA2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	7.0	CHEMBL2068	Homo sapiens	Activity	%	7.0
Not Active	16497498	CHEMBL3777941	Inhibition of human EPHA2 (591 to 976 residues) at 1 uM by radioactive [33P]-ATP filter binding assay	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	16507192	CHEMBL3778984	Inhibition of recombinant EPHA2 (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	=	Activity	%	92.0	CHEMBL2068	Homo sapiens	Activity	%	92.0
	16508164	CHEMBL3778375	Inhibition of N-terminal His6-tagged recombinant human EPHA2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	0.0	CHEMBL2068	Homo sapiens	Activity	%	0.0
	16509141	CHEMBL3778375	Inhibition of N-terminal His6-tagged recombinant human EPHA2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	3.0	CHEMBL2068	Homo sapiens	Activity	%	3.0
Not Active	16514119	CHEMBL3782167	Inhibition of partial length human EPHA2 expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	16559579	CHEMBL3794764	Inhibition of human N-terminal GST-tagged EPHA2 cytoplasmic domain (572 to 976 residues) expressed in baculovirus expression system using fluorescence labelled Blk/Lyntide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	0.9	CHEMBL2068	Homo sapiens	INH	%	0.9
	16559580	CHEMBL3794764	Inhibition of human N-terminal GST-tagged EPHA2 cytoplasmic domain (572 to 976 residues) expressed in baculovirus expression system using fluorescence labelled Blk/Lyntide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	-1.6	CHEMBL2068	Homo sapiens	INH	%	-1.6
	16559581	CHEMBL3794764	Inhibition of human N-terminal GST-tagged EPHA2 cytoplasmic domain (572 to 976 residues) expressed in baculovirus expression system using fluorescence labelled Blk/Lyntide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	0.6	CHEMBL2068	Homo sapiens	INH	%	0.6
	16563797	CHEMBL3802300	Inhibition of EPHA2 (unknown origin) by Z-LYTE assay	B	CC(NC(=O)c1ccc2[nH]nc(-c3ccncc3)c2c1)c1cccc(Cl)c1		CHEMBL3798631	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16563798	CHEMBL3802300	Inhibition of EPHA2 (unknown origin) by Z-LYTE assay	B	Cc1cc(-c2n[nH]c3ccc(C(=O)NC(C)c4c(Cl)cncc4Cl)cc23)ccn1		CHEMBL3798257	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16574801	CHEMBL3802407	Inhibition of recombinant EPHA2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1000 nM incubated for 60 mins by ELISA relative to control	B	Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1		CHEMBL3797579	=	Inhibition	%	6.1	CHEMBL2068	Homo sapiens	INH	%	6.1
	16578333	CHEMBL3804387	Inhibition of partial length wild type human EPHA2 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	74.0	CHEMBL2068	Homo sapiens	Activity	%	74.0
	16593542	CHEMBL3811545	Inhibition of GST-tagged human recombinant EPHA2 (560 to 976 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL2068	Homo sapiens	INH	%	40.0
	16594895	CHEMBL3812244	Inhibition of human EPHA2 (593 to 891 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	16611858	CHEMBL3816748	Inhibition of human EPHA2 (591 to 976 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-53.0	CHEMBL2068	Homo sapiens	Activity	%	-53.0
	16611859	CHEMBL3816748	Inhibition of human EPHA2 (591 to 976 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-16.0	CHEMBL2068	Homo sapiens	Activity	%	-16.0
	16611860	CHEMBL3816748	Inhibition of human EPHA2 (591 to 976 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	17.0	CHEMBL2068	Homo sapiens	Activity	%	17.0
	16611861	CHEMBL3816748	Inhibition of human EPHA2 (591 to 976 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	25.0	CHEMBL2068	Homo sapiens	Activity	%	25.0
	16614458	CHEMBL3817324	Inhibition of human EPHA2 at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	12.0	CHEMBL2068	Homo sapiens	INH	%	12.0
	16618232	CHEMBL3816223	Inhibition of recombinant human GST-tagged cytoplasmic EPHA2 (560 to 976 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	16621484	CHEMBL3820477	Inhibition of ECK (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL2068	Homo sapiens	IC50	nM	30000.0
	16622199	CHEMBL3820477	Inhibition of ECK (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	262.6	CHEMBL2068	Homo sapiens	IC50	nM	262.6
	16628473	CHEMBL3820176	Inhibition of human recombinant EPHA2 receptor (591 to 976 residues) expressed in insect Sf21 cells at 1 uM using poly(Glu4-Tyr1) as substrate after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	>	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	16653349	CHEMBL3830185	Inhibition of recombinant human EPHA2 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178	>	IC50	nM	100.0	CHEMBL2068	Homo sapiens	IC50	nM	100.0
	16654248	CHEMBL3829781	Inhibition of human EPHA2 (591 to 976 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	38.0	CHEMBL2068	Homo sapiens	Activity	%	38.0
	16777254	CHEMBL3864911	Inhibition of recombinant EPHA2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(CC3(O)CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3958173	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905348	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCN(c2noc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)n2)CC1		CHEMBL3977320	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905378	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3951527	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905623	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905624	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OC[C@H]1CN2CCCC[C@H]2CO1		CHEMBL3968192	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905625	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3977450	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905626	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3959516	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905627	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3956820	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905628	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3893890	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905629	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3928396	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905630	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3946242	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905631	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN2CCOCC2CO1		CHEMBL3943570	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905632	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3908311	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905633	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3905501	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905634	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3924147	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905635	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3971781	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905636	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3914441	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905637	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@H]1CN2CCC[C@@H]2CO1		CHEMBL3917220	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905638	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3968522	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905639	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@@H]1CN2CCC[C@@H]2CO1		CHEMBL3977759	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905640	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3928883	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905641	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@H]1CN2CCC[C@H]2CO1		CHEMBL3931623	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905642	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3959774	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905643	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3962487	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905644	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3922278	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905645	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3924998	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905646	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3896122	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905647	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3893416	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905648	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OC[C@@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3934134	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905649	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OC[C@@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3931427	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905650	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCCC[C@H]2C(=O)N1		CHEMBL3940489	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905651	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCCC[C@@H]2C(=O)N1		CHEMBL3900059	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905652	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2C(=O)N1		CHEMBL3947712	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905653	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@@H]2C(=O)N1		CHEMBL3945072	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905654	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2C(=O)N1		CHEMBL3986135	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905655	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2C(=O)N1C		CHEMBL3983466	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905656	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN2CSC[C@H]2CO1		CHEMBL3917294	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905657	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3920036	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905658	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3946590	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905659	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3986404	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905660	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3961005	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905661	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3Cl)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3958481	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905662	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3895424	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905663	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1C[C@H]2OCC3(OCCO3)[C@H]2O1		CHEMBL3964605	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905664	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3955486	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905665	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3924380	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905666	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC(F)F)CO[C@H]12		CHEMBL3921689	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905667	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3955359	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905668	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3964556	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905669	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3910031	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905670	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCO[C@H]1CO[C@@H]2[C@@H](Oc3cc4ncnc(Nc5ccc(Br)c(Cl)c5)c4cc3OC)CO[C@H]12		CHEMBL3907230	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905671	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cccc(Br)c3C)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3895458	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905672	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cccc(Cl)c3C)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3959160	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905673	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2CCO[C@H]12		CHEMBL3932115	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905674	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@H](OC)CO[C@H]12		CHEMBL3929354	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905675	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1cscn1		CHEMBL3968322	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905676	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1cccnc1		CHEMBL3965901	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905677	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CC1		CHEMBL3928696	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905678	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CCCO1		CHEMBL3926038	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905679	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC1CCCC1		CHEMBL3952048	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905680	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@@H]1O[C@@H](OC)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL3949434	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905681	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC(=O)N1CCOCC1		CHEMBL3914264	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905682	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCCCN2C(=O)OC(C)(C)C)n1		CHEMBL3904510	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905683	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCN(C(=O)OC(C)(C)C)CC2)n1		CHEMBL3958507	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905684	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(-c2ccc(N3CCCC3)cc2)cs1		CHEMBL3955873	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905685	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN(CC)c1ccc(-c2csc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)n2)cc1		CHEMBL3922630	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905686	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(-c2ccc(O)c(C(N)=O)c2)cs1		CHEMBL3943632	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905687	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1CCCCC1		CHEMBL3979687	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905688	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CCCCC1		CHEMBL3954731	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905689	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CCC1		CHEMBL3919501	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905690	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1OCCO1		CHEMBL3929188	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905691	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1OCCCO1		CHEMBL3949535	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905692	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCN1CCOCC1		CHEMBL3968843	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905693	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCN1CCCC1		CHEMBL3905012	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905694	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCN1CCCCC1		CHEMBL3907764	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905695	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCN1C(=O)c2ccccc2C1=O		CHEMBL3909626	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905696	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(-c2cccnc2)cs1		CHEMBL3896044	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905697	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(-c2ccccn2)cs1		CHEMBL3976826	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905698	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(-c2ccncc2)cs1		CHEMBL3916485	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905699	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(N2CCOCC2)n1		CHEMBL3923250	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905700	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(N2CCOCC2)no1		CHEMBL3936025	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905701	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(N(C)C)no1		CHEMBL3960730	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905702	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(CN2CCN(C)CC2)cs1		CHEMBL3913860	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905703	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc2c(s1)CNCC2		CHEMBL3945353	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905704	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(CN2CCOCC2)cs1		CHEMBL3942671	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905705	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(CN2CCCN(C)CC2)cs1		CHEMBL3952188	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905706	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(COCc2ccccc2)no1		CHEMBL3984213	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905707	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3936151	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905708	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(C2CCNCC2)n1		CHEMBL3945860	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905709	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(C2CCN(C)CC2)n1		CHEMBL3898088	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905710	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(N2CCN(C(=O)OC(C)(C)C)CC2)no1		CHEMBL3900858	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905711	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(N2CCNCC2)no1		CHEMBL3957171	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905712	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(N2CCN(C)CC2)no1		CHEMBL3959857	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905713	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCCCC1c1nc(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)no1		CHEMBL3952693	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905714	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1ccc(-c2nc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)no2)cc1		CHEMBL3985840	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905715	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(-c2ccc(C(F)(F)F)cc2)n1		CHEMBL3983201	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905716	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(-c2ccc(Cl)cc2)n1		CHEMBL3963620	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905717	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(-c2c(C)noc2C)n1		CHEMBL3937857	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905718	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc2ccc(Cl)cc12		CHEMBL3929002	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905719	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(-c2ccc(C(C)(C)C)cc2)no1		CHEMBL3951099	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905720	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(-c2ccccc2OC)n1		CHEMBL3933848	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905721	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nnc(-c2ccc(C)cc2)o1		CHEMBL3944502	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905722	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nccn1Cc1ccccc1		CHEMBL3895848	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905723	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1c(-c2c(Cl)cccc2Cl)noc1C		CHEMBL3893128	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905724	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1cc(F)cc2c1OCOC2		CHEMBL3952493	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905725	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1cc(Br)cc(Br)c1		CHEMBL3961982	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905726	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1cc(F)cc(F)c1		CHEMBL3900296	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905727	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(CS(=O)(=O)c2ccccn2)no1		CHEMBL3903022	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905728	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(-c2ccccc2)n1		CHEMBL3946018	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905729	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1ccc2nc(C(F)(F)F)cc(Cl)c2c1		CHEMBL3948661	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905730	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1CCCN1C		CHEMBL3914671	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905731	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCC(c2nc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)no2)CC1		CHEMBL3959254	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905732	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCCC(c2nc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)no2)C1		CHEMBL3960016	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905733	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(N(C)C)n1		CHEMBL3971864	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905734	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3983938	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905735	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCC(c2nc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)cs2)CC1		CHEMBL3904481	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905736	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc([C@@H]2CCCN2)no1		CHEMBL3952023	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905737	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc([C@@H]2CCCN2)n1		CHEMBL3949400	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905738	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(COC(=O)c2ccccc2)n1		CHEMBL3900567	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905739	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(CO)n1		CHEMBL3939717	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905740	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc2c(s1)CN(C)CC2		CHEMBL3938621	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905741	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc([C@@H]2CSCN2)n1		CHEMBL3927549	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905742	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(C2CCCCN2)n1		CHEMBL3977030	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905743	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(C2CCCCN2C)n1		CHEMBL3967776	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905744	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(C2CCCNC2)n1		CHEMBL3893575	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905745	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(C2CCCN(C)C2)n1		CHEMBL3930406	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905746	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCCCC1c1nc(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)cs1		CHEMBL3952805	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905747	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCCC(c2nc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)cs2)C1		CHEMBL3897215	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905748	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCC[C@H]1c1noc(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)n1		CHEMBL3898627	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905749	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCC[C@H]1c1nc(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)cs1		CHEMBL3910064	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905750	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCC2N=C(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)SC2C1		CHEMBL3959195	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905751	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCCN1CCCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3914599	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905752	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CC2CC2)CCCO1		CHEMBL3966752	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905753	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COCCN1CCCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3986301	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905754	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(C)C)CCCO1		CHEMBL3947408	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905755	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(N2CCNCC2)n1		CHEMBL3944780	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905756	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCCN2)n1		CHEMBL3909596	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905757	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCCC1c1nc(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)no1		CHEMBL3906789	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905758	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc([C@@H]2CCCN2C)no1		CHEMBL3933123	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905759	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc([C@@H]2CCCN2C)n1		CHEMBL3930429	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905760	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCN(c2nc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)cs2)CC1		CHEMBL3895123	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905761	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)CCN1C		CHEMBL3983179	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905762	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C2CCCC2)CCO1		CHEMBL3965096	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905763	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(C)C)CCO1		CHEMBL3952315	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905764	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCCc2ccccc2)CCO1		CHEMBL3899485	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905765	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3923013	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905766	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCOC(=O)C(C)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3937598	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905767	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	C=CCCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3955495	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905768	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCOCCO)CCO1		CHEMBL3918670	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905769	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COC(=O)CCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3978177	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905770	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCCCCC#N)CCO1		CHEMBL3923153	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905771	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CC2C=CC=CO2)CCO1		CHEMBL3925935	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905772	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCCC#N)CCO1		CHEMBL3898808	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905773	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(Cc2ccc(F)cc2)CCO1		CHEMBL3910102	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905774	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COC(=O)CCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3979195	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905775	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	C=CCCCCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3981613	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905776	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3942082	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905777	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCCCCCO)CCO1		CHEMBL3949560	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905778	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(C)=O)CCO1		CHEMBL3985254	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905779	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CC2CC2)CCO1		CHEMBL3897256	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905780	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	C#CCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3932578	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905781	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(c2ccncc2)CCO1		CHEMBL3935265	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905782	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(Cc2ccccn2)CCO1		CHEMBL3916759	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905783	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCC#CCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3919493	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905784	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(N2CCN(C)CC2)n1		CHEMBL3958678	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905785	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCCN2C)n1		CHEMBL3956056	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905786	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3893032	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905787	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCN(C(C)=O)CC1COc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3)c2cc1OC		CHEMBL3890263	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905788	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc(Nc2ncnc3cc(OCC4CN(C)CCO4)c(OC)cc23)c(OC)cc1Cl		CHEMBL3944702	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905789	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cccc(Br)c3C)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3912287	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905790	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)c(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3906715	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905791	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cccc(Cl)c3C)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3896927	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905792	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cccc(Cl)c3Cl)ncnc2cc1OCC1CN(C(C)=N)CCCO1		CHEMBL3968519	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905793	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3966040	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905794	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)ccc3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3949155	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905795	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3951755	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905796	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)cc3Cl)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3904192	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905797	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)cc3Br)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3913993	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905798	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3Cl)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3944791	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905799	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCN(C)CC1COc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3)c2cc1OC		CHEMBL3968030	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905800	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(/C(N)=N/C#N)CCO1		CHEMBL3897525	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905801	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(CN2CCCC2)n1		CHEMBL3900295	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905802	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C2CCOCC2)CCO1		CHEMBL3928180	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905803	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCC(CC)CN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3921228	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905804	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CC2CCCCC2)CCO1		CHEMBL3895890	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905805	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCO)CCO1		CHEMBL3893176	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905806	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CC#CCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3933897	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905807	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C2CCC2)CCO1		CHEMBL3931193	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905808	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCC2OCCO2)CCO1		CHEMBL3979728	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905809	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCC2CCCCC2)CCO1		CHEMBL3951403	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905810	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	C=CCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3944857	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905811	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CC[C@@H](C)CN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3985896	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905812	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCCCF)CCO1		CHEMBL3983245	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905813	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(C)C(C)=O)CCO1		CHEMBL3895645	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905814	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCC(=O)CN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3965938	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905815	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3929942	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905816	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCCCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3932698	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905817	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCCCCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3976896	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905818	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCCCCCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3979317	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905819	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCc2ccccc2)CCO1		CHEMBL3916297	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905820	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3919051	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905821	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	C=CCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3946469	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905822	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1OCCN(CC(=O)c2ccccc2)C1=O		CHEMBL3965160	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905823	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCF)CCO1		CHEMBL3955447	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905824	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CC=C(C)C)CCO1		CHEMBL3932218	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905825	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C/C=C/Br)CCO1		CHEMBL3898138	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905826	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CC(N)=O)CCO1		CHEMBL3916567	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905827	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCCOC2CCCCO2)CCCO1		CHEMBL3963821	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905828	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCC(C)C)CCCO1		CHEMBL3947769	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905829	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CC2CCCCC2)CCCO1		CHEMBL3912646	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905830	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCC2CCCCC2)CCCO1		CHEMBL3914394	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905831	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCC(CC)CN1CCCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3928439	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905832	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(S(C)(=O)=O)CCCO1		CHEMBL3925803	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905833	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C2CCN(C)CC2)CCO1		CHEMBL3951258	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905834	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3953937	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905835	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCC1CN(/C(N)=N/C#N)CCCO1		CHEMBL3913496	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905836	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(C)c(Br)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3916225	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905837	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN1CCN(CC)C(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3937092	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905838	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(/C(N)=N/C#N)CC1		CHEMBL3939874	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905839	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(S(C)(=O)=O)CCO1		CHEMBL3892030	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905840	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(S(=O)(=O)Cc2ccccc2)CCO1		CHEMBL3901787	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905841	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(S(=O)(=O)c2ccc(F)cc2)CCO1		CHEMBL3958778	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905842	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCS(=O)(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3961472	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905843	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(S(=O)(=O)c2ccccc2)CCO1		CHEMBL3933398	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905844	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(S(=O)(=O)CCCCl)CCO1		CHEMBL3923692	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905845	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCCCS(=O)(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3893845	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905846	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(S(=O)(=O)c2ccc(C)cc2)CCO1		CHEMBL3970332	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905847	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2c(C)noc2C)CCO1		CHEMBL3947700	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905848	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cccc(CC(=O)N2CCOC(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)C2)c1		CHEMBL3945062	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905849	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCCC(C)C(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3986123	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905850	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCCCc1ccc(C(=O)N2CCOC(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)C2)cc1		CHEMBL3983450	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905851	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)Cc2ccc(Cl)cc2)CCO1		CHEMBL3941200	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905852	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCCC(CCC)C(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3959038	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905853	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)CCC(C)C)CCO1		CHEMBL3942387	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905854	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2cc(F)ccc2F)CCO1		CHEMBL3982666	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905855	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)C2CCCC2)CCO1		CHEMBL3920114	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905856	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCC(C(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1)c1ccccc1		CHEMBL3894418	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905857	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2c(F)ccc(F)c2F)CCO1		CHEMBL3929966	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905858	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2ccoc2)CCO1		CHEMBL3969472	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905859	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCC(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3976226	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905860	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCCCCC(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3931724	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905861	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCCCC(CC)C(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3953606	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905862	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)CCc2ccccc2)CCO1		CHEMBL3918306	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905863	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)C(C)(C)C)CCO1		CHEMBL3907879	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905864	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2cccc3ccccc23)CCO1		CHEMBL3905114	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905865	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2cccnc2Cl)CCO1		CHEMBL3968956	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905866	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2ccc(Cl)nc2)CCO1		CHEMBL3966429	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905867	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2ccc3c(c2)OCO3)CCO1		CHEMBL3962355	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905868	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CC(C)Oc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CNCCO1		CHEMBL3959638	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905869	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COCCOc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CNCCO1		CHEMBL3964536	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905870	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCOc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CNCCO1		CHEMBL3917442	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905871	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCOc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3941402	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905872	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)cc3C)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3892117	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905873	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(C)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3907215	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905874	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CN/C(=N\C#N)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(C)c4)c3cc2OC)C1		CHEMBL3904460	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905875	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3945177	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905876	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CC(C)Oc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3937297	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905877	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COCCOc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3913719	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905878	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)cc3Cl)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3911207	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905879	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(C)=O)CCCO1		CHEMBL3958466	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905880	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2O)C1		CHEMBL3955824	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905881	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Br)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3899410	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905882	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)CC(=O)O)CCO1		CHEMBL3896699	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905883	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COC(=O)CCC(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3899440	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905884	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cccc(Br)c3Cl)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3977221	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905885	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COCCN/C(=N\C#N)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3986102	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905886	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN/C(=N\C#N)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3942161	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905887	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(/C(=N/C#N)N2CCCCC2)CCO1		CHEMBL3940839	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905888	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(/C(=N/C#N)N2CCCC2)CCO1		CHEMBL3971050	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905889	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(/C(=N/C#N)N2CCN(C)CC2)CCO1		CHEMBL3973632	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905890	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCC1(C)CN(C)CC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)O1		CHEMBL3931393	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905891	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(C)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3934095	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905892	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1CNC(C)(C)CO1		CHEMBL3962203	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905893	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1CN(C)C(C)(C)CO1		CHEMBL3959495	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905894	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1CN(C(=O)OC(C)(C)C)C(C)(C)CO1		CHEMBL3916953	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905895	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)C(C)(C)CO1		CHEMBL3914180	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905896	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3977503	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905897	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3968233	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905898	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1CN(C)CC(C)(C)O1		CHEMBL3939133	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905899	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(F)c3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3941947	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905900	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(F)c(Br)cc3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3952465	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905901	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(F)c(Br)c(F)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3955083	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905902	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3C)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3921390	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905903	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3C)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3924098	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905904	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OCC1COCCN1C		CHEMBL3958898	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905905	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3923449	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905906	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3906936	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905907	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3909744	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905908	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(C)c(Cl)c3Cl)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3891059	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905909	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)C(C)(C)C(=O)O1		CHEMBL3893846	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905910	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OCC1CN(C)C(C)(C)CO1		CHEMBL3981432	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905911	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OCC1CN(C)C(C)(C)CO1		CHEMBL3972712	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905912	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OCC1CN(C)C(C)(C)CO1		CHEMBL3921482	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905913	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OCC1CN(C)C(C)(C)CO1		CHEMBL3918761	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905914	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCC1CN(C)C(C)(C)CO1		CHEMBL3939671	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905915	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCC1CN(C)C(C)(C)CO1		CHEMBL3895129	<	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905916	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN(C)CC(=O)N1		CHEMBL3935851	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905917	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN(C)CC(=O)N1		CHEMBL3933130	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905918	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN(C)CC(=O)N1C		CHEMBL3891130	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905919	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN(C)CC(=O)N1C		CHEMBL3909603	=	IC50	nM	50.0	CHEMBL2068	Homo sapiens	IC50	nM	50.0
	16905920	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1OC1=CO[C@H]2[C@H]1OC[C@@]21COC(C)(C)O1		CHEMBL3965625	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905921	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1CO[C@@H]2[C@@H](OS(C)(=O)=O)CO[C@@H]21		CHEMBL3986082	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905922	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@H]12		CHEMBL3945028	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905923	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](SC)CO[C@H]12		CHEMBL3947643	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905924	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@H]2[C@@H]1OC[C@@H]2N1CCOCC1		CHEMBL3921861	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905925	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@H]2[C@@H]1OC[C@@H]2N1CCN(C)CC1		CHEMBL3972940	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905926	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@H]2[C@@H]1OC[C@@H]2N1CCCC1		CHEMBL3923645	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905927	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC(C)=O)CO[C@H]12		CHEMBL3933359	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905928	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](O)CO[C@H]12		CHEMBL3893363	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905929	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](S(C)(=O)=O)CO[C@H]12		CHEMBL3896067	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905930	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](N)CO[C@H]12		CHEMBL3976788	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905931	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CN[C@H]1CO[C@@H]2[C@@H](Oc3cc4ncnc(Nc5ccc(Br)c(Cl)c5)c4cc3OC)CO[C@H]12		CHEMBL3974328	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905932	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	CCN(CC)[C@H]1CO[C@@H]2[C@@H](Oc3cc4ncnc(Nc5ccc(Br)c(Cl)c5)c4cc3OC)CO[C@@H]21		CHEMBL3909572	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905933	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@H]2[C@@H]1OC[C@@H]2N1CCCCC1		CHEMBL3927849	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905934	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](NC(C)=O)CO[C@H]12		CHEMBL3961417	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905935	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1CO[C@@H]2[C@@H](NC(F)(F)F)CO[C@H]12		CHEMBL3958721	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905936	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1CO[C@@H]2[C@@H](NS(C)(=O)=O)CO[C@H]12		CHEMBL3943734	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905937	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1OC1CCN(C)C1		CHEMBL3971560	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905938	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1CCOC1		CHEMBL3939828	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905939	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](F)CO[C@H]12		CHEMBL3937048	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905940	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(N[C@H]3COC[C@@H]3OC)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](O)CO[C@H]12		CHEMBL3916828	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905941	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(N4CCN(C)CC4)cc3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](F)CO[C@H]12		CHEMBL3924442	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905942	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(N4CCN(C)C(F)C4)cc3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](F)CO[C@H]12		CHEMBL3890300	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905943	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(N4CCN(C)CC4)c(Cl)c3Cl)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](F)CO[C@H]12		CHEMBL3893058	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905944	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3N3CCN(C)CC3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](F)CO[C@H]12		CHEMBL3985116	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	16905945	CHEMBL3883065	Inhibition of recombinant human N-terminal His6-tagged EphA2 (N598 to R890 residues) expressed in baculovirus using poly-EY as substrate after 180 mins by luciferase coupled chemiluminescence assay	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2C(F)(F)F		CHEMBL3938869	=	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
Active	17899380	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	1429.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	1429.0
Inactive	17899381	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899382	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899383	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899384	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899385	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899386	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899387	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899388	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	661.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	661.0
Inactive	17899389	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899390	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899391	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899392	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899393	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899394	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899395	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899396	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899397	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899398	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899399	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899400	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899401	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899402	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899403	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Kd	nM	832.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	832.0
Inactive	17899404	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899405	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899406	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899407	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	178.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	178.0
Inactive	17899408	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899409	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	118.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	118.0
Inactive	17899410	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899411	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	27.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	27.0
Inactive	17899412	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899413	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899414	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899415	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899416	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899417	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899418	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899419	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899420	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899421	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	63.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	63.0
Inactive	17899422	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899423	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899424	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899425	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899426	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899427	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899428	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899429	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899430	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	=	Kd	nM	202.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	202.0
Inactive	17899431	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899432	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899433	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	6.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	6.0
Inactive	17899434	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899435	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	501.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	501.0
Inactive	17899436	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899437	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899438	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899439	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899440	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899441	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899442	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899443	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899444	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899445	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899446	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899447	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899448	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899449	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	30.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30.0
Inactive	17899450	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899451	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899452	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	24.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	24.0
Inactive	17899453	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899454	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899455	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899456	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899457	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899458	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899459	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899460	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899461	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899462	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899463	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899464	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899465	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899466	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899467	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899468	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899469	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899470	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899471	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899472	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899473	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899474	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899475	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899476	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899477	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899478	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	144.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	144.0
Inactive	17899479	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899480	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899481	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899482	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899483	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899484	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	1266.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	1266.0
Inactive	17899485	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899486	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899487	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899488	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899489	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899490	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899491	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899492	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899493	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899494	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899495	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899496	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Kd	nM	746.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	746.0
Inactive	17899497	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899498	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899499	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899500	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	110.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	110.0
Inactive	17899501	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899502	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899503	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899504	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899505	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899506	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899507	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899508	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899509	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899510	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899511	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899512	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899513	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	1.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	1.0
Inactive	17899514	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899515	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899516	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899517	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	729.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	729.0
Inactive	17899518	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899519	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899520	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899521	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899522	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899523	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899524	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899525	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	3931.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	3931.0
Inactive	17899526	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899527	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	=	Kd	nM	807.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	807.0
Inactive	17899528	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899529	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899530	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	626.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	626.0
Inactive	17899531	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899532	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899533	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899534	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	147.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	147.0
Inactive	17899535	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899536	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899537	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899538	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899539	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899540	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899541	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899542	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Kd	nM	309.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	309.0
Inactive	17899543	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899544	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899545	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	Kd	nM	2565.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	2565.0
Inactive	17899546	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899547	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899548	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	=	Kd	nM	1350.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	1350.0
Inactive	17899549	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899550	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899551	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899552	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899553	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899554	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899555	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899556	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899557	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	90.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	90.0
Inactive	17899558	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899559	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899560	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899561	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899562	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899563	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899564	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	32.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	32.0
Inactive	17899565	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899566	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899567	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899568	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899569	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899570	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899571	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899572	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899573	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899574	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899575	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899576	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899577	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899578	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	1252.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	1252.0
Inactive	17899579	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17899580	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	=	Kd	nM	8198.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	8198.0
Inactive	17899581	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899582	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899583	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899584	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899585	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899586	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899587	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899588	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899589	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899590	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899591	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899592	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899593	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899594	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899595	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899596	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899597	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899598	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899599	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899600	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899601	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899602	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899603	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	772.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	772.0
Inactive	17899604	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899605	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899606	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899607	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899608	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899609	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899610	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899611	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899612	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899613	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899614	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899615	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899616	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899617	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Active	17899618	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	=	Kd	nM	1188.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	1188.0
Inactive	17899619	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899620	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899621	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899622	CHEMBL3991701	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL2068	Homo sapiens	Kd apparent	nM	30000.0
	17964895	CHEMBL3995004	Inhibition of human EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	80.0	CHEMBL2068	Homo sapiens	Activity	%	80.0
	17979246	CHEMBL3998051	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain (560 to 976 residues) expressed in baculovirus expression system at 10 uM by Z'-LYTE assay relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	9.0	CHEMBL2068	Homo sapiens	INH	%	9.0
	18012395	CHEMBL4004215	Inhibition of recombinant human N-terminal GST-tagged EPHA2 cytoplasmic domain (572 to 976 residues) expressed in baculovirus expression system	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	>	IC50	nM	50000.0	CHEMBL2068	Homo sapiens	IC50	uM	50.0
	18053079	CHEMBL4011846	Inhibition of EPHA2 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-6.2	CHEMBL2068	Homo sapiens	INH	%	-6.2
	18086009	CHEMBL4018647	Inhibition of recombinant EPH-A2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4105329	>	IC50	nM	10.0	CHEMBL2068	Homo sapiens	IC50	nM	10.0
	18086010	CHEMBL4018647	Inhibition of recombinant EPH-A2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1		CHEMBL4067871	>	IC50	nM	100.0	CHEMBL2068	Homo sapiens	IC50	nM	100.0
	18086011	CHEMBL4018647	Inhibition of recombinant EPH-A2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	>	IC50	nM	10.0	CHEMBL2068	Homo sapiens	IC50	nM	10.0
	18086012	CHEMBL4018647	Inhibition of recombinant EPH-A2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12		CHEMBL4075917	>	IC50	nM	100.0	CHEMBL2068	Homo sapiens	IC50	nM	100.0
	18096347	CHEMBL4021234	Inhibition of EPHA2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 5 to 10 mins followed by substrate/ATP addition measured after 30 to 60 mins by mobility shift assay	B	CC(c1cc2cc(-c3cnn(C)c3)cnc2cc1F)n1nnc2ncc(-c3cnn(CCO)c3)nc21		CHEMBL4074262	>	IC50	nM	30000.0	CHEMBL2068	Homo sapiens	IC50	nM	30000.0
	18114380	CHEMBL4025114	Inhibition of wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	87.0	CHEMBL2068	Homo sapiens	Activity	%	87.0
	18121799	CHEMBL4026906	Binding affinity to recombinant human GST-tagged EphA2 cytoplasmic domain (560 to 976 residues) expressed in baculovirus expression system by fluorescence polarization assay	B	NC(=O)[C@H](CCCCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)NC(=O)CN1C[C@H](Cc2ccccc2)NC(=O)CN(C(=O)CCC(=O)O)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)Cc2ccc3c(c2)OCO3)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCC2CCCCC2)C[C@H](Cc2ccccc2)NC(=O)c2ccc(cc2)CSCCC1=O		CHEMBL4071045	=	Kd	nM	81.0	CHEMBL2068	Homo sapiens	Kd	nM	81.0
Active	18121806	CHEMBL4026905	Inhibition of recombinant human GST-tagged EphA2 cytoplasmic domain (560 to 976 residues) expressed in baculovirus expression system assessed as decrease in poly(Glu-Tyr) phosphorylation at 2 uM after 40 mins by Western blot method	B	NC(=O)CN1C[C@H](Cc2ccccc2)NC(=O)CN(C(=O)CCC(=O)O)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)Cc2ccc3c(c2)OCO3)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCC2CCCCC2)C[C@H](Cc2ccccc2)NC(=O)c2ccc(cc2)CSCCC1=O		CHEMBL4093682		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	18121807	CHEMBL4026905	Inhibition of recombinant human GST-tagged EphA2 cytoplasmic domain (560 to 976 residues) expressed in baculovirus expression system assessed as decrease in poly(Glu-Tyr) phosphorylation at 2 uM after 40 mins by Western blot method	B	CC(C)C[C@H]1CN(C(=O)CC2CC2)CC(=O)N[C@@H](CCCCN)CN(C(=O)CCc2ccccc2)CC(=O)N[C@H](Cc2ccccc2)CN(CC(N)=O)C(=O)CCSCc2ccc(cc2)C(=O)N[C@H](Cc2ccccc2)CN(C(=O)CC2CC2)CC(=O)N1		CHEMBL4090299		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Dose-dependent effect	18121808	CHEMBL4026913	Inhibition of EphA2 autophosphorylation at Ser897 in human C13 cells after 24 hrs by Western blot method	B	NC(=O)CN1C[C@H](Cc2ccccc2)NC(=O)CN(C(=O)CCC(=O)O)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)Cc2ccc3c(c2)OCO3)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCC2CCCCC2)C[C@H](Cc2ccccc2)NC(=O)c2ccc(cc2)CSCCC1=O		CHEMBL4093682		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	18121809	CHEMBL4026913	Inhibition of EphA2 autophosphorylation at Ser897 in human C13 cells after 24 hrs by Western blot method	B	NC(=O)CN1C[C@H](Cc2ccccc2)NC(=O)CN(C(=O)CCC(=O)O)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)Cc2ccc3c(c2)OCO3)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCC2CCCCC2)C[C@H](Cc2ccccc2)NC(=O)c2ccc(cc2)CSCCC1=O		CHEMBL4093682	=	IC50	nM	5000.0	CHEMBL2068	Homo sapiens	IC50	uM	5.0
	18121813	CHEMBL4026917	Inhibition of EphA2 (unknown origin) transfected in human C13 cells assessed as decrease in cell migration at 10 uM after 24 hrs by crystal violet staining based matrigel assay relative to control	B	NC(=O)CN1C[C@H](Cc2ccccc2)NC(=O)CN(C(=O)CCC(=O)O)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)Cc2ccc3c(c2)OCO3)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCC2CCCCC2)C[C@H](Cc2ccccc2)NC(=O)c2ccc(cc2)CSCCC1=O		CHEMBL4093682	=	Inhibition	%	70.0	CHEMBL2068	Homo sapiens	INH	%	70.0
Active	18121814	CHEMBL4026919	Inhibition of recombinant human GST-tagged EphA2 cytoplasmic domain (560 to 976 residues) autophosphorylation expressed in baculovirus expression system at 2 uM by Western blot method	B	NC(=O)CN1C[C@H](Cc2ccccc2)NC(=O)CN(C(=O)CCC(=O)O)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)Cc2ccc3c(c2)OCO3)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCC2CCCCC2)C[C@H](Cc2ccccc2)NC(=O)c2ccc(cc2)CSCCC1=O		CHEMBL4093682		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	18121815	CHEMBL4026918	Inhibition of EphA2 (unknown origin) transfected in human C13 cells assessed as decrease in cell invasion at 10 uM after 24 hrs by crystal violet staining based matrigel assay relative to control	B	NC(=O)CN1C[C@H](Cc2ccccc2)NC(=O)CN(C(=O)CCC(=O)O)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)Cc2ccc3c(c2)OCO3)C[C@H](CCC(=O)O)NC(=O)CN(C(=O)CCC2CCCCC2)C[C@H](Cc2ccccc2)NC(=O)c2ccc(cc2)CSCCC1=O		CHEMBL4093682	=	Inhibition	%	80.0	CHEMBL2068	Homo sapiens	INH	%	80.0
Not Active	18121816	CHEMBL4026917	Inhibition of EphA2 (unknown origin) transfected in human C13 cells assessed as decrease in cell migration at 10 uM after 24 hrs by crystal violet staining based matrigel assay relative to control	B	CC(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@@H](CCC(=O)O)CN(CC(=O)C[C@@H](CCC(=O)O)CN(CC(=O)N[C@@H](Cc1ccccc1)CN(CC(N)=O)C(=O)CCS)C(=O)CCC(=O)O)C(=O)Cc1ccc2c(c1)OCO2)C(=O)CCC1CCCCC1		CHEMBL4081722		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Not Active	18121817	CHEMBL4026917	Inhibition of EphA2 (unknown origin) transfected in human C13 cells assessed as decrease in cell migration at 10 uM after 24 hrs by crystal violet staining based matrigel assay relative to control	B	CC(C)C[C@H]1CN(C(=O)CC2CC2)CC(=O)N[C@@H](CCCCN)CN(C(=O)CCc2ccccc2)CC(=O)N[C@H](Cc2ccccc2)CN(CC(N)=O)C(=O)CCSCc2ccc(cc2)C(=O)N[C@H](Cc2ccccc2)CN(C(=O)CC2CC2)CC(=O)N1		CHEMBL4090299		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Active	18149660	CHEMBL4033347	Inhibition of human EPHA2 at 0.5 uM relative to control	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(CN5CCOCC5)c(C(F)(F)F)c4)c4ccccc34)c2cc1OC		CHEMBL4075561		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Active	18149661	CHEMBL4033347	Inhibition of human EPHA2 at 0.5 uM relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	18153321	CHEMBL4034317	Inhibition of EphA2 activation loop (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	0.5	CHEMBL2068	Homo sapiens	INH	%	0.5
	18203638	CHEMBL4043925	Inhibition of wild-type human partial length EPHA2 (T593 to V891 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	18232146	CHEMBL4050359	Inhibition of human EPHA2 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	87.0	CHEMBL2068	Homo sapiens	Activity	%	87.0
	18250457	CHEMBL4054274	Inhibition of EPH-A2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 100 uM after 1 hr by ELISA relative to control	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	Inhibition	%	13.0	CHEMBL2068	Homo sapiens	INH	%	13.0
	18250458	CHEMBL4054275	Inhibition of EPH-A2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA relative to control	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	100.0	CHEMBL2068	Homo sapiens	INH	%	100.0
	18253473	CHEMBL4055020	Inhibition of wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	81.0	CHEMBL2068	Homo sapiens	Activity	%	81.0
	18253474	CHEMBL4055020	Inhibition of wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	18265776	CHEMBL4057226	Inhibition of EPHA2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	8.0	CHEMBL2068	Homo sapiens	INH	%	8.0
	18265974	CHEMBL4057424	Inhibition of EPHA2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-0.3	CHEMBL2068	Homo sapiens	INH	%	-0.3
	18274869	CHEMBL4118335	Inhibition of EphA2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VLEDDPEATYTTSGGKIPIR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-44.4	CHEMBL2068	Homo sapiens	INH	%	-44.4
	18274870	CHEMBL4118335	Inhibition of EphA2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VLEDDPEATYTTSGGKIPIR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-36.2	CHEMBL2068	Homo sapiens	INH	%	-36.2
	18274871	CHEMBL4118335	Inhibition of EphA2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VLEDDPEATYTTSGGKIPIR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-20.9	CHEMBL2068	Homo sapiens	INH	%	-20.9
	18282747	CHEMBL4120332	Inhibition of EPHA2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	8.0	CHEMBL2068	Homo sapiens	INH	%	8.0
	18282974	CHEMBL4120559	Inhibition of EPHA2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-0.3	CHEMBL2068	Homo sapiens	INH	%	-0.3
	18283143	CHEMBL4120728	Inhibition of EPHA2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-2.3	CHEMBL2068	Homo sapiens	INH	%	-2.3
	18286300	CHEMBL4121535	Inhibition of recombinant GST-tagged human EPHA2 (560 to 976 residues) cytoplasmic domain expressed in baculovirus expression system at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	-7.0	CHEMBL2068	Homo sapiens	INH	%	-7.0
Active	18361382	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)c4ccc5ccccc5c4)CC3)nc(N)c2cc1OC		CHEMBL6323		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361383	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N)c2cc1OC		CHEMBL4163275		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361384	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)c4ccc5c(c4)OCO5)CC3)nc(N)c2cc1OC		CHEMBL4171178		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361385	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1ccc(CC(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)CC2)cc1		CHEMBL4168670		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361386	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cccc(CC(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)CC2)c1		CHEMBL4176529		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361387	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)Cc4ccccc4)CC3)nc(N)c2cc1OC		CHEMBL4168488		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361388	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)Cc4ccc5ccccc5c4)CC3)nc(N)c2cc1OC		CHEMBL4176585		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361389	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)C(C)c4ccccc4)CC3)nc(N)c2cc1OC		CHEMBL4165067		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361390	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)c4ccccn4)CC3)nc(N)c2cc1OC		CHEMBL4175687		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361391	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)c4ccncc4)CC3)nc(N)c2cc1OC		CHEMBL4161652		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361392	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	CCc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)CC2)cc1		CHEMBL4164627		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361393	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)c4ccc(I)cc4)CC3)nc(N)c2cc1OC		CHEMBL4173015		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361394	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)c4ccc(Cl)c([N+](=O)[O-])c4)CC3)nc(N)c2cc1OC		CHEMBL4168909		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361395	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(C)=O)CC3)nc(N)c2cc1OC		CHEMBL136561		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361396	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	CCC(=O)N1CCN(c2nc(N)c3cc(OC)c(OC)cc3n2)CC1		CHEMBL4165489		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361397	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	CCCC(=O)N1CCN(c2nc(N)c3cc(OC)c(OC)cc3n2)CC1		CHEMBL4171516		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361398	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)C4CCCCC4)CC3)nc(N)c2cc1OC		CHEMBL4160904		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361399	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC		CHEMBL2		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361400	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)c4cccs4)CC3)nc(N)c2cc1OC		CHEMBL469049		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361401	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)c4ccno4)CC3)nc(N)c2cc1OC		CHEMBL4159829		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361402	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)CC2)cc1		CHEMBL333187		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361403	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)c4ccc(Br)cc4)CC3)nc(N)c2cc1OC		CHEMBL4163200		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361404	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	CCCCCC(=O)N1CCN(c2nc(N)c3cc(OC)c(OC)cc3n2)CC1		CHEMBL4171119		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361405	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)Cc4ccc(OCc5ccccc5)cc4)CC3)nc(N)c2cc1OC		CHEMBL4166644		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361406	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1ccc(C(=O)N2CCN(C(=O)c3ccc(OC)cc3)CC2)cc1		CHEMBL4174556		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361407	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	CSc1ccc(C(=O)N2CCN(C(=O)c3ccc(SC)cc3)CC2)cc1		CHEMBL4159397		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361408	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)CCCCCCCCCCC(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC		CHEMBL4170029		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361409	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)CCCCC(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC		CHEMBL4162761		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361410	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(NC(C)=O)c2cc1OC		CHEMBL4173468		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361411	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)Cc4ccc(OCc5ccccc5)cc4)CC3)nc(NC(C)=O)c2cc1OC		CHEMBL4166204		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361412	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)Cc4ccc(OCc5ccccc5)cc4)CC3)nc(N3CCCCC3)c2cc1OC		CHEMBL4176823		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361413	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	COc1cc2nc(N3CCN(C(=O)Cc4ccc(OCc5ccccc5)cc4)CC3)nc(N3CCCC3)c2cc1OC		CHEMBL4169630		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	18361414	CHEMBL4141780	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 2 to 50 uM after 30 mins by immunoprecipitation and immunoblot assay relative to 50 uM doxazosin	B	CCOc1cc2nc(N3CCN(C(=O)Cc4ccc(OCc5ccccc5)cc4)CC3)nc(N)c2cc1OCC		CHEMBL4175309		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361415	CHEMBL4141782	Binding affinity to EphA2 in human MDA-MB-231 cells assessed as induction of EphA2 receptor internalization at 0.4 uM after 1 hr by immunofluorescence microscopy	B	COc1cc2nc(N3CCN(C(=O)CCCCCCCCCCC(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC		CHEMBL4170029		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361416	CHEMBL4141783	Binding affinity to EphA2 in human MDA-MB-231 cells assessed as induction of EphA2 receptor internalization at 50 uM after 1 hr by immunofluorescence microscopy	B	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC		CHEMBL707		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18361423	CHEMBL4141781	Agonist activity against EphA2 (unknown origin) overexpressed in MDA-MB-231-A2 cells assessed as increase in phosphorylated EphA2 levels at 50 uM after 30 mins by immunoprecipitation and immunoblot assay	B	COc1cc2nc(N3CCN(C(=O)CCCCCCCCCCC(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC		CHEMBL4170029		Activity			CHEMBL2068	Homo sapiens	Activity		
	18409082	CHEMBL4151616	Inhibition of EPHA2 (unknown origin) at 1 uM	B	CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12		CHEMBL4168305	>	Inhibition	%	90.0	CHEMBL2068	Homo sapiens	INH	%	90.0
	18409094	CHEMBL4151628	Binding affinity to human EPHA2	B	CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12		CHEMBL4168305	=	Kd	nM	260.0	CHEMBL2068	Homo sapiens	Kd	nM	260.0
	18431054	CHEMBL4155735	Inhibition of recombinant GST-tagged human EPHA2 cytoplasmic domain expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	63.0	CHEMBL2068	Homo sapiens	INH	%	63.0
	18440180	CHEMBL4157004	Binding affinity to wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	79.0	CHEMBL2068	Homo sapiens	Activity	%	79.0
	18443271	CHEMBL4157943	Inhibition of human EPHA2 assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	107.0	CHEMBL2068	Homo sapiens	Activity	%	107.0
	18449899	CHEMBL4178133	Inhibition of human EPHA2 (591 to 976 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	99.0	CHEMBL2068	Homo sapiens	Activity	%	99.0
	18462167	CHEMBL4180854	Inhibition of EPHA2 (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	80.0	CHEMBL2068	Homo sapiens	Activity	%	80.0
	18484620	CHEMBL4185783	Binding affinity to wild-type human partial length EPHA2 (T593 to V891 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	96.0	CHEMBL2068	Homo sapiens	Activity	%	96.0
	18485001	CHEMBL4185783	Binding affinity to wild-type human partial length EPHA2 (T593 to V891 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	93.0	CHEMBL2068	Homo sapiens	Activity	%	93.0
	18489508	CHEMBL4187249	Inhibition of wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	98.0	CHEMBL2068	Homo sapiens	Activity	%	98.0
	18502863	CHEMBL4189701	Inhibition of recombinant human EPHA2 using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	18502864	CHEMBL4189701	Inhibition of recombinant human EPHA2 using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA	B	C=CC(=O)N[C@@H]1Cn2c(c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1=C		CHEMBL4211949	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	18507807	CHEMBL4190955	Inhibition of recombinant human EPHA2 (596 to 900 residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	9.0	CHEMBL2068	Homo sapiens	INH	%	9.0
Active	18571303	CHEMBL4221074	Agonist activity against EphA2 (unknown origin) expressed in HEK293T/17 cells assessed as increase in phosphorylated EphA2 levels at 10 nM after 30 mins by immunoprecipitation assay	B	C#CCCCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCCNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCO)NC(=O)[C@H](CCCC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCO)NC(=O)[C@H](CCCC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)C(=O)NCC(N)=O		CHEMBL4227953		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18571310	CHEMBL4221075	Agonist activity against EphA2 (unknown origin) expressed in HEK293T/17 cells assessed as increase in phosphorylated EphA2 levels up to 1 uM after 30 mins by immunoprecipitation assay	B	C#CCCCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCCNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCO)NC(=O)[C@H](CCCC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCO)NC(=O)[C@H](CCCC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)C(=O)NCC(N)=O		CHEMBL4227953		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18571311	CHEMBL4221073	Agonist activity against EphA2 (unknown origin) expressed in HEK293T/17 cells assessed as increase in phosphorylated EphA2 levels at 100 uM after 30 mins by immunoprecipitation assay	B	CCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)C(=O)N[C@@H](CCO)C(=O)N[C@@H](CO)C(N)=O		CHEMBL4225642		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	18571312	CHEMBL4221073	Agonist activity against EphA2 (unknown origin) expressed in HEK293T/17 cells assessed as increase in phosphorylated EphA2 levels at 100 uM after 30 mins by immunoprecipitation assay	B	CSCC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](CO)C(=O)O		CHEMBL4227246		Activity			CHEMBL2068	Homo sapiens	Activity		
	18571313	CHEMBL4221070	Displacement of biotin-labeled 123B9 from EphA2-LBD (unknown origin) after 15 mins by DELFIA	B	CCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)C(=O)N[C@@H](CCO)C(=O)N[C@@H](CO)C(N)=O		CHEMBL4225642	=	IC50	nM	4900.0	CHEMBL2068	Homo sapiens	IC50	uM	4.9
	18571314	CHEMBL4221070	Displacement of biotin-labeled 123B9 from EphA2-LBD (unknown origin) after 15 mins by DELFIA	B	C#CCCCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCCNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCO)NC(=O)[C@H](CCCC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCO)NC(=O)[C@H](CCCC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)C(=O)NCC(N)=O		CHEMBL4227953	=	IC50	nM	4100.0	CHEMBL2068	Homo sapiens	IC50	uM	4.1
	18571317	CHEMBL4221071	Binding affinity to EphA2-LBD (unknown origin) by ITC assay	B	CCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)C(=O)N[C@@H](CCO)C(=O)N[C@@H](CO)C(N)=O		CHEMBL4225642	=	Kd	nM	3900.0	CHEMBL2068	Homo sapiens	Kd	uM	3.9
	18571318	CHEMBL4221071	Binding affinity to EphA2-LBD (unknown origin) by ITC assay	B	C#CCCCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCCNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCO)NC(=O)[C@H](CCCC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCO)NC(=O)[C@H](CCCC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)C(=O)NCC(N)=O		CHEMBL4227953	=	Kd	nM	4900.0	CHEMBL2068	Homo sapiens	Kd	uM	4.9
	18577633	CHEMBL4222219	Inhibition of recombinant human GST-tagged EPHA2 expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)n2)c1		CHEMBL4225781	=	Inhibition	%	5.3	CHEMBL2068	Homo sapiens	INH	%	5.3
	18577657	CHEMBL4222219	Inhibition of recombinant human GST-tagged EPHA2 expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	=	Inhibition	%	-7.6	CHEMBL2068	Homo sapiens	INH	%	-7.6
	18577681	CHEMBL4222219	Inhibition of recombinant human GST-tagged EPHA2 expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3699588	=	Inhibition	%	-6.3	CHEMBL2068	Homo sapiens	INH	%	-6.3
	18653665	CHEMBL4230071	Inhibition of EPH-A2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	100.0	CHEMBL2068	Homo sapiens	INH	%	100.0
	18653666	CHEMBL4230071	Inhibition of EPH-A2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	90.0	CHEMBL2068	Homo sapiens	INH	%	90.0
	18655552	CHEMBL4230683	Binding affinity to wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	18663784	CHEMBL4232888	Inhibition of human EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	18664001	CHEMBL4232985	Binding affinity to human EPHA2 (T593 to V891 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL2068	Homo sapiens	Kd	uM	5.0
	18693981	CHEMBL4253434	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	6.0	CHEMBL2068	Homo sapiens	INH	%	6.0
	18694063	CHEMBL4253516	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	4.0	CHEMBL2068	Homo sapiens	INH	%	4.0
	18697631	CHEMBL4254304	Inhibition of wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	95.0	CHEMBL2068	Homo sapiens	Activity	%	95.0
	18702497	CHEMBL4255110	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	Inhibition	%	0.0	CHEMBL2068	Homo sapiens	INH	%	0.0
	18702542	CHEMBL4255110	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	Inhibition	%	-1.0	CHEMBL2068	Homo sapiens	INH	%	-1.0
	18702586	CHEMBL4255110	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	Inhibition	%	0.0	CHEMBL2068	Homo sapiens	INH	%	0.0
	18702638	CHEMBL4255110	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	Inhibition	%	-1.0	CHEMBL2068	Homo sapiens	INH	%	-1.0
	18702682	CHEMBL4255110	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	Inhibition	%	1.0	CHEMBL2068	Homo sapiens	INH	%	1.0
	18702725	CHEMBL4255110	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	Inhibition	%	0.0	CHEMBL2068	Homo sapiens	INH	%	0.0
	18737832	CHEMBL4261407	Inhibition of recombinant human EphA2 (596 to 900 residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	341.0	CHEMBL2068	Homo sapiens	IC50	nM	341.0
	18751125	CHEMBL4263789	Inhibition of EPH-A2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	1.0	CHEMBL2068	Homo sapiens	INH	%	1.0
	18751631	CHEMBL4264272	Binding affinity to wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	84.0	CHEMBL2068	Homo sapiens	Activity	%	84.0
	18764596	CHEMBL4267101	Inhibition of human EPHA2 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	=	Inhibition	%	70.0	CHEMBL2068	Homo sapiens	INH	%	70.0
	18764597	CHEMBL4267101	Inhibition of human EPHA2 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL2068	Homo sapiens	INH	%	70.0
	18764598	CHEMBL4267101	Inhibition of human EPHA2 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL2068	Homo sapiens	INH	%	70.0
	18769916	CHEMBL4268042	Inhibition of recombinant human EPHA2 at 1000 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCOCC4)ncc32)cc1		CHEMBL4282231	=	Inhibition	%	46.3	CHEMBL2068	Homo sapiens	INH	%	46.3
Not Determined	18769917	CHEMBL4268042	Inhibition of recombinant human EPHA2 at 1000 nM after 60 mins by ELISA relative to control	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	18769918	CHEMBL4268042	Inhibition of recombinant human EPHA2 at 1000 nM after 60 mins by ELISA relative to control	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	100.0	CHEMBL2068	Homo sapiens	INH	%	100.0
Not Determined	18769919	CHEMBL4268042	Inhibition of recombinant human EPHA2 at 1000 nM after 60 mins by ELISA relative to control	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	18769920	CHEMBL4268043	Inhibition of recombinant human EPHA2 at 100 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCOCC4)ncc32)cc1		CHEMBL4282231	=	Inhibition	%	3.9	CHEMBL2068	Homo sapiens	INH	%	3.9
	18782837	CHEMBL4270703	Inhibition of EPHA2 (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	>	Activity	%	80.0	CHEMBL2068	Homo sapiens	Activity	%	80.0
	18784709	CHEMBL4271246	Binding affinity to EphA2 (unknown origin)	B	C[C@H](CCC(=O)N[C@H](CC(=O)O)Cc1c[nH]c2ccccc12)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4CCCC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL4059908	>	Ki	nM	15000.0	CHEMBL2068	Homo sapiens	Ki	uM	15.0
	18784715	CHEMBL4271239	Binding affinity to human EphA2 ligand binding domain (27 to 200 residues) expressed in Escherichia coli Rosetta-gami B(DE3) by ITC	B	CCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)C(=O)N[C@@H](CCO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCNC(=O)CCCc1cn(CCCCCOC(=O)COCC(=O)O[C@@H](C(=O)O[C@H]2C[C@@]3(O)[C@@H](OC(=O)c4ccccc4)[C@H]4[C@](C)(C(=O)[C@H](OC(C)=O)C(=C2C)C3(C)C)[C@@H](O)C[C@H]2OC[C@]24OC(C)=O)[C@@H](NC(=O)c2ccccc2)c2ccccc2)nn1)C(=O)O		CHEMBL4283329	=	Kd	nM	4000.0	CHEMBL2068	Homo sapiens	Kd	uM	4.0
	18784716	CHEMBL4271239	Binding affinity to human EphA2 ligand binding domain (27 to 200 residues) expressed in Escherichia coli Rosetta-gami B(DE3) by ITC	B	CCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](CCO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCNC(=O)CCCc1cn(CCCCCCOC(=O)COCC(=O)O[C@@H](C(=O)O[C@H]2C[C@@]3(O)[C@@H](OC(=O)c4ccccc4)[C@H]4[C@](C)(C(=O)[C@H](OC(C)=O)C(=C2C)C3(C)C)[C@@H](O)C[C@H]2OC[C@]24OC(C)=O)[C@@H](NC(=O)c2ccccc2)c2ccccc2)nn1)C(=O)O		CHEMBL4291184	=	Kd	nM	33000.0	CHEMBL2068	Homo sapiens	Kd	uM	33.0
	18784717	CHEMBL4271239	Binding affinity to human EphA2 ligand binding domain (27 to 200 residues) expressed in Escherichia coli Rosetta-gami B(DE3) by ITC	B	CSCC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCNC(=O)CCCc1cn(CCCCCCOC(=O)COCC(=O)O[C@@H](C(=O)O[C@H]2C[C@@]3(O)[C@@H](OC(=O)c4ccccc4)[C@H]4[C@](C)(C(=O)[C@H](OC(C)=O)C(=C2C)C3(C)C)[C@@H](O)C[C@H]2OC[C@]24OC(C)=O)[C@@H](NC(=O)c2ccccc2)c2ccccc2)nn1)C(=O)O		CHEMBL4281226	=	Kd	nM	10000.0	CHEMBL2068	Homo sapiens	Kd	uM	10.0
	18786394	CHEMBL4271725	Inhibition of recombinant EPH-A2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)c3)ccc12		CHEMBL4290371	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	18811977	CHEMBL4276183	Inhibition of human EPHA2 at 100 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	94.8	CHEMBL2068	Homo sapiens	INH	%	94.8
	18811978	CHEMBL4276183	Inhibition of human EPHA2 at 100 uM	B	O=C(NCc1ccccc1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4281295	=	Inhibition	%	17.4	CHEMBL2068	Homo sapiens	INH	%	17.4
	18811979	CHEMBL4276183	Inhibition of human EPHA2 at 100 uM	B	O=C1CC(c2ccc(C(=O)NCc3cccc(Cl)c3)cc2)Sc2ccccc2N1		CHEMBL4277682	=	Inhibition	%	13.8	CHEMBL2068	Homo sapiens	INH	%	13.8
Not Active	18847323	CHEMBL4304897	Inhibition of wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	18857941	CHEMBL4307787	Binding affinity to wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	90.0	CHEMBL2068	Homo sapiens	Activity	%	90.0
	18885112	CHEMBL4313081	Inhibition of human EPHA2 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA relative to control	A	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	18885113	CHEMBL4313081	Inhibition of human EPHA2 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA relative to control	A	C=CC(=O)NCc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4541330	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	18892865	CHEMBL4314831	Inhibition of recombinant human EphA2 (596 to 900 residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	91.0	CHEMBL2068	Homo sapiens	Activity	%	91.0
	18930941	CHEMBL4325599	Inhibition of recombinant human N-terminal His6-tagged EphA2 (596 to 900 residues) expressed in baculovirus infected Sf21 insect cells at 1000 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	92.3	CHEMBL2068	Homo sapiens	INH	%	92.3
	18930965	CHEMBL4325623	Inhibition of recombinant human N-terminal His6-tagged EphA2 (596 to 900 residues) expressed in baculovirus infected Sf21 insect cells at 100 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	31.4	CHEMBL2068	Homo sapiens	INH	%	31.4
	18937885	CHEMBL4327673	Inhibition of human EPHA2 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	101.93	CHEMBL2068	Homo sapiens	Activity	%	101.93
	18937886	CHEMBL4327673	Inhibition of human EPHA2 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	103.66	CHEMBL2068	Homo sapiens	Activity	%	103.66
	18938513	CHEMBL4328033	Inhibition of human EPHA2 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2068	Homo sapiens	Activity	%	65.0
	18938891	CHEMBL4328397	Inhibition of human EPHA2 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	74.5	CHEMBL2068	Homo sapiens	IC50	10'-8M	7.45
	18951024	CHEMBL4331422	Inhibition of human EPHA2 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	Cc1ccc(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)cc1NC(=O)C1(c2ncnc3[nH]cnc23)CC1		CHEMBL4466555	=	IC50	nM	13.5	CHEMBL2068	Homo sapiens	IC50	nM	13.5
	18958858	CHEMBL4333377	Binding affinity to wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	18964259	CHEMBL4335067	Inhibition of recombinant human EphA2 (596 to 900 residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	18964260	CHEMBL4335067	Inhibition of recombinant human EphA2 (596 to 900 residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	92.0	CHEMBL2068	Homo sapiens	Activity	%	92.0
	18971884	CHEMBL4336894	Inhibition of recombinant human EphA2 (596 to 900 residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	68.0	CHEMBL2068	Homo sapiens	Activity	%	68.0
	19009317	CHEMBL4345224	Inhibition of wild type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CCN(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4531680	>	Inhibition	%	80.0	CHEMBL2068	Homo sapiens	INH	%	80.0
	19030019	CHEMBL4349158	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain (560 to 976 residues) expressed in baculovirus expression system assessed as enzyme residual activity at 0.4 uM using tyrosine-01 peptide as substrate incubated for 60 mins by Z'-Lyte assay relative to control	B	C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1		CHEMBL4443805	=	Activity	%	95.0	CHEMBL2068	Homo sapiens	Activity	%	95.0
Not Active	19039797	CHEMBL4351845	Inhibition of recombinant human EphA2 (596 to 900 residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Active	19041091	CHEMBL4352352	Inhibition of human EPHA2 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
	19059560	CHEMBL4357861	Binding affinity to wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	19090131	CHEMBL4365705	Inhibition of wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	19091906	CHEMBL4366380	Inhibition of human EPHA2 at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	19.22	CHEMBL2068	Homo sapiens	INH	%	19.22
	19144783	CHEMBL4377799	Inhibition of recombinant human EphA2 (596 to 900 residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	15.0	CHEMBL2068	Homo sapiens	INH	%	15.0
	19147835	CHEMBL4379309	Inhibition of recombinant human EphA2 (596 to 900 residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2068	Homo sapiens	IC50	uM	10.0
	19159388	CHEMBL4382492	Binding affinity to wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	75.0	CHEMBL2068	Homo sapiens	Activity	%	75.0
	19159846	CHEMBL4382858	Inhibition of recombinant EPHA2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
	19161580	CHEMBL4383426	Inhibition of wild type C-terminal FLAG-tagged human TEL fused EPHA2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay	B	CN1CCN(Cc2ccc(NC(=O)CCSc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)cc2C(F)(F)F)CC1		CHEMBL4439424	=	GI50	nM	120.0	CHEMBL2068	Homo sapiens	GI50	uM	0.12
	19191619	CHEMBL4389211	Inhibition of wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	19191874	CHEMBL4389688	Inhibition of wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	98.0	CHEMBL2068	Homo sapiens	INH	%	98.0
	19199908	CHEMBL4391314	Binding affinity to wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	91.0	CHEMBL2068	Homo sapiens	Activity	%	91.0
	19225459	CHEMBL4395879	Inhibition of human recombinant EPHA2 at 1 uM using Ulight-TK peptide as substrate measured after 30 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	95.53	CHEMBL2068	Homo sapiens	INH	%	95.53
	19236738	CHEMBL4398811	Inhibition of EPHA2 (unknown origin) at 100 nM relative to control	B	COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL4443483	<	Inhibition	%	25.0	CHEMBL2068	Homo sapiens	INH	%	25.0
	19266402	CHEMBL4405352	Inhibition of wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	19275982	CHEMBL4407985	Inhibition of recombinant human EPhA2 (596 to 900 residues) at 1 uM using poly(Glu, Tyr) 4:1as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	61.0	CHEMBL2068	Homo sapiens	INH	%	61.0
	19295868	CHEMBL4412345	Inhibition of EPH-A2 (unknown origin) at 1000 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	100.0	CHEMBL2068	Homo sapiens	INH	%	100.0
	19295898	CHEMBL4412375	Inhibition of EPH-A2 (unknown origin) at 100 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	100.0	CHEMBL2068	Homo sapiens	INH	%	100.0
	19295928	CHEMBL4412405	Inhibition of EPH-A2 (unknown origin) at 10 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	86.6	CHEMBL2068	Homo sapiens	INH	%	86.6
	19312944	CHEMBL4416499	Inhibition of recombinant human N-terminal His6-tagged EphA2 (596 to 900 residues) expressed by baculovirus infected Sf21 insect cells at 10 uM using poly (Glu4-Tyr) (4:1) as substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	<	Inhibition	%	50.0	CHEMBL2068	Homo sapiens	INH	%	50.0
	19432878	CHEMBL4429544	Inhibition of EPHA2 (unknown origin) at 1 uM	B	Cc1nccc(Nc2cc(NC3CCN(c4ccc(C#N)cc4)CC3)c(C(N)=O)cn2)n1		CHEMBL4463436	=	Inhibition	%	11.0	CHEMBL2068	Homo sapiens	INH	%	11.0
	19445429	CHEMBL4432494	Inhibition of recombinant EPHA2 (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	Nc1nccc(Oc2ccc(NC(=O)c3cc4ccccc4n(-c4ccccc4)c3=O)cc2F)c1Cl		CHEMBL4582423	=	Inhibition	%	95.5	CHEMBL2068	Homo sapiens	INH	%	95.5
	19445479	CHEMBL4432494	Inhibition of recombinant EPHA2 (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Inhibition	%	97.3	CHEMBL2068	Homo sapiens	INH	%	97.3
	19475361	CHEMBL4479456	Inhibition of human EPHA2	B	C[C@@H](c1cc2cccnc2cc1F)n1cnc2ncc(-c3cnn(C)c3)nc21		CHEMBL4068255	>	IC50	nM	30000.0	CHEMBL2068	Homo sapiens	IC50	nM	30000.0
	20600516	CHEMBL4603468	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system using tyrosine-01 peptide as substrate incubated for 60 mins in presence of ATP by Z'-Lyte assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2068	Homo sapiens	IC50	uM	100.0
	20601676	CHEMBL4603808	Inhibition of recombinant human GST-tagged EPHA2 (560 to 976 residues) expressed in baculovirus expression system using Tyr01 peptide as substrate at 0.6 uM incubated for 1 hr by Z'lyte assay relative to control	B	C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12		CHEMBL4646281	=	Inhibition	%	1.0	CHEMBL2068	Homo sapiens	INH	%	1.0
	20607384	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)[C@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N(C)C(=O)CCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CSCc2cc3cc(c2)CSC[C@H](NC(=O)[C@H](Cc2cccc4ccccc24)NC(=O)[C@H](Cc2ccccc2)NC(=O)C(C)(C)NC(=O)CNC(=O)[C@H](Cc2cccc4ccccc24)NC(=O)C(C)(C)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(=O)O)C(=O)N[C@@H](C(N)=O)CSC3		CHEMBL4642849	=	Ki	nM	2.83	CHEMBL2068	Homo sapiens	Ki	nM	2.83
	20607385	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CSCCC3=O)NC1=O		CHEMBL4640044	=	Ki	nM	5.78	CHEMBL2068	Homo sapiens	Ki	nM	5.78
	20607386	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@H](NC1=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)CSCCC3=O		CHEMBL4641388	=	Ki	nM	115.0	CHEMBL2068	Homo sapiens	Ki	nM	115.0
	20607387	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CSCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC1=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)CSCCC3=O		CHEMBL4639187	=	Ki	nM	81.7	CHEMBL2068	Homo sapiens	Ki	nM	81.7
	20607388	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CSCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC1=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)CSCCC3=O		CHEMBL4634115	=	Ki	nM	3102.0	CHEMBL2068	Homo sapiens	Ki	nM	3102.0
	20607389	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	C[C@H](N)C(=O)N[C@H]1CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)CSCCC3=O		CHEMBL4637447	=	Ki	nM	2618.0	CHEMBL2068	Homo sapiens	Ki	nM	2618.0
	20607390	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC[C@H](C)[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CSCCC(=O)N3CN(CN(C3)C(=O)CCSC[C@H](NC(=O)[C@H](C)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC1=O		CHEMBL4638181	=	Ki	nM	160.0	CHEMBL2068	Homo sapiens	Ki	nM	160.0
	20607391	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC[C@H](C)[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CSCCC(=O)N3CN(CN(C3)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC1=O)C(=O)CCSC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N2		CHEMBL4649266	=	Ki	nM	815.0	CHEMBL2068	Homo sapiens	Ki	nM	815.0
	20607392	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]2CSCCC(=O)N3CN(CN(C3)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC1=O)C(=O)CCSC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N2		CHEMBL4645245	=	Ki	nM	223.0	CHEMBL2068	Homo sapiens	Ki	nM	223.0
	20607393	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CSCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CSCCC(=O)N3CN(CN(C3)C(=O)CCSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)CCSC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2		CHEMBL4642437	=	Ki	nM	39.1	CHEMBL2068	Homo sapiens	Ki	nM	39.1
	20607394	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CSCC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)[C@@H]2CSCCC(=O)N3CN(CN(C3)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)CCSC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N2		CHEMBL4635141	=	Ki	nM	210.0	CHEMBL2068	Homo sapiens	Ki	nM	210.0
	20607395	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CSCc3cc(cc(c3)CSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc3ccc(O)cc3)NC1=O)CSC[C@H](NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N2		CHEMBL4648501	=	Ki	nM	268.0	CHEMBL2068	Homo sapiens	Ki	nM	268.0
	20607396	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CSCC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CSCc3cc(cc(c3)CSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC1=O)CSC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N2		CHEMBL4639176	=	Ki	nM	931.0	CHEMBL2068	Homo sapiens	Ki	nM	931.0
	20607397	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC[C@H](C)[C@@H]1NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)N)CSCc2cc3cc(c2)CSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)N[C@@H](CCC(=O)O)C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CSC3)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O		CHEMBL4645672	=	Ki	nM	82.5	CHEMBL2068	Homo sapiens	Ki	nM	82.5
	20607398	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSCc3cc(cc(c3)CSC[C@H](NC(=O)C3CCCN3C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](C)N)C(C)C)C(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N2)CSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC1=O		CHEMBL4642167	=	Ki	nM	0.54	CHEMBL2068	Homo sapiens	Ki	nM	0.54
	20607399	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSCc3cc(cc(c3)CSC[C@H](NC(=O)[C@H](C)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N2)CSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc2cnc[nH]2)NC1=O		CHEMBL4638393	=	Ki	nM	263.0	CHEMBL2068	Homo sapiens	Ki	nM	263.0
	20607400	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)N)CSCc2cc3cc(c2)CSC[C@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)CSC3		CHEMBL4638336	=	Ki	nM	26.5	CHEMBL2068	Homo sapiens	Ki	nM	26.5
	20607401	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)N)CSCc2cc3cc(c2)CSC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)CSC3		CHEMBL4637860	=	Ki	nM	83.4	CHEMBL2068	Homo sapiens	Ki	nM	83.4
	20607402	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CSCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](C)N)CSCc2cc3cc(c2)CSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CSC3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O		CHEMBL4644287	=	Ki	nM	56.1	CHEMBL2068	Homo sapiens	Ki	nM	56.1
	20607403	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CSCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](C)N)CSCc2cc3cc(c2)CSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CSC3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O		CHEMBL4647046	=	Ki	nM	101.0	CHEMBL2068	Homo sapiens	Ki	nM	101.0
	20607404	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCNC(=N)N)NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@H](NC1=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)CSCCC3=O		CHEMBL4641389	=	Ki	nM	2.0	CHEMBL2068	Homo sapiens	Ki	nM	2.0
	20607405	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCNC(=N)N)NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CSCCC3=O)NC1=O		CHEMBL4637500	=	Ki	nM	9.0	CHEMBL2068	Homo sapiens	Ki	nM	9.0
	20607406	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@H](NC1=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)CSCCC3=O		CHEMBL4643355	=	Ki	nM	5.2	CHEMBL2068	Homo sapiens	Ki	nM	5.2
	20607407	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccc4ccccc4c2)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CSCCC3=O)NC1=O		CHEMBL4632996	=	Ki	nM	539.0	CHEMBL2068	Homo sapiens	Ki	nM	539.0
	20607408	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2cccc4ccccc24)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CSCCC3=O)NC1=O		CHEMBL4633239	=	Ki	nM	2439.0	CHEMBL2068	Homo sapiens	Ki	nM	2439.0
	20607409	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CSCCC3=O)NC1=O		CHEMBL4643893	=	Ki	nM	6.8	CHEMBL2068	Homo sapiens	Ki	nM	6.8
	20607410	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CSCCC3=O)NC1=O		CHEMBL4636597	=	Ki	nM	4.8	CHEMBL2068	Homo sapiens	Ki	nM	4.8
	20607411	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CSCCC3=O)NC1=O		CHEMBL4643498	=	Ki	nM	12.9	CHEMBL2068	Homo sapiens	Ki	nM	12.9
	20607412	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CSCCC3=O)NC1=O		CHEMBL4649686	=	Ki	nM	1.5	CHEMBL2068	Homo sapiens	Ki	nM	1.5
	20607413	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC2CCC2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CSCCC3=O)NC1=O		CHEMBL4634880	=	Ki	nM	5.5	CHEMBL2068	Homo sapiens	Ki	nM	5.5
	20607414	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C2CCCC2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CSCCC3=O)NC1=O		CHEMBL4642586	=	Ki	nM	34.5	CHEMBL2068	Homo sapiens	Ki	nM	34.5
	20607415	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CSCCC3=O)NC1=O		CHEMBL4635897	=	Ki	nM	14.5	CHEMBL2068	Homo sapiens	Ki	nM	14.5
	20607416	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CSCCC3=O)NC1=O		CHEMBL4634220	=	Ki	nM	2.8	CHEMBL2068	Homo sapiens	Ki	nM	2.8
	20607417	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CSCCC3=O)NC1=O		CHEMBL4648601	=	Ki	nM	5.8	CHEMBL2068	Homo sapiens	Ki	nM	5.8
	20607418	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N(C)C(=O)CCN)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@H](NC1=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(=O)O)C(=O)N[C@@H](CC1CCc2ccccc21)C(=O)NC(CCCCNC(=N)N)C(=O)N[C@H](C(N)=O)CSCCC3=O		CHEMBL4636032	=	Ki	nM	5.74	CHEMBL2068	Homo sapiens	Ki	nM	5.74
	20607419	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	COc1cc2cc(c1Cl)N(C)C(=O)C[C@@H](OC(=O)[C@@H](C)N(C)C(=O)CCSSCCCC(=O)NCCC(=O)N(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H]1CSCCC(=O)N3CN4CN(C3)C(=O)CCSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]3CCCN3C1=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(=O)O)C(=O)N[C@@H](CC1CCc3ccccc31)C(=O)NC(CCCCNC(=N)N)C(=O)N[C@H](C(N)=O)CSCCC4=O)[C@@]1(C)O[C@@H]1[C@@H](C)[C@H]1C[C@](O)(NC(=O)O1)[C@@H](OC)/C=C/C=C(\C)C2		CHEMBL4634551	=	Ki	nM	3.1	CHEMBL2068	Homo sapiens	Ki	nM	3.1
	20607420	CHEMBL4605307	Binding affinity to 6x-His-tagged human EphA2 ecto-domain residues (Lys27 to Asn529 residues) expressed in HEK293 cells incubated for 60 mins by fluorescence polarization assay	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N(C)CC(=O)N(C)C(=O)CCOC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)CSCCC(=O)N2CN3CN(C2)C(=O)CCSC[C@H](NC1=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(=O)O)C(=O)N[C@@H](CC1CCc2ccccc21)C(=O)NC(CCCCNC(=N)N)C(=O)N[C@H](C(N)=O)CSCCC3=O		CHEMBL4637644	=	Ki	nM	5.07	CHEMBL2068	Homo sapiens	Ki	nM	5.07
	22423111	CHEMBL4674126	Inhibition of human EPHA2 using poly[Glu:Tyr] (4:1) as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL2068	Homo sapiens	INH	%	80.0
	22423659	CHEMBL4674405	Inhibition of human EPHA2 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	60.16	CHEMBL2068	Homo sapiens	Activity	%	60.16
	22423660	CHEMBL4674405	Inhibition of human EPHA2 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	93.54	CHEMBL2068	Homo sapiens	Activity	%	93.54
Dose-dependent effect	22469691	CHEMBL4684874	Antagonist activity at EphA2-Fc in human PC3 cells assessed as reduction in ephrin-A1-Fc stimulated EphA2 phosphorylation preincubated for 20 mins followed by ephrin-A1 stimulation and measured after 20 mins by ELISA	B	C[C@H](CCC(=O)N[C@H](CC(=O)O)Cc1c[nH]c2ccccc12)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OC(N)=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL4078429		Activity			CHEMBL2068	Homo sapiens	Activity		
	22469692	CHEMBL4684874	Antagonist activity at EphA2-Fc in human PC3 cells assessed as reduction in ephrin-A1-Fc stimulated EphA2 phosphorylation preincubated for 20 mins followed by ephrin-A1 stimulation and measured after 20 mins by ELISA	B	C[C@H](CCC(=O)N[C@H](CC(=O)O)Cc1c[nH]c2ccccc12)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OC(N)=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL4078429	=	IC50	nM	6400.0	CHEMBL2068	Homo sapiens	IC50	uM	6.4
Dose-dependent effect	22469693	CHEMBL4684874	Antagonist activity at EphA2-Fc in human PC3 cells assessed as reduction in ephrin-A1-Fc stimulated EphA2 phosphorylation preincubated for 20 mins followed by ephrin-A1 stimulation and measured after 20 mins by ELISA	B	CCNC(=O)O[C@@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@H]4[C@H](C)CCC(=O)N[C@H](CC(=O)O)Cc4c[nH]c5ccccc45)[C@@H]3CC[C@@H]2C1		CHEMBL4761556		Activity			CHEMBL2068	Homo sapiens	Activity		
	22469694	CHEMBL4684874	Antagonist activity at EphA2-Fc in human PC3 cells assessed as reduction in ephrin-A1-Fc stimulated EphA2 phosphorylation preincubated for 20 mins followed by ephrin-A1 stimulation and measured after 20 mins by ELISA	B	CCNC(=O)O[C@@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@H]4[C@H](C)CCC(=O)N[C@H](CC(=O)O)Cc4c[nH]c5ccccc45)[C@@H]3CC[C@@H]2C1		CHEMBL4761556	=	IC50	nM	1500.0	CHEMBL2068	Homo sapiens	IC50	uM	1.5
Dose-dependent effect	22469695	CHEMBL4684874	Antagonist activity at EphA2-Fc in human PC3 cells assessed as reduction in ephrin-A1-Fc stimulated EphA2 phosphorylation preincubated for 20 mins followed by ephrin-A1 stimulation and measured after 20 mins by ELISA	B	CCCCNC(=O)O[C@@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@H]4[C@H](C)CCC(=O)N[C@H](CC(=O)O)Cc4c[nH]c5ccccc45)[C@@H]3CC[C@@H]2C1		CHEMBL4780052		Activity			CHEMBL2068	Homo sapiens	Activity		
	22469696	CHEMBL4684874	Antagonist activity at EphA2-Fc in human PC3 cells assessed as reduction in ephrin-A1-Fc stimulated EphA2 phosphorylation preincubated for 20 mins followed by ephrin-A1 stimulation and measured after 20 mins by ELISA	B	CCCCNC(=O)O[C@@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@H]4[C@H](C)CCC(=O)N[C@H](CC(=O)O)Cc4c[nH]c5ccccc45)[C@@H]3CC[C@@H]2C1		CHEMBL4780052	=	IC50	nM	3500.0	CHEMBL2068	Homo sapiens	IC50	uM	3.5
Dose-dependent effect	22469697	CHEMBL4684874	Antagonist activity at EphA2-Fc in human PC3 cells assessed as reduction in ephrin-A1-Fc stimulated EphA2 phosphorylation preincubated for 20 mins followed by ephrin-A1 stimulation and measured after 20 mins by ELISA	B	CCCCCCNC(=O)O[C@@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@H]4[C@H](C)CCC(=O)N[C@H](CC(=O)O)Cc4c[nH]c5ccccc45)[C@@H]3CC[C@@H]2C1		CHEMBL4756215		Activity			CHEMBL2068	Homo sapiens	Activity		
	22469698	CHEMBL4684874	Antagonist activity at EphA2-Fc in human PC3 cells assessed as reduction in ephrin-A1-Fc stimulated EphA2 phosphorylation preincubated for 20 mins followed by ephrin-A1 stimulation and measured after 20 mins by ELISA	B	CCCCCCNC(=O)O[C@@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@H]4[C@H](C)CCC(=O)N[C@H](CC(=O)O)Cc4c[nH]c5ccccc45)[C@@H]3CC[C@@H]2C1		CHEMBL4756215	=	IC50	nM	4100.0	CHEMBL2068	Homo sapiens	IC50	uM	4.1
Dose-dependent effect	22469699	CHEMBL4684874	Antagonist activity at EphA2-Fc in human PC3 cells assessed as reduction in ephrin-A1-Fc stimulated EphA2 phosphorylation preincubated for 20 mins followed by ephrin-A1 stimulation and measured after 20 mins by ELISA	B	C[C@H](CCC(=O)N[C@H](CC(=O)O)Cc1c[nH]c2ccccc12)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OC(=O)NC5CCCCC5)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL4761852		Activity			CHEMBL2068	Homo sapiens	Activity		
	22469700	CHEMBL4684874	Antagonist activity at EphA2-Fc in human PC3 cells assessed as reduction in ephrin-A1-Fc stimulated EphA2 phosphorylation preincubated for 20 mins followed by ephrin-A1 stimulation and measured after 20 mins by ELISA	B	C[C@H](CCC(=O)N[C@H](CC(=O)O)Cc1c[nH]c2ccccc12)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OC(=O)NC5CCCCC5)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL4761852	=	IC50	nM	12000.0	CHEMBL2068	Homo sapiens	IC50	uM	12.0
	22469706	CHEMBL4684876	Competitive inhibition of biotinylated ephrin-A1-Fc binding to EphA2 (unknown origin)	B	C[C@H](CCC(=O)N[C@H](CC(=O)O)Cc1c[nH]c2ccccc12)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3735125	=	Ki	nM	400.0	CHEMBL2068	Homo sapiens	Ki	uM	0.4
	22469707	CHEMBL4684876	Competitive inhibition of biotinylated ephrin-A1-Fc binding to EphA2 (unknown origin)	B	C[C@H](CCC(=O)N[C@H](CC(=O)O)Cc1c[nH]c2ccccc12)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OC(N)=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL4078429	=	Ki	nM	800.0	CHEMBL2068	Homo sapiens	Ki	uM	0.8
	22469708	CHEMBL4684876	Competitive inhibition of biotinylated ephrin-A1-Fc binding to EphA2 (unknown origin)	B	CCNC(=O)O[C@@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@H]4[C@H](C)CCC(=O)N[C@H](CC(=O)O)Cc4c[nH]c5ccccc45)[C@@H]3CC[C@@H]2C1		CHEMBL4761556	=	Ki	nM	300.0	CHEMBL2068	Homo sapiens	Ki	uM	0.3
	22802044	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Delta Tm	degrees C	8.0	CHEMBL2068	Homo sapiens	deltaTm	degrees C	8.0
	22802045	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2ccccc2)n1		CHEMBL312873	=	Delta Tm	degrees C	2.9	CHEMBL2068	Homo sapiens	deltaTm	degrees C	2.9
	22802046	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccccc1NC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1		CHEMBL4790278	=	Delta Tm	degrees C	1.2	CHEMBL2068	Homo sapiens	deltaTm	degrees C	1.2
	22802047	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc3ccccc3c2)n(-c2ccccc2)n1		CHEMBL102547	=	Delta Tm	degrees C	1.6	CHEMBL2068	Homo sapiens	deltaTm	degrees C	1.6
	22802048	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CCOc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL4751695	=	Delta Tm	degrees C	1.0	CHEMBL2068	Homo sapiens	deltaTm	degrees C	1.0
	22802049	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(F)cc2)n(-c2ccccc2)n1		CHEMBL4741055	=	Delta Tm	degrees C	-2.2	CHEMBL2068	Homo sapiens	deltaTm	degrees C	-2.2
	22802050	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccccc2)n1		CHEMBL4762688	=	Delta Tm	degrees C	0.8	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.8
	22802051	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCc3ccccc3)cc2)n(-c2ccccc2)n1		CHEMBL4785824	=	Delta Tm	degrees C	1.5	CHEMBL2068	Homo sapiens	deltaTm	degrees C	1.5
	22802052	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1cc(C)cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)c1		CHEMBL4783603	=	Delta Tm	degrees C	0.7	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.7
	22802053	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(F)cc1NC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1		CHEMBL4759399	=	Delta Tm	degrees C	1.6	CHEMBL2068	Homo sapiens	deltaTm	degrees C	1.6
	22802054	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(F)c(F)c2)n(-c2ccccc2)n1		CHEMBL4765042	=	Delta Tm	degrees C	2.2	CHEMBL2068	Homo sapiens	deltaTm	degrees C	2.2
	22802055	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2ccccc2)n1		CHEMBL314023	=	Delta Tm	degrees C	1.6	CHEMBL2068	Homo sapiens	deltaTm	degrees C	1.6
	22802056	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(S(=O)(=O)NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL4750748	=	Delta Tm	degrees C	0.2	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.2
	22802057	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	COc1cccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)c1		CHEMBL4746299	=	Delta Tm	degrees C	1.8	CHEMBL2068	Homo sapiens	deltaTm	degrees C	1.8
	22802058	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Delta Tm	degrees C	1.7	CHEMBL2068	Homo sapiens	deltaTm	degrees C	1.7
	22802059	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1		CHEMBL4759890	=	Delta Tm	degrees C	0.8	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.8
	22802060	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4784705	=	Delta Tm	degrees C	0.4	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.4
	22802061	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc(F)cc2)n1		CHEMBL4784725	=	Delta Tm	degrees C	0.4	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.4
	22802062	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4744374	=	Delta Tm	degrees C	0.7	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.7
	22802063	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(C(C)(C)C)n1		CHEMBL4742158	=	Delta Tm	degrees C	0.5	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.5
	22802064	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc(Br)cc2)n1		CHEMBL4797231	=	Delta Tm	degrees C	0.3	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.3
	22802065	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(-c2ccccc2)cc1NC(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4787226	=	Delta Tm	degrees C	0.9	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.9
	22802066	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1cc(-c2ccccc2)nn1-c1ccccc1		CHEMBL4777689	=	Delta Tm	degrees C	0.5	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.5
	22802067	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccccc2)n1		CHEMBL4764223	=	Delta Tm	degrees C	2.7	CHEMBL2068	Homo sapiens	deltaTm	degrees C	2.7
	22802068	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(F)cc(F)c2)cc1		CHEMBL4741029	=	Delta Tm	degrees C	1.9	CHEMBL2068	Homo sapiens	deltaTm	degrees C	1.9
	22802069	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cc(F)cc(F)c1		CHEMBL4754583	=	Delta Tm	degrees C	0.4	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.4
	22802070	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc(F)cc2)n1		CHEMBL4780554	=	Delta Tm	degrees C	1.9	CHEMBL2068	Homo sapiens	deltaTm	degrees C	1.9
	22802071	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4798321	=	Delta Tm	degrees C	0.9	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.9
	22802072	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(C(C)(C)C)n1		CHEMBL4791471	=	Delta Tm	degrees C	0.0	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.0
	22802073	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc(Br)cc2)n1		CHEMBL4757882	=	Delta Tm	degrees C	1.3	CHEMBL2068	Homo sapiens	deltaTm	degrees C	1.3
	22802074	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(-c2ccccc2)cc1NC(=O)Nc1cc(F)cc(F)c1		CHEMBL4740104	=	Delta Tm	degrees C	0.3	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.3
	22802075	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1cc(F)cc(F)c1)Nc1cc(-c2ccccc2)nn1-c1ccccc1		CHEMBL4789547	=	Delta Tm	degrees C	1.1	CHEMBL2068	Homo sapiens	deltaTm	degrees C	1.1
	22802076	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Delta Tm	degrees C	7.0	CHEMBL2068	Homo sapiens	deltaTm	degrees C	7.0
	22802077	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4787113	=	Delta Tm	degrees C	0.4	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.4
	22802078	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(N)cc2)n1		CHEMBL4756419	=	Delta Tm	degrees C	2.0	CHEMBL2068	Homo sapiens	deltaTm	degrees C	2.0
	22802079	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(C(F)(F)F)cc2)n1		CHEMBL4740208	=	Delta Tm	degrees C	0.6	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.6
	22802080	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(OC(F)(F)F)cc2)n1		CHEMBL4756465	=	Delta Tm	degrees C	0.9	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.9
	22802081	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(C#N)cc2)n1		CHEMBL4786417	=	Delta Tm	degrees C	0.8	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.8
	22802082	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(S(C)(=O)=O)cc2)n1		CHEMBL4757100	=	Delta Tm	degrees C	1.2	CHEMBL2068	Homo sapiens	deltaTm	degrees C	1.2
	22802083	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(NC(=O)C3CC3)cc2)n1		CHEMBL4788823	=	Delta Tm	degrees C	3.0	CHEMBL2068	Homo sapiens	deltaTm	degrees C	3.0
	22802084	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(NS(C)(=O)=O)cc2)n1		CHEMBL4754044	=	Delta Tm	degrees C	2.8	CHEMBL2068	Homo sapiens	deltaTm	degrees C	2.8
	22802085	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)C(=O)Nc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL4782612	=	Delta Tm	degrees C	2.8	CHEMBL2068	Homo sapiens	deltaTm	degrees C	2.8
	22802086	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C2CC2)nn1-c1ccc(OC(F)(F)F)cc1		CHEMBL4790434	=	Delta Tm	degrees C	0.2	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.2
	22802087	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	N#Cc1ccc(-n2nc(C3CC3)cc2NC(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL4742987	=	Delta Tm	degrees C	0.5	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.5
	22802088	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C2CC2)nn1-c1ccc([N+](=O)[O-])cc1		CHEMBL4755558	=	Delta Tm	degrees C	0.2	CHEMBL2068	Homo sapiens	deltaTm	degrees C	0.2
	22802089	CHEMBL4711698	Inhibition of EPHA2 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C(F)(F)F)nn1-c1ccc([N+](=O)[O-])cc1		CHEMBL4794564	=	Delta Tm	degrees C	1.0	CHEMBL2068	Homo sapiens	deltaTm	degrees C	1.0
	22820470	CHEMBL4716237	Inhibition of recombinant N-terminal His6-tagged human EphA2 (596 to 900 residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	97.0	CHEMBL2068	Homo sapiens	Activity	%	97.0
	22820471	CHEMBL4716237	Inhibition of recombinant N-terminal His6-tagged human EphA2 (596 to 900 residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	18.0	CHEMBL2068	Homo sapiens	Activity	%	18.0
	22836186	CHEMBL4718853	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system at 500 nM using Tyr 01 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	11.0	CHEMBL2068	Homo sapiens	INH	%	11.0
	22836187	CHEMBL4718853	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system at 500 nM using Tyr 01 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	23.0	CHEMBL2068	Homo sapiens	INH	%	23.0
	22836188	CHEMBL4718853	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system at 500 nM using Tyr 01 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	54.0	CHEMBL2068	Homo sapiens	INH	%	54.0
	22836189	CHEMBL4718853	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system at 500 nM using Tyr 01 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	21.0	CHEMBL2068	Homo sapiens	INH	%	21.0
	22836190	CHEMBL4718853	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system at 500 nM using Tyr 01 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	7.0	CHEMBL2068	Homo sapiens	INH	%	7.0
	22836191	CHEMBL4718853	Inhibition of recombinant human GST-tagged EPHA2 cytoplasmic domain expressed in baculovirus expression system at 500 nM using Tyr 01 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	16.0	CHEMBL2068	Homo sapiens	INH	%	16.0
	22843768	CHEMBL4720754	Inhibition of human EPHA2 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	39.9	CHEMBL2068	Homo sapiens	IC50	10^-8M	3.99
	22844119	CHEMBL4721105	Inhibition of human EPHA2 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	81.42	CHEMBL2068	Homo sapiens	Activity	%	81.42
	22844690	CHEMBL4721365	Inhibition of wild type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	105.91	CHEMBL2068	Homo sapiens	Activity	%	105.91
	22874826	CHEMBL4725517	Inhibition of human EphA2 assessed as remaining enzyme activity at 1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	5.0	CHEMBL2068	Homo sapiens	Activity	%	5.0
	22874860	CHEMBL4725551	Inhibition of human EphA2 assessed as remaining enzyme activity at 0.1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	58.0	CHEMBL2068	Homo sapiens	Activity	%	58.0
	22874886	CHEMBL4725577	Inhibition of human EphA2 assessed as remaining enzyme activity at 0.01 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	90.0	CHEMBL2068	Homo sapiens	Activity	%	90.0
Not Active	22889505	CHEMBL4729024	Inhibition of wild-type human partial length EPHA2 (T593 to V891 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL2068	Homo sapiens	INH		
Active	22892112	CHEMBL4729694	Agonist activity at EPHA2 receptor (unknown origin) transfected in human U251 cells assessed as induction of EPHA2 phosphorylation at 2 uM incubated for 1 hr by immunoprecipitation/immunoblot analysis	B	COc1cc2nc(N3CCN(C(=O)CCCCCCCCCCC(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC		CHEMBL4170029		Activity			CHEMBL2068	Homo sapiens	Activity		
Not Active	22892113	CHEMBL4729694	Agonist activity at EPHA2 receptor (unknown origin) transfected in human U251 cells assessed as induction of EPHA2 phosphorylation at 2 uM incubated for 1 hr by immunoprecipitation/immunoblot analysis	B	COc1cc2nc(N3CCN(C(=O)OCCOC(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC		CHEMBL4800258		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	22892114	CHEMBL4729694	Agonist activity at EPHA2 receptor (unknown origin) transfected in human U251 cells assessed as induction of EPHA2 phosphorylation at 2 uM incubated for 1 hr by immunoprecipitation/immunoblot analysis	B	COc1cc2nc(N3CCN(C(=O)Oc4ccc(C(C)(C)c5ccc(OC(=O)N6CCN(c7nc(N)c8cc(OC)c(OC)cc8n7)CC6)cc5)cc4)CC3)nc(N)c2cc1OC		CHEMBL4760980		Activity			CHEMBL2068	Homo sapiens	Activity		
Active	22892115	CHEMBL4729694	Agonist activity at EPHA2 receptor (unknown origin) transfected in human U251 cells assessed as induction of EPHA2 phosphorylation at 2 uM incubated for 1 hr by immunoprecipitation/immunoblot analysis	B	COc1cc2nc(N3CCN(C(=O)c4cccc(NC(=O)OCCOCCOCCOC(=O)Nc5cccc(C(=O)N6CCN(c7nc(N)c8cc(OC)c(OC)cc8n7)CC6)c5)c4)CC3)nc(N)c2cc1OC		CHEMBL4743476		Activity			CHEMBL2068	Homo sapiens	Activity		
	22949120	CHEMBL4765747	Inhibition of human EPHA2 assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	22949121	CHEMBL4765747	Inhibition of human EPHA2 assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	111.0	CHEMBL2068	Homo sapiens	Activity	%	111.0
	22949122	CHEMBL4765747	Inhibition of human EPHA2 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	106.0	CHEMBL2068	Homo sapiens	Activity	%	106.0
	22949123	CHEMBL4765747	Inhibition of human EPHA2 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	110.0	CHEMBL2068	Homo sapiens	Activity	%	110.0
	22949124	CHEMBL4765747	Inhibition of human EPHA2 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	98.0	CHEMBL2068	Homo sapiens	Activity	%	98.0
	22949125	CHEMBL4765747	Inhibition of human EPHA2 assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	99.0	CHEMBL2068	Homo sapiens	Activity	%	99.0
	22949126	CHEMBL4765748	Inhibition of human EPHA2 assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	84.0	CHEMBL2068	Homo sapiens	Activity	%	84.0
	22949127	CHEMBL4765748	Inhibition of human EPHA2 assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	98.0	CHEMBL2068	Homo sapiens	Activity	%	98.0
	22949128	CHEMBL4765748	Inhibition of human EPHA2 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	89.0	CHEMBL2068	Homo sapiens	Activity	%	89.0
	22949129	CHEMBL4765748	Inhibition of human EPHA2 assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	98.0	CHEMBL2068	Homo sapiens	Activity	%	98.0
	22949130	CHEMBL4765748	Inhibition of human EPHA2 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	89.0	CHEMBL2068	Homo sapiens	Activity	%	89.0
	22949131	CHEMBL4765748	Inhibition of human EPHA2 assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	90.0	CHEMBL2068	Homo sapiens	Activity	%	90.0
	22952823	CHEMBL4766760	Inhibition of recombinant human EphA2 (596 to 900 residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	-1.0	CHEMBL2068	Homo sapiens	Activity	%	-1.0
	22953065	CHEMBL4767002	Inhibition of recombinant human EphA2 (596 to 900 residues) using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	104.0	CHEMBL2068	Homo sapiens	IC50	uM	0.10400000000000001
	23122546	CHEMBL4804897	Inhibition of human EPHA2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	23123241	CHEMBL4805485	Inhibition of human EPHA2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	23123650	CHEMBL4805894	Inhibition of DNA-tagged human EPHA2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	97.0	CHEMBL2068	Homo sapiens	Activity	%	97.0
	23124572	CHEMBL4806502	Inhibition of human EPHA2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	95.0	CHEMBL2068	Homo sapiens	Activity	%	95.0
	23124573	CHEMBL4806502	Inhibition of human EPHA2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL2068	Homo sapiens	Activity	%	100.0
	23127403	CHEMBL4807592	Inhibition of EPHA2 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	0.0	CHEMBL2068	Homo sapiens	Activity	%	0.0
	23127404	CHEMBL4807592	Inhibition of EPHA2 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	0.0	CHEMBL2068	Homo sapiens	Activity	%	0.0
	23128047	CHEMBL4807824	Inhibition of EPHA2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL2068	Homo sapiens	Activity	%	25.0
	23128048	CHEMBL4807824	Inhibition of EPHA2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL2068	Homo sapiens	Activity	%	25.0
	23128049	CHEMBL4807824	Inhibition of EPHA2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL2068	Homo sapiens	Activity	%	25.0
	23128926	CHEMBL4808102	Inhibition of EPHA2 (unknown origin) at 0.5 uM relative to control	B	CSc1nc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3Br)cc2)c(-c2ccc(F)cc2)o1		CHEMBL4875968	=	Inhibition	%	25.0	CHEMBL2068	Homo sapiens	INH	%	25.0
	23180033	CHEMBL4816236	Inhibition of EphA2 (unknown origin) at 1 uM by ELISA	B	CCCC(C)Oc1ccc(C(=O)Nc2ccc3nc(SCC(=O)N[C@@H](C)c4ccccc4)sc3c2)c(OC)c1C		CHEMBL4864495	=	Inhibition	%	1.1	CHEMBL2068	Homo sapiens	INH	%	1.1
	23180034	CHEMBL4816236	Inhibition of EphA2 (unknown origin) at 1 uM by ELISA	B	CCCC(C)Oc1ccc(C(=O)Nc2ccc3nc(SCC(=O)N[C@@H](C)c4ccc(OC)cc4)sc3c2)c(OC)c1C		CHEMBL4846365	=	Inhibition	%	0.0	CHEMBL2068	Homo sapiens	INH	%	0.0
	23180035	CHEMBL4816236	Inhibition of EphA2 (unknown origin) at 1 uM by ELISA	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	100.0	CHEMBL2068	Homo sapiens	INH	%	100.0
	23216095	CHEMBL4823610	Inhibition of recombinant human EphA2 (596 to 900 residues) using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873571	>	IC50	nM	100.0	CHEMBL2068	Homo sapiens	IC50	nM	100.0
Not Active	23223185	CHEMBL4825028	Binding affinity to N-terminal His tagged EphA2 LBD (27 to 200 residues) (unknown origin) expressed in Origami (DE3) cells by isothermal titration calorimetry	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)[C@H]2CCC[C@H](N)C2)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)NCC(=O)Nc2ccc(CN3CCOCC3)cc2)cc1		CHEMBL4853905		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	23223186	CHEMBL4825028	Binding affinity to N-terminal His tagged EphA2 LBD (27 to 200 residues) (unknown origin) expressed in Origami (DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(CN2CCOCC2)cc1		CHEMBL4853333		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	23223187	CHEMBL4825028	Binding affinity to N-terminal His tagged EphA2 LBD (27 to 200 residues) (unknown origin) expressed in Origami (DE3) cells by isothermal titration calorimetry	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)[C@H]2CCC[C@H](N)C2)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)NCC(=O)Nc2ccc(N3CCOCC3)cc2)cc1		CHEMBL4879331		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Determined	23223188	CHEMBL4825028	Binding affinity to N-terminal His tagged EphA2 LBD (27 to 200 residues) (unknown origin) expressed in Origami (DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(N2CCOCC2)cc1		CHEMBL4865183		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	23223189	CHEMBL4825028	Binding affinity to N-terminal His tagged EphA2 LBD (27 to 200 residues) (unknown origin) expressed in Origami (DE3) cells by isothermal titration calorimetry	B	COc1ccc2[nH]cc(CCNC(=O)[C@H](Cc3ccncc3)NC(=O)[C@H](Cc3ccc(Cl)cc3)NC(=O)[C@H](Cc3c[nH]c4ccc(O)cc34)NC(=O)CCCN)c2c1		CHEMBL4293477		Kd			CHEMBL2068	Homo sapiens	Kd		
Not Active	23223190	CHEMBL4825028	Binding affinity to N-terminal His tagged EphA2 LBD (27 to 200 residues) (unknown origin) expressed in Origami (DE3) cells by isothermal titration calorimetry	B	CC(C)[C@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]2CCCN2C(=O)CCN)CSSC[C@H](C(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4878061		Kd			CHEMBL2068	Homo sapiens	Kd		
	23285160	CHEMBL4838205	Inhibition of EPHA2 (unknown origin) by ELISA	B	CC(C)n1cc(C(=O)Nc2cc(F)c(-c3c[nH]c4ncnc(N)c34)cc2F)c(=O)c(-c2ccc(F)cc2)c1		CHEMBL4871361	>	IC50	nM	500.0	CHEMBL2068	Homo sapiens	IC50	nM	500.0
	23297800	CHEMBL4841280	Inhibition of EPHA2 (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	>	IC50	nM	1000.0	CHEMBL2068	Homo sapiens	IC50	nM	1000.0
Not Active	23317381	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	84.0	CHEMBL2068	Homo sapiens	% Control	%	84.0
Not Active	23317849	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	89.0	CHEMBL2068	Homo sapiens	% Control	%	89.0
Not Active	23318518	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	62.0	CHEMBL2068	Homo sapiens	% Control	%	62.0
Not Active	23318999	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	89.0	CHEMBL2068	Homo sapiens	% Control	%	89.0
Not Active	23319636	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23320111	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	97.8	CHEMBL2068	Homo sapiens	% Control	%	97.8
Not Active	23320789	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23321257	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23321887	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23322355	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23323044	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	95.0	CHEMBL2068	Homo sapiens	% Control	%	95.0
Not Active	23323512	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	94.0	CHEMBL2068	Homo sapiens	% Control	%	94.0
Not Active	23323995	CHEMBL4880614	EphA2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	13.0	CHEMBL2068	Homo sapiens	% inhibition	%	13.0
Not Active	23324366	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23325001	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	93.0	CHEMBL2068	Homo sapiens	% Control	%	93.0
Not Active	23325469	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23326116	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	91.0	CHEMBL2068	Homo sapiens	% Control	%	91.0
Not Active	23326584	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	80.0	CHEMBL2068	Homo sapiens	% Control	%	80.0
Not Active	23327284	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23327752	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	84.0	CHEMBL2068	Homo sapiens	% Control	%	84.0
Not Active	23328339	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	81.0	CHEMBL2068	Homo sapiens	% Control	%	81.0
Not Active	23328807	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	97.0	CHEMBL2068	Homo sapiens	% Control	%	97.0
Not Active	23329328	CHEMBL4881035	EphA2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	100.0	CHEMBL2068	Homo sapiens	% residual kinase activity	%	100.0
Not Active	23329753	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23330221	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23330977	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23331445	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23332032	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	79.6	CHEMBL2068	Homo sapiens	% Control	%	79.6
Not Active	23332498	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23333216	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23333855	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	76.0	CHEMBL2068	Homo sapiens	% Control	%	76.0
Not Active	23334323	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	80.0	CHEMBL2068	Homo sapiens	% Control	%	80.0
Not Active	23334889	CHEMBL4881513	EphA2 (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	4.0	CHEMBL2068	Homo sapiens	% inhibition	%	4.0
Not Active	23335302	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23335770	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23336397	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	79.0	CHEMBL2068	Homo sapiens	% Control	%	79.0
Not Active	23336865	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	92.0	CHEMBL2068	Homo sapiens	% Control	%	92.0
Not Active	23337580	CHEMBL4881951	EPHA2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	99.0	CHEMBL2068	Homo sapiens	% Ctrl	%	99.0
Not Active	23337946	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23338414	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	89.0	CHEMBL2068	Homo sapiens	% Control	%	89.0
Not Active	23339026	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	81.0	CHEMBL2068	Homo sapiens	% Control	%	81.0
Not Active	23339494	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	67.0	CHEMBL2068	Homo sapiens	% Control	%	67.0
Not Active	23340131	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23340599	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23341256	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23341724	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	94.0	CHEMBL2068	Homo sapiens	% Control	%	94.0
Not Active	23342340	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23342808	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	94.0	CHEMBL2068	Homo sapiens	% Control	%	94.0
Not Active	23343250	CHEMBL4882435	EPHA2 Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	85.0	CHEMBL2068	Homo sapiens	% Ctrl	%	85.0
Not Active	23343438	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23343906	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	95.0	CHEMBL2068	Homo sapiens	% Control	%	95.0
Not Active	23344544	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	93.0	CHEMBL2068	Homo sapiens	% Control	%	93.0
Not Active	23345117	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	80.0	CHEMBL2068	Homo sapiens	% Control	%	80.0
Not Active	23345585	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	71.0	CHEMBL2068	Homo sapiens	% Control	%	71.0
Not Active	23346162	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23346631	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23347239	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23347722	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23348301	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23348769	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23349356	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	84.0	CHEMBL2068	Homo sapiens	% Control	%	84.0
Not Active	23349974	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23350442	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23351047	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23351515	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23352031	CHEMBL4882722	EPHA2 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-4.26	CHEMBL2068	Homo sapiens	% Inhibition	%	-4.2599
Not Active	23352539	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	72.0	CHEMBL2068	Homo sapiens	% Control	%	72.0
Not Active	23353007	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23353889	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23354357	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23355089	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23355557	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23356193	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23356661	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23357270	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23357917	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	81.0	CHEMBL2068	Homo sapiens	% Control	%	81.0
Not Active	23358385	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23358971	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23359569	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	89.0	CHEMBL2068	Homo sapiens	% Control	%	89.0
Not Active	23360037	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	88.0	CHEMBL2068	Homo sapiens	% Control	%	88.0
Not Active	23360622	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23361090	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23361663	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23362199	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23362667	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	68.0	CHEMBL2068	Homo sapiens	% Control	%	68.0
Not Active	23363240	CHEMBL4883236	EPHA2 Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	-6.258	CHEMBL2068	Homo sapiens	% inhibition	%	-6.2584
Not Active	23363241	CHEMBL4883236	EPHA2 Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	-4.089	CHEMBL2068	Homo sapiens	% inhibition	%	-4.0887
Not Active	23364309	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23364777	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	92.0	CHEMBL2068	Homo sapiens	% Control	%	92.0
Not Active	23365516	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	92.0	CHEMBL2068	Homo sapiens	% Control	%	92.0
Not Active	23366059	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	80.0	CHEMBL2068	Homo sapiens	% Control	%	80.0
Not Active	23366649	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23367117	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	80.0	CHEMBL2068	Homo sapiens	% Control	%	80.0
Not Active	23367553	CHEMBL4883906	EPHA2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	119.0	CHEMBL2068	Homo sapiens	% Residual activity with Skepinone-L	%	119.0
Not Active	23367995	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	99.0	CHEMBL2068	Homo sapiens	% Control	%	99.0
Not Active	23368463	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23369062	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23369530	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23370050	CHEMBL4884294	EphA2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	88.0	CHEMBL2068	Homo sapiens	% residual kinase activity	%	88.0
Not Active	23370498	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	61.0	CHEMBL2068	Homo sapiens	% Control	%	61.0
Not Active	23370966	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	82.0	CHEMBL2068	Homo sapiens	% Control	%	82.0
Not Active	23371775	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23372243	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
	23373717	CHEMBL4885494	EphA2(EPA2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2068	Homo sapiens	pIC50		6.0
Not Active	23375235	CHEMBL4886217	EPH receptor A2  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	7.0	CHEMBL2068	Homo sapiens	% inhibition	%	7.0
Not Active	23375670	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	75.0	CHEMBL2068	Homo sapiens	% Control	%	75.0
Not Active	23376138	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	84.0	CHEMBL2068	Homo sapiens	% Control	%	84.0
Not Active	23376715	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23377184	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23378043	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	76.0	CHEMBL2068	Homo sapiens	% Control	%	76.0
Not Active	23378511	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23379678	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	83.0	CHEMBL2068	Homo sapiens	% Control	%	83.0
Not Active	23380146	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	86.0	CHEMBL2068	Homo sapiens	% Control	%	86.0
Not Active	23380840	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23381488	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	75.0	CHEMBL2068	Homo sapiens	% Control	%	75.0
Not Active	23381956	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	56.0	CHEMBL2068	Homo sapiens	% Control	%	56.0
Not Active	23382400	CHEMBL4887119	ECK Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		Inhibition	%	18.0	CHEMBL2068	Homo sapiens	% inhibition	%	18.0
Not Active	23382580	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	86.0	CHEMBL2068	Homo sapiens	% Control	%	86.0
Not Active	23383048	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	80.0	CHEMBL2068	Homo sapiens	% Control	%	80.0
Not Active	23383773	CHEMBL4887413	EPHA2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	93.0	CHEMBL2068	Homo sapiens	% Ctrl	%	93.0
Not Active	23383774	CHEMBL4887413	EPHA2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	63.0	CHEMBL2068	Homo sapiens	% Ctrl	%	63.0
Not Active	23384259	CHEMBL4887854	EphA2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-0.55	CHEMBL2068	Homo sapiens	% inhibition	%	-0.55
Not Active	23384649	CHEMBL4888175	EPHA2 SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1	Outside typical range	CHEMBL4795065		Inhibition	%	-12.0	CHEMBL2068	Homo sapiens	% Inhibition	%	-12.0
Not Active	23384963	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL2068	Homo sapiens	% Control	%	100.0
Not Active	23385430	CHEMBL4879687	KinomeScan assay: inhibition of EPHA2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	83.0	CHEMBL2068	Homo sapiens	% Control	%	83.0
Not Active	23385878	CHEMBL4888351	EphA2 Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	6.0	CHEMBL2068	Homo sapiens	% inhibition	%	6.0
